Independence Holding (IHC) 10-K 16 Mar 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Mar. 06, 2015	Jun. 30, 2014
Document and Entity Information
Entity Registrant Name	Independence Holding Company
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Entity Central Index Key	701869
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		17,352,918
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Entity Public Float			$107,255

INDEPENDENCE_HOLDING_COMPANY_C

INDEPENDENCE HOLDING COMPANY CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Investments:
Short-term investments	$50		$50
Securities purchased under agreements to resell	16,790		22,594
Trading securities	11,095		7,125
Fixed maturities, available-for-sale	583,880		542,287
Equity securities, available-for-sale	13,895		11,803
Other investments	25,251		25,123
Total investments	650,961		608,982
Cash and cash equivalents	25,083		24,229
Deferred acquisition costs	30,806		29,777
Due and unpaid premiums	62,628		59,435
Due from reinsurers	278,242		380,229
Premium and claim funds	32,553		37,353
Goodwill	50,318		50,318
Other assets	57,126		78,712
TOTAL ASSETS	1,187,717		1,269,035
LIABILITIES:
Policy benefits and claims	236,803		237,754
Future policy benefits	277,041		287,449
Funds on deposit	186,782		274,826
Unearned premiums	9,455		12,423
Other policyholders' funds	18,802		25,129
Due to reinsurers	47,945		37,113
Accounts payable, accruals and other liabilities	67,641		71,889
Debt	4,000		6,000
Junior subordinated debt securities	38,146		38,146
TOTAL LIABILITIES	886,615		990,729
IHC STOCKHOLDERS' EQUITY:
Preferred stock		[1]		[1]
Common Stock	18,531	[2],[3]	18,524	[2],[4]
Paid-in capital	127,098		126,239
Accumulated other comprehensive income (loss)	22		-10,472
Treasury stock, at cost	-12,141	[5]	-8,169	[6]
Retained earnings	157,667		142,669
TOTAL IHC STOCKHOLDERS' EQUITY	291,177		268,791
NONCONTROLLING INTERESTS IN SUBSIDIARIES	9,925		9,515
TOTAL EQUITY	301,102		278,306
TOTAL LIABILITIES AND EQUITY	$1,187,717		$1,269,035
[1]	None issued.
[2]	$1.00 par value.
[3]	23,000,000 shares authorized, 18,531,158 shares issued and 17,371,040 shares outstanding.
[4]	23,000,000 shares authorized, 18,523,733 shares issued and 17,660,390 shares outstanding.
[5]	1,160,118 treasury shares
[6]	863,343 treasury shares

INDEPENDENCE_HOLDING_COMPANY_C1

INDEPENDENCE HOLDING COMPANY CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
STATEMENT OF FINANCIAL POSITION
Preferred Stock, shares issued	0	0
Common Stock, par value	$1	$1
Common Stock, shares authorized	23,000,000	23,000,000
Common Stock, shares issued	18,531,158	18,523,733
Common Stock, shares outstanding	17,371,040	17,660,390
Treasury Stock, shares	1,160,118	863,343

INDEPENDENCE_HOLDING_COMPANY_C2

INDEPENDENCE HOLDING COMPANY CONSOLIDATED STATEMENTS OF INCOME (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
REVENUES:
Premiums earned	$479,048	$495,991	$356,067
Net investment income	21,692	27,471	33,356
Fee income	20,646	26,954	29,290
Other income	4,859	4,878	4,953
Net realized investment gains	7,688	19,750	5,099
Other-than-temporary impairment losses:
Total other-than-temporary impairment losses			-992
Portion of losses recognized in other comprehensive income			288
Net impairment losses recognized in earnings			-704
TOTAL REVENUES	533,933	575,044	428,061
EXPENSES:
Insurance benefits, claims and reserves	326,035	354,790	244,791
Selling, general and administrative expenses	177,848	179,553	149,999
Amortization of deferred acquisition costs	4,941	15,132	6,566
Interest expense on debt	1,797	1,915	2,091
TOTAL EXPENSES	510,621	551,390	403,447
Income (loss) before income taxes	23,312	23,654	24,614
Income taxes (benefits)	6,391	8,398	2,003
Net income (loss)	16,921	15,256	22,611
(Income) loss from noncontrolling interests in subsidiaries	-628	-1,477	-2,950
NET INCOME (LOSS) ATTRIBUTABLE TO IHC	$16,293	$13,779	$19,661
Basic income (loss) per common share	$0.93	$0.78	$1.09
WEIGHTED AVERAGE SHARES OUTSTANDING	17,471	17,758	17,979
Diluted income (loss) per common share	$0.92	$0.77	$1.09
WEIGHTED AVERAGE DILUTED SHARES OUTSTANDING	17,636	17,871	18,088

INDEPENDENCE_HOLDING_COMPANY_C3

INDEPENDENCE HOLDING COMPANY CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
STATEMENT OF COMPREHENSIVE INCOME
Net income (loss)	$16,921	$15,256	$22,611
Unrealized gains (losses) on available-for-sale securities	15,389	-38,439	11,115
Tax (benefit) on unrealized gains (losses) on available-for-sale securities	4,768	-12,252	3,672
Unrealized gains (losses) on available-for-sale securities, net of tax	10,621	-26,187	7,443
Portion of losses recognized in other comprehensive income			-288
Tax benefit on other-than-temporary impairment losses			-41
Portion of losses recognized in other comprehensive income, net of tax			-247
Unrealized gains (losses) on cash flow hedge, pre-tax	120	159	131
Tax (benefit) on unrealized gains (losses) on cash flow hedge	48	63	52
Unrealized gains (losses) on cash flow hedge, net of taxes	72	96	79
Other comprehensive income (loss), net of tax	10,693	-26,091	7,275
Comprehensive income (loss), net of tax	27,614	-10,835	29,886
(Income) loss from noncontrolling interests in subsidiaries	-628	-1,477	-2,950
Net unrealized (gains) losses on available-for-sale securities, net of tax, attributable to noncontrolling interests	-199	665	-118
Other comprehensive (income) loss, net of tax, attributable to noncontrolling interests	-199	665	-118
Comprehensive (income) loss, net of tax, attributable to noncontrolling interests	-827	-812	-3,068
Comprehensive income (loss), net of tax, attributable to IHC	$26,787	($11,647)	$26,818

INDEPENDENCE_HOLDING_COMPANY_C4

INDEPENDENCE HOLDING COMPANY CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (USD $)	COMMON STOCK	PAID-IN CAPITAL	ACCUMULATED OTHER COMPREHENSIVE INCOME(LOSS)	TREASURY STOCK, AT COST	RETAINED EARNINGS	TOTAL IHC STOCKHOLDERS' EQUITY		NON-CONTROLLING INTERESTS	Total
In Thousands, except Share data
Stockholders Equity, Value at Dec. 31, 2011	$18,451	$126,298	$7,853	($3,277)	$111,752	$261,077		$15,067	$276,144
Stockholders Equity, Shares at Dec. 31, 2011	18,450,917			-398,257
Net income (loss)					19,661	19,661		2,950	22,611
Other comprehensive income (loss), net of tax			7,157			7,157		118	7,275
Repurchases of common stock, Value				-1,256		-1,256			-1,256
Repurchases of common stock, Shares				-130,781
Purchases of noncontrolling interests		29	3			32		-90	-58
Common stock dividend					-1,271	-1,271	[1]		-1,271	[1]
Share-based compensation and related tax effects, Value	11	233				244			244
Share-based compensation and related tax effects, Shares	11,075
Distributions to noncontrolling interests								-890	-890
Other capital transactions		29			11	40		8	48
Stockholders Equity, Value at Dec. 31, 2012	18,462	126,589	15,013	-4,533	130,153	285,684		17,163	302,847
Stockholders Equity, Shares at Dec. 31, 2012	18,461,992			-529,038
Net income (loss)					13,779	13,779		1,477	15,256
Other comprehensive income (loss), net of tax			-25,426			-25,426		-665	-26,091
Repurchases of common stock, Value				-3,636		-3,636			-3,636
Repurchases of common stock, Shares				-334,305
Purchases of noncontrolling interests		-1,168	-59			-1,227		-7,598	-8,825
Common stock dividend					-1,241	-1,241	[1]		-1,241	[1]
Share-based compensation and related tax effects, Value	62	792				854			854
Share-based compensation and related tax effects, Shares	61,741
Distributions to noncontrolling interests								-888	-888
Other capital transactions		26			-22	4		26	30
Stockholders Equity, Value at Dec. 31, 2013	18,524	126,239	-10,472	-8,169	142,669	268,791		9,515	278,306
Stockholders Equity, Shares at Dec. 31, 2013	18,523,733			-863,343
Net income (loss)					16,293	16,293		628	16,921
Other comprehensive income (loss), net of tax			10,494			10,494		199	10,693
Repurchases of common stock, Value				-3,972		-3,972			-3,972
Repurchases of common stock, Shares				-296,775
Common stock dividend					-1,223	-1,223	[1]		-1,223	[1]
Share-based compensation and related tax effects, Value	7	756				763			763
Share-based compensation and related tax effects, Shares	7,425
Distributions to noncontrolling interests								-472	-472
Other capital transactions		103			-72	31		55	86
Stockholders Equity, Value at Dec. 31, 2014	$18,531	$127,098	$22	($12,141)	$157,667	$291,177		$9,925	$301,102
Stockholders Equity, Shares at Dec. 31, 2014	18,531,158			-1,160,118
[1]	$0.07 per share

INDEPENDENCE_HOLDING_COMPANY_C5

INDEPENDENCE HOLDING COMPANY CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS PROVIDED BY (USED BY) OPERATING ACTIVITIES:
Net income (loss)	$16,921	$15,256	$22,611
Adjustments to reconcile net income to net change in cash from operating activities:
Amortization of deferred acquisition costs	4,941	15,132	6,566
Net realized investment gains	-7,688	-19,750	-5,099
Net impairment losses recognized in earnings			704
Equity income from equity method investments	-1,106	-2,506	-1,435
Depreciation and amortization	3,932	4,577	4,228
Share-based compensation expense	820	1,001	832
Deferred tax expense (benefits)	5,628	8,692	-1,200
Other adjustments to reconcile net income	8,629	4,573	7,010
Changes in assets and liabilities:
Net sales (purchases) of trading securities	-4,719	1,603	-1,289
Change in insurance liabilities	-94,876	36,136	-137,440
(Additions) reductions to deferred acquisition costs, net	-6,223	-5,827	-5,795
Change in amount due from reinsurers	101,987	-213,349	1,011
Change in premium and claim funds	4,800	3,243	3,008
Change in current income tax liability	2,241	-951	1,673
Change in due and unpaid premiums	-3,193	-10,005	-12,089
Change in other assets	2,580	-219	-1,807
Change in other liabilities	-7,343	78	3,117
Net change in cash from operating activities	27,331	-162,316	-115,394
CASH FLOWS PROVIDED BY (USED BY) INVESTING ACTIVITIES:
Net sales (purchases) of securities under resale and repurchase agreements	5,804	11,362	-16,698
Sales of equity securities	288	11,529	14,689
Purchases of equity securities	-1,228	-7,517	-7,354
Sales of fixed maturities	353,143	551,756	483,092
Maturities and other repayments of fixed maturities	45,091	57,090	74,416
Purchases of fixed maturities	-421,285	-462,823	-412,753
Change in other investments			1,080
Cash paid in acquisitions of companies, net of cash acquired			-243
Other investing activites	2,334	20,292	-13,362
Net change in cash from investing activities	-15,853	181,689	122,867
CASH FLOWS PROVIDED BY (USED BY) FINANCING ACTIVITIES:
Payments for repurchases of common stock	-3,972	-3,636	-1,244
Cash paid in acquisitions of noncontrolling interests		-8,825	-58
Proceeds (withdrawals) of investment-type insurance contracts	-2,988	-3,262	3,320
Repayment of long-term debt	-2,000	-2,000	-2,000
Dividends paid	-1,233	-620	-1,681
Proceeds from exercise of stock options		430
Other financing activities	-431	-1,176	-92
Net change in cash from financing activities	-10,624	-19,089	-1,755
Net change in cash and cash equivalents	854	284	5,718
Cash and cash equivalents, beginning of period	24,229	23,945	18,227
Cash and cash equivalents, end of period	$25,083	$24,229	$23,945

Note_1_Organization_Consolidat

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies	12 Months Ended
	Dec. 31, 2014
Notes
Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies	Note 1.            Organization, Consolidation, Basis of Presentation and Accounting Policies
	(A)       Business and Organization
	Independence Holding Company, a Delaware corporation (“IHC”), is a holding company principally engaged in the life and health insurance business through: (i) its insurance companies, Standard Security Life Insurance Company of New York ("Standard Security Life"),  Madison National Life Insurance Company, Inc. ("Madison National Life"), Independence American Insurance Company (“Independence American”); and (ii) its marketing and administrative companies, including IHC Risk Solutions, LLC, IHC Health Solutions, Inc., IHC Specialty Benefits Inc. and IHC Carrier Solutions, Inc.  IHC also owns a significant equity interest in a managing general underwriter (“MGU”) that writes medical stop-loss. Standard Security Life, Madison National Life and Independence American are sometimes collectively referred to as the “Insurance Group”. IHC and its subsidiaries (including the Insurance Group) are sometimes collectively referred to as the "Company", or “IHC”, or are implicit in the terms “we”, “us” and “our”.
	Geneve Corporation, a diversified financial holding company, and its affiliated entities, held 52.7% of IHC's outstanding common stock at December 31, 2014.
	(B)       Consolidation
	American Independence Corp
	At December 31, 2014, the Company owned approximately 90% of the outstanding common stock of American Independence Corp. ("AMIC"). AMIC is an insurance holding company engaged in the insurance and reinsurance business. The Company has increased its ownership in AMIC through various transactions described below. Because IHC had a controlling interest in AMIC prior to these transactions, these purchases and acquisitions were accounted for as equity transactions. Accordingly, any differences between the fair value of the consideration paid and the carrying value of the noncontrolling interests acquired were recognized as changes in IHC’s equity.
	In 2013, IHC’s ownership in AMIC increased to 90% as a result of: (i) share repurchases by AMIC; and (ii) a tender offer whereby IHC purchased tendered shares of AMIC common stock for cash.
	In 2012, IHC purchased shares of AMIC common stock increasing its ownership interest in AMIC to 78.6% as of December 31, 2012.
	Effects of Ownership Changes in Subsidiaries
	The following table summarizes the effects of any changes in the Company’s ownership interests in its subsidiaries on the equity attributable to IHC for the years indicated (in thousands).
			2014		2013		2012
	Changes in IHC’s paid-in capital:
	Purchases of AMIC shares	$	-	$	(1,571)	$	29
	Repurchases of shares by AMIC		-		403		-
	Net transfers from noncontrolling interests	$	-	$	(1,168)	$	29
	(C)       Basis of Presentation
	The Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect:  (i) the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements; and (ii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	(D)       Reclassifications
	Certain amounts in prior year’s Consolidated Financial Statements and Notes thereto have been reclassified to conform to the 2014 presentation.
	(E)       Cash Equivalents and Short-Term Investments
	Cash equivalents are carried at cost which approximates fair value and include principally interest-bearing deposits at brokers, money market instruments and U.S. Treasury securities with original maturities of less than 91 days.  Investments with original maturities of 91 days to one year are considered short-term investments and are carried at cost which approximates fair value.
	(F)        Securities Purchased Under Agreements to Resell
	Securities purchased under agreements to resell ("resale agreements") are carried at the amounts at which the securities will be subsequently resold as specified in the agreements. Resale agreements are utilized to invest excess funds on a short-term basis. At December 31, 2014, the Company had $16,790,000 invested in resale agreements, all of which settled on January 2, 2015 and were subsequently reinvested. The Company maintains control of securities purchased under resale agreements, values the collateral on a daily basis and obtains additional collateral, if necessary, to protect the Company in the event of default by the counterparties.
	(G)        Investment Securities
	(i) Investments in fixed maturities, redeemable preferred securities and equity securities are accounted for as follows:
	(a) Securities which are held for trading purposes are carried at estimated fair value ("fair value").  Changes in fair value are credited or charged, as appropriate, to net realized investment gains (losses) in the Consolidated Statements of Income.
	(b) Securities not held for trading purposes which may or may not be held to maturity ("available-for-sale securities") are carried at fair value. Unrealized gains and losses deemed temporary, net of deferred income taxes and adjustments to deferred policy acquisition costs, are credited or charged, as appropriate, to other comprehensive income or loss. Premiums and discounts on debt securities purchased at other than par value are amortized and accreted, respectively, to interest income in the Consolidated Statements of Income, using the constant yield method over the period to maturity.
	(ii) Gains or losses on sales of securities are determined on the basis of specific identification and are recorded in net realized investment gains (losses) in the Consolidated Statements of Income on the trade date.
	(iii) Fair value is determined using quoted market prices when available. In some cases, we use quoted market prices for similar instruments in active markets and/or model-derived valuations where inputs are observable in active markets. When there are limited or inactive trading markets, we use industry-standard pricing methodologies, including discounted cash flow models, whose inputs are based on management assumptions and available current market information. Further, we retain independent pricing vendors to assist in valuing certain instruments. Most of the securities in our portfolio are classified in either Level 1 or Level 2 of the Fair Value Hierarchy.
	The Company periodically reviews and assesses the vendor’s qualifications and the design and appropriateness of its pricing methodologies.  Management will on occasion challenge pricing information on certain individual securities and, through communications with the vendor, obtain information about the assumptions, inputs and methodologies used in pricing those securities, and corroborate it against documented pricing methodologies. Validation procedures are in place to determine completeness and accuracy of pricing information, including, but not limited to: (i) review of exception reports that (a) identify any zero or un-priced securities; (b) identify securities with no price change; and (c) identify securities with significant price changes; (ii) performance of trend analyses; (iii) periodic comparison of pricing to alternative pricing sources; and (iv) comparison of pricing changes to expectations based on rating changes, benchmarks or control groups.  In certain circumstances, pricing is unavailable from the vendor and broker pricing information is used to determine fair value. In these instances, management will assess the quality of the data sources, the underlying assumptions and the reasonableness of the broker quotes based on the current market information available. To determine if an exception represents an error, management will often have to exercise judgment. Procedures to resolve an exception vary depending on the significance of the security and its related class, the frequency of the exception, the risk of material misstatement, and the availability of information for the security. These procedures include, but are not limited to; (i) a price challenge process with the vendor; (ii) pricing from a different vendor; (iii) a reasonableness review;  and (iv) a change in price based on better information, such as an actual market trade, among other things.  Management considers all facts and relevant information obtained during the above procedures to determine the proper classification of each security in the Fair Value Hierarchy.
	(iv) The Company reviews its investment securities regularly and determines whether other-than-temporary impairments have occurred. The factors considered by management in its regular review to identify and recognize other-than-temporary impairment losses on fixed maturities include, but are not limited to:  the length of time and extent to which the fair value has been less than cost; the Company's intent to sell, or be required to sell, the debt security before the anticipated recovery of its remaining amortized cost basis; the financial condition and near-term prospects of the issuer; adverse changes in ratings announced by one or more rating agencies; subordinated credit support; whether the issuer of a debt security has remained current on principal and interest payments; current expected cash flows; whether the decline in fair value appears to be issuer specific or, alternatively, a reflection of general market or industry conditions including the effect of changes in market interest rates. If the Company intends to sell a debt security, or it is more likely than not that it would be required to sell a debt security before the recovery of its amortized cost basis, the entire difference between the security's amortized cost basis and its fair value at the balance sheet date would be recognized by a charge to total other-than-temporary impairment losses in the Consolidated Statement of Income.  If a decline in fair value of a debt security is judged by management to be other-than-temporary and; (i) the Company does not intend to sell the security; and (ii) it is not more likely than not that it will be required to sell the security prior to recovery of the security’s amortized cost, the Company assesses whether the present value of the cash flows to be collected from the security is less than its amortized cost basis. To the extent that the present value of the cash flows generated by a debt security is less than the amortized cost basis, a credit loss exists. For any such security, the impairment is bifurcated into (a) the amount of the total impairment related to the credit loss, and (b) the amount of the total impairment related to all other factors. The amount of the other-than-temporary impairment related to the credit loss is recognized by a charge to total other-than-temporary impairment losses in the Consolidated Statement of Income, establishing a new cost basis for the security. The amount of the other-than-temporary impairment related to all other factors is recognized in other comprehensive income (loss). It is reasonably possible that further declines in estimated fair values of such investments, or changes in assumptions or estimates of anticipated recoveries and/or cash flows, may cause further other-than-temporary impairments in the near term, which could be significant.
	In assessing corporate debt securities for other-than-temporary impairment, the Company evaluates the ability of the issuer to meet its debt obligations and the value of the company or specific collateral securing the debt position. For mortgage-backed securities where loan level data is not available, the Company uses a cash flow model based on the collateral characteristics. Assumptions about loss severity and defaults used in the model are primarily based on actual losses experienced and defaults in the collateral pool. Prepayment speeds, both actual and estimated, are also considered. The cash flows generated by the collateral securing these securities are then determined with these default, loss severity and prepayment assumptions. These collateral cash flows are then utilized, along with consideration for the issue’s position in the overall structure, to determine the cash flows associated with the mortgage-backed security held by the Company. In addition, the Company evaluates other asset-backed securities for other-than-temporary impairment by examining similar characteristics referenced above for mortgage-backed securities.  The Company evaluates U.S. Treasury securities and obligations of U.S. Government corporations, U.S. Government agencies, and obligations of states and political subdivisions for other-than-temporary impairment by examining the terms and collateral of the security.
	Equity securities may experience other-than-temporary impairment in the future based on the prospects for full recovery in value in a reasonable period of time and the Company’s ability and intent to hold the security to recovery. If a decline in fair value is judged by management to be other-than-temporary or management does not have the intent or ability to hold a security, a loss is recognized by a charge to total other-than-temporary impairment losses in the Consolidated Statement of Income. For the purpose of other-than-temporary impairment evaluations, redeemable preferred stocks are evaluated in a manner similar to debt securities. Declines in the creditworthiness of the issuer of debt securities with both debt and equity-like features are evaluated using the equity model in consideration of other-than-temporary impairment.
	Subsequent increases and decreases, if not an other-than-temporary impairment, in the fair value of available-for-sale securities that were previously impaired, are recorded in other comprehensive income (loss).
	(H)       Other Investments
	Investment partnership interests relate to limited investment partnerships that are relatively insensitive to interest rates. All securities held by these partnerships are carried at fair value with changes in fair value credited or charged, as appropriate, to the Consolidated Statements of Income. The Company's investment partnership interests are carried at a value which approximates the Company's equity in the underlying net assets of the partnerships or the equivalent of the net asset value per share. Operating partnership interests relate to insurance related limited operating partnerships. The Company's operating partnership interests are carried on the equity method which approximates the Company's equity in the underlying net assets of the partnership. Equity income or loss on partnership interests are credited or charged, as appropriate, to the Consolidated Statements of Income.
	Policy loans are stated at their aggregate unpaid balances.
	(I)        Deferred Acquisition Costs ("DAC")
	Costs that vary with and are primarily related to the successful acquisition of insurance policies and investment type contracts are deferred and recorded as deferred policy acquisition costs ("DAC").  These costs are principally broker fees, agent commissions, and the purchase prices of the acquired blocks of insurance policies and investment type policies. DAC is amortized to expense and reported separately in the Consolidated Statements of Income. All DAC within a particular product type is amortized on the same basis using the following methods:
	For traditional life insurance and other premium paying policies, amortization of DAC is charged to expense over the related premium revenue recognition period.  Assumptions used in the amortization of DAC are determined based upon the conditions as of the date of policy issue or assumption and are not generally revised during the life of the policy.
	For long duration type contracts, such as annuities and universal life business, amortization of DAC is charged to expense over the life of the underlying contracts based on the present value of the estimated gross profits ("EGPs") expected to be realized over the life of the book of contracts.  EGPs consist of margins based on expected mortality rates, persistency rates, interest rate spreads, and other revenues and expenses. The Company regularly evaluates its EGPs to determine if actual experience or other evidence suggests that earlier estimates should be revised. If the Company determines that the current assumptions underlying the EGPs are no longer the best estimate for the future due to changes in actual versus expected mortality rates, persistency rates,  interest rate spreads, or other revenues and expenses,  the future EGPs are updated using the new assumptions and prospective unlocking occurs.  These updated EGPs are utilized for future amortization calculations.   The total amortization recorded to date is adjusted through a current charge or credit to the Consolidated Statements of Income.
	Internal replacements of insurance and investment contracts determined to result in a  replacement contract that is substantially changed from the original contract will be accounted for as an extinguishment of the original contract, resulting in a release of the unamortized deferred acquisition costs, unearned revenue, and deferral of sales inducements associated with the replaced contract.
	Deferred acquisition costs have been increased (decreased) by $(323,000), $5,681,000 and $(2,930,000) in 2014, 2013 and 2012 respectively, representing the amortization of DAC due to unrealized gains and losses on investment securities available-for-sale. A corresponding increase or decrease was recorded in other comprehensive income or loss.
	(J)        Property and Equipment
	Property and equipment of $3,086,000 and $3,815,000 are included in other assets at December 31, 2014 and 2013, respectively, net of accumulated depreciation and amortization of $14,030,000 and $13,090,000, respectively.
	Improvements are capitalized while repair and maintenance costs are charged to operations as incurred. Depreciation of property and equipment has been provided on the straight-line method over the estimated useful lives of the respective assets. Amortization of leasehold improvements has been provided on the straight-line method over the shorter of the lease term or the estimated useful life of the asset.
	(K)       Goodwill and Other Intangible Assets
	Goodwill carrying amounts are evaluated for impairment at the reporting unit level, which is equivalent to an operating segment, at least annually. If the fair value of a reporting unit is less than its carrying amount, further evaluation is required to determine if a write-down of goodwill is required. In determining the fair value of each reporting unit, we used an income approach, applying a discounted cash flow method which included a residual value.  Based on historical experience, we make assumptions as to: (i) expected future performance and future economic conditions, (ii) projected operating earnings, (iii) projected new and renewal business as well as profit margins on such business, and (iv) a discount rate that incorporated an appropriate risk level for the reporting unit. Any impairment of goodwill would be charged to expense.
	Other intangible assets are amortized to expense over their estimated useful lives and are subject to impairment testing. Any impairment of other intangible assets would be charged to expense.
	(L)      Insurance Liabilities
	The Company maintains loss reserves to cover its estimated liability for unpaid losses and loss adjustment expenses, where material, including legal, other fees, and costs not associated with specific claims but related to the claims payment function), for reported and unreported claims incurred as of the end of each accounting period.  These loss reserves are based on actuarial assumptions and are maintained at levels that are in accordance with U.S. GAAP.  Many factors could affect these reserves, including economic and social conditions, frequency and severity of claims, medical trend resulting from the influences of underlying cost inflation, changes in utilization and demand for medical services, and changes in doctrines of legal liability and damage awards in litigation. Therefore, the Company’s reserves are necessarily based on estimates, assumptions and analysis of historical experience. The Company’s results depend upon the variation between actual claims experience and the assumptions used in determining reserves and pricing products. Reserve assumptions and estimates require significant judgment and, therefore, are inherently uncertain. The Company cannot determine with precision the ultimate amounts that will be paid for actual claims or the timing of those payments. The Company's estimate of loss represents management's best estimate of the Company's liability at the balance sheet date.
	Loss reserves differ for short-duration and long-duration insurance policies, including annuities. Reserves are based on approved actuarial methods, but necessarily include assumptions about expenses, mortality, morbidity, lapse rates and future yield on related investments.
	Policy Benefits and Claims
	All of the Company’s short-duration contracts are generated from its accident, health, disability and pet insurance business, and are accounted for based on actuarial estimates of the amount of loss inherent in that period’s claims, including losses incurred for which claims have not been reported. Short-duration contract loss estimates rely on actuarial observations of ultimate loss experience for similar historical events.
	Medical Stop-Loss
	Liabilities for policy benefits and claims on medical stop-loss coverage are computed using completion factors and expected Net Loss Ratios derived from actual historical premium and claim data. Policy benefits and claims for medical stop-loss insurance are more volatile in nature than those for fully insured medical insurance.  This is primarily due to the excess nature of medical stop-loss, with very high deductibles applying to specific claims on any individual claimant and in the aggregate for a given group.  The level of these deductibles makes it more difficult to predict the amount and payment pattern of such claims.  Furthermore, these excess claims are highly sensitive to changes in factors such as medical trend, provider contracts and medical treatment protocols, adding to the difficulty in predicting claim values and estimating reserves.  Also, because medical stop-loss is in excess of an underlying benefit plan, there is an additional layer of claim reporting and processing that can affect claim payment patterns.  Finally, changes in the distribution of business by effective month can affect reserve estimates due to the timing of claim occurrences and the time required to accumulate claims against the stop-loss deductible.
	The two “primary” or “key” assumptions underlying the calculation of policy benefits and claims for Medical Stop-Loss business are (i) projected Net Loss Ratio, and (ii) claim development patterns.  The projected Net Loss Ratio is set at expected levels consistent with the underlying assumptions (“Projected Net Loss Ratio”). Claim development patterns are set quarterly as reserve estimates are developed and are based on recent claim development history (“Claim Development Patterns”).  The Company uses the Projected Net Loss Ratio to establish reserves until developing losses provide a better indication of ultimate results and it is feasible to set reserves based on Claim Development Patterns. The Company has concluded that a reasonably likely change in the Projected Net Loss Ratio assumption could have a material effect on the Company’s financial condition, results of operations, or liquidity (“Material Effect”) but a reasonably likely change in the Claim Development Pattern would not have a Material Effect.
	Projected Net Loss Ratio
	Generally, during the first twelve months of an underwriting year, policy benefits for Medical Stop-Loss are first set at the Projected Net Loss Ratio, which is set using assumptions developed using completed prior experience trended forward. The Projected Net Loss Ratio is the Company’s best estimate of future performance until such time as developing losses provide a better indication of ultimate results.
	Major factors that affect the Projected Net Loss Ratio assumption in reserving for Medical Stop-Loss relate to: (i) frequency and severity of claims; (ii) changes in medical trend resulting from the influences of underlying cost inflation, changes in utilization and demand for medical services, the impact of new medical technology and changes in medical treatment protocols; and (iii) the adherence to the Company’s underwriting guidelines.
	Claim Development Patterns
	Subsequent to the first twelve months of an underwriting year, the Company’s developing losses provide a better indication of ultimate losses. At this point, claims have developed to a level where Claim Development Patterns can be applied to generate reasonably reliable estimates of ultimate claim levels.  Development factors based on historical patterns are applied to paid and reported claims to estimate fully developed claims. Claim Development Patterns are reviewed quarterly as reserve estimates are developed and are based on recent claim development history. The Company must determine whether changes in development represent true indications of emerging experience or are simply due to random claim fluctuations.
	The Company also establishes its best estimates of claim development factors to be applied to more developed treaty year experience.  While these factors are based on historical Claim Development Patterns, actual claim development may vary from these estimates.
Predicting ultimate claims and estimating reserves in Medical Stop-Loss is more complex than fully insured medical and disability business due to the “excess of loss” nature of these products with very high deductibles applying to specific claims on any individual claimant and in the aggregate for a given group.  The level of these deductibles makes it more difficult to predict the amount and payment pattern of such claims.  Fluctuations in results for specific coverage are primarily due to the severity and frequency of individual claims, whereas fluctuations in aggregate coverage are largely attributable to frequency of underlying claims rather than severity. Liabilities for first dollar medical reserves and disability coverages are computed using completion factors and expected Net Loss Ratios derived from actual historical premium and claim data.
Due to the short-term nature of Medical Stop-Loss, redundancies or deficiencies will typically emerge during the course of the following year rather than over a number of years.  For Employer Stop-Loss, as noted above, the Company maintains its reserves based on underlying assumptions until it determines that an adjustment is appropriate based on emerging experience from all of its MGUs for prior underwriting years.
Fully Insured Health
Policy benefits and claims for Fully Insured Health business are established to provide for the liability for incurred but not paid claims.  Policy benefits and claims are calculated using standard actuarial methods and practices. The “primary” assumption in the determination of Fully Insured Health reserves is that historical Claim Development Patterns are representative of future Claim Development Patterns. Factors which may affect this assumption include changes in claim payment processing times and procedures, changes in time delay in submission of claims, and the incidence of unusually large claims. Liabilities for policy benefits and claims for fully insured medical and disability coverage are computed using completion factors and expected Net Loss Ratios derived from actual historical premium and claim data.  The reserving analysis includes a review of claim processing statistical measures and large claim early notifications; the potential impacts of any changes in these factors are not material. The delay in submission of claims tends to be stable over time and not subject to significant volatility.
While these calculations are based on standard methodologies, they are estimates based on historical patterns.  To the extent that actual claim payment patterns differ from historical patterns, such estimated reserves may be redundant or inadequate.  The effects of such deviations are evaluated by considering claim backlog statistics and reviewing the reasonableness of projected claim ratios.  Other factors which may affect the accuracy of policy benefits and claim estimates include the proportion of large claims which may take longer to adjudicate, changes in billing patterns by providers and changes in claim management practices such as hospital bill audits.
Long Term Disability
Policy benefits and claims for the Company’s long term disability products are developed using actuarial principles and assumptions that consider, among other things, future offsets and recoveries, elimination periods, interest rates, probability of rehabilitation or mortality, incidence and termination rates based on the Company’s experience.  The liability for policy benefits and claims is made up of case reserves, incurred but not reported reserves, reopen reserves, and loss adjustment expense.  Incurred but not reported and reopen reserves are calculated by a hind-sight study, which takes historical experience and develops the reserve as a percentage of premiums from prior years.
The two “primary” assumptions on which long term disability reserves are based are: (i) morbidity levels; and (ii) recovery rates. If morbidity levels increase, for example due to an epidemic or a recessionary environment, the Company would increase reserves because there would be more new claims than expected.  In regard to the assumed recovery rate, if disabled lives recover more quickly than anticipated then the existing claims reserves would be reduced; if less quickly, the existing claims reserves would be increased.
Management believes that the Company's methods of estimating the liabilities for policy benefits and claims provided appropriate levels of reserves at December 31, 2014 and 2013. Changes in the Company's policy benefits and claims estimates are generally recorded through a charge or credit to its earnings.
Future Policy Benefits
The liability for future policy benefits consists of the liabilities associated with the Company’s long-duration contracts, primarily its life and annuity products. For traditional life insurance products, the Company computes the liability for future policy benefits primarily using the net premium method based on anticipated investment yield, mortality, and withdrawals. These methods are widely used in the life insurance industry to estimate the liabilities for future policy benefits. Inherent in these calculations are management and actuarial judgments and estimates that could significantly impact the ending reserve liabilities and, consequently, operating results.  Actual results may differ, and these estimates are subject to interpretation and change.
Management believes that the Company's methods of estimating the liabilities for future policy benefits provided appropriate levels of reserves at December 31, 2014 and 2013. Changes in the Company's future policy benefits estimates are recorded through a charge or credit to its earnings.
Funds on Deposit
Funds received (net of mortality and expense charges) for certain long-duration contracts (principally deferred annuities and universal life policies) are credited directly to a policyholder liability account, funds on deposit. Withdrawals are recorded directly as a reduction of respective policyholders' funds on deposit. Amounts on deposit were credited at annual rates ranging from 3.0% to 8.0% in 2014, 2.5% to 8.0% in 2013, and 2.7% to 8.0% in 2012.
Other Policyholders’ Funds
Other policyholders’ funds represent interest-bearing liabilities arising from the sale of products, such as universal life, interest-sensitive life and annuities.  Policyholder funds are primarily comprised of deposits received and interest credited to the benefit of the policyholder less surrenders and withdrawals, mortality charges and administrative expenses.
Interest credited to policyholder funds represents interest accrued or paid on interest-sensitive life policies and investment policies.  These amounts are reported in insurance benefits, claims and reserves on the Consolidated Statements of Income.  Credit rates for certain annuities and interest-sensitive life policies are adjusted periodically by the Company to reflect current market conditions, subject to contractually guaranteed minimum rates.
(M)      Derivative Instruments
All derivatives, whether designated in hedging relationships or not, are required to be recorded in the balance sheet as assets or liabilities at fair value. Hedge accounting is permitted only if certain criteria are met, including a requirement that a highly effective relationship exist between the derivative instrument and the hedged item, both at inception of the hedge and on an ongoing basis. Results of effective hedges are recognized in other comprehensive income or loss for cash flow hedges. The ineffective portions of hedge results are recognized in current earnings.
At December 31, 2014, the Company had an interest rate swap agreement that converts an outstanding term loan from a variable rate to a fixed rate. This agreement was designated and effective as a cash flow hedge. The objective of the swap is to reduce the variability in cash flows associated with the re-pricing of interest rates on certain variable rate debt. Changes in fair value of the swap were recorded through other comprehensive income or loss.
(N)       Deferred Income Taxes
The provision for deferred income taxes is based on the asset and liability method of accounting for income taxes. Under this method, deferred income taxes are recognized by applying enacted statutory tax rates to temporary differences between amounts reported in the Consolidated Financial Statements and the tax bases of existing assets and liabilities in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is recognized for the portion of deferred tax assets that, in management's judgment, is not likely to be realized.  A liability for uncertain tax positions is recorded when it is more likely than not that a tax position will not be sustained upon examination by taxing authorities. The effect on deferred income taxes of a change in tax rates or laws is recognized in income tax expense in the period that includes the enactment date.
Interest and penalties are classified as other interest expense and are included in selling, general and administrative expenses in the Consolidated Statements of Income.
(O)     Reinsurance
Amounts paid for or recoverable under reinsurance contracts are included in total assets or total liabilities as due from reinsurers or due to reinsurers. The cost of reinsurance related to long-duration contracts is accounted for over the life of the underlying reinsured policies using assumptions consistent with those used to account for the underlying policies.
(P)       Insurance Premium Revenue Recognition and Policy Charges
Premiums from short-duration medical insurance contracts are intended to cover expected claim costs resulting from insured events that occur during a fixed period of short duration.  The Company has the ability to not renew the contract or to revise the premium rates at the end of each annual contract period to cover future insured events.  Insurance premiums from annual health contracts are collected monthly and are recognized as revenue evenly as insurance protection is provided.
Premiums related to long-term and short-term disability contracts are recognized on a pro rata basis over the applicable contract term.
Traditional life insurance products consist principally of products with fixed and guaranteed premiums and benefits, primarily term and whole life insurance products.  Revenue from these products are recognized as premium when due.
Annuities and interest-sensitive life contracts, such as universal life and interest sensitive whole life, are contracts whose terms are not fixed and guaranteed.  Premiums from these policies are reported as funds on deposit.  Policy charges consist of fees assessed against the policyholder for cost of insurance (mortality risk), policy administration and early surrender.  These revenues are recognized when assessed against the policyholder account balance.
Policies that do not subject the Company to significant risk arising from mortality or morbidity are considered investment contracts. Deposits received for such contracts are reported as other policyholder funds.  Policy charges for investment contracts consist of fees assessed against the policyholder account for maintenance, administration and surrender of the policy prior to contractually specified dates, and are recognized when assessed against the policyholder account balance.
(Q)      Participating Policies
Participating policies represented 13.7%, 11.7% and 11.4% of the individual life insurance in-force and provide for the payment of dividends.
Dividends to policyholders are determined annually and are payable only upon declaration by the Board of Directors of the insurance companies.
(R)      Income Per Common Share
Included in the diluted earnings per share calculation for 2014, 2013 and 2012 are 165,000, 113,000 and 109,000 incremental common shares, respectively, primarily from the dilutive effect of share-based payment awards, computed using the treasury stock method.
(S)       Share-Based Compensation
Compensation costs for equity awards, such as stock options and non-vested stock, are measured based on grant-date fair value and are recognized in the Consolidated Statements of Income over the requisite service period (which is usually the vesting period). For such awards with only service conditions, the Company recognizes the compensation cost on a straight-line basis over the requisite service period for the entire award.
Compensation costs for liability-classified awards, such as share appreciation rights (“SARs”) and share-based performance awards, are measured and accrued each reporting period in the Consolidated Statements of Income as the requisite service or performance conditions are met.
(T)       Recent Accounting Pronouncements
Recently Adopted Accounting Standards
In July 2013, the Financial Accounting Standards Board (“FASB”) issued guidance for the presentation of unrecognized tax benefits to better reflect the manner in which an entity would settle, at the reporting date, any additional income taxes that would result from the disallowance of a tax position when net operating loss carryforwards, similar tax losses, or tax credit carryforwards exist. The adoption of this guidance, effective January 1, 2014, did not have an effect on the Company’s consolidated financial statements.
In July 2011, the FASB issued guidance specifying that the liability for the fees paid to the Federal Government by health insurers as a result of recent healthcare reform legislation should be estimated and recorded in full once the entity provides qualifying health insurance in the applicable calendar year in which the fee is payable with a corresponding deferred cost that is amortized to expense using a straight-line method of allocation unless another method better allocates the fee over the calendar year that it is payable. The amendments in this Update became effective January 1, 2014 and in accordance with the provisions, IHC recorded the estimated gross liability for the mandated fees payable to the Federal Government of $1,500,000 and the corresponding deferred cost in the first quarter of 2014. The amounts were recorded in accounts payable, accruals and other liabilities and in other assets, respectively, on the Consolidated Balance Sheet. Upon final assessment in June 2014, the Company increased its gross liability for the mandated fees payable to the Federal Government to $1,816,000. The deferred asset was amortized ratably over the calendar year to selling, general and administrative expense in the Consolidated Statement of Income.
Recently Issued Accounting Standards Not Yet Adopted
In February 2015, the FASB issued guidance that modifies the evaluation of whether limited partnerships and similar legal entities are variable interest entities or voting interest entities for the purpose of consolidation. For public entities, this guidance is effective for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years. Early adoption is permitted. Management has not yet determined the impact that the adoption of this guidance will have on the Company’s consolidated financial statements.
In June 2014, the FASB issued explicit guidance for entities that grant their employees share-based payments in which the terms of the award include a performance target that affects vesting and could be achieved after the requisite service period.  This guidance is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2015. Earlier adoption is permitted. The guidance may be applied either prospectively to all awards granted or modified after the effective date or retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements.
In May 2014, the FASB issued revenue recognition guidance for entities that either enter into contracts with customers to transfer goods or services or enter into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards such as insurance contracts or lease contracts. The amendment provides specific steps that an entity should apply in order to achieve its main objective which is recognizing revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For public entities, this guidance is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period, and requires one of two specified retrospective methods of application. Early application is prohibited. Management has not yet determined the impact that the adoption of this guidance will have on the Company’s consolidated financial statements.
In April 2014, the FASB issued guidance: (i) improving the definition of discontinued operations by limiting the reporting of discontinued operations to disposals of components that represent strategic shifts that have (or will have) a major effect on an entity’s operations and financial results; and (ii) requiring expanded disclosures for discontinued operations. Public entities are required to apply this guidance to: (i) all disposals (or classifications as held for sale) of components of the entity that occur within annual periods beginning on or after December 15, 2014, and interim periods within those years; and (ii) to all businesses that, on acquisition, are classified as held for sale that occur within annual periods beginning on or after December 15, 2014, and interim periods within those years. Early adoption is permitted, but only for disposals (or classifications as held for sale) that have not been reported in previously issued financial statements. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements.

Note_2_Investment_Securities

Note 2. Investment Securities	12 Months Ended
	Dec. 31, 2014
Notes
Note 2. Investment Securities	Note 2.                        Investment Securities
	The cost (amortized cost with respect to certain fixed maturities), gross unrealized gains, gross unrealized losses and fair value of investment securities are as follows for the periods indicated (in thousands):
			December 31, 2014
					GROSS		GROSS
			AMORTIZED		UNREALIZED		UNREALIZED		FAIR
			COST		GAINS		LOSSES		VALUE
	FIXED MATURITIES
	AVAILABLE-FOR-SALE:
	Corporate securities	$	264,162	$	1,076	$	(3,314)	$	261,924
	CMOs - residential (1)		5,073		55		(22)		5,106
	CMOs - commercial		975		-		(22)		953
	U.S. Government obligations		22,766		126		-		22,892
	Agency MBS - residential (2)		65		4		-		69
	GSEs (3)		14,706		36		(86)		14,656
	States and political subdivisions		238,514		3,253		(2,386)		239,381
	Foreign governments		34,863		136		(299)		34,700
	Redeemable preferred stocks		4,036		163		-		4,199
	Total fixed maturities	$	585,160	$	4,849	$	(6,129)	$	583,880
	EQUITY SECURITIES
	AVAILABLE-FOR-SALE:
	Common stocks	$	8,452	$	1,452	$	(147)	$	9,757
	Nonredeemable preferred stocks		4,004		134		-		4,138
	Total equity securities	$	12,456	$	1,586	$	(147)	$	13,895
			December 31, 2013
					GROSS		GROSS
			AMORTIZED		UNREALIZED		UNREALIZED		FAIR
			COST		GAINS		LOSSES		VALUE
	FIXED MATURITIES
	AVAILABLE-FOR-SALE:
	Corporate securities	$	215,412	$	1,315	$	(7,467)	$	209,260
	CMOs - residential (1)		2,457		8		(8)		2,457
	CMOs - commercial		975		-		(382)		593
	U.S. Government obligations		15,596		271		(6)		15,861
	Agency MBS - residential (2)		79		4		-		83
	GSEs (3)		28,484		4		(340)		28,148
	States and political subdivisions		256,645		2,435		(9,377)		249,703
	Foreign governments		34,437		20		(2,107)		32,350
	Redeemable preferred stocks		4,036		74		(278)		3,832
	Total fixed maturities	$	558,121	$	4,131	$	(19,965)	$	542,287
	EQUITY SECURITIES
	AVAILABLE-FOR-SALE:
	Common stocks	$	7,517	$	328	$	(70)	$	7,775
	Nonredeemable preferred stocks		4,004		58		(34)		4,028
	Total equity securities	$	11,521	$	386	$	(104)	$	11,803
	(1)         Collateralized mortgage obligations (“CMOs”).
	(2)         Mortgage-backed securities (“MBS”).
	(3)         Government-sponsored enterprises (“GSEs’) are private enterprises established and chartered by the Federal Government or its various insurance and lease programs which carry the full faith and credit obligation of the U.S. Government.
	The amortized cost and fair value of fixed maturities available-for-sale at December 31, 2014, by contractual maturity, are shown below (in thousands). Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. CMOs and MBSs are shown separately, as they are not due at a single maturity.
				AMORTIZED			FAIR
				COST			VALUE
	Due in one year or less		$	14,551		$	14,440
	Due after one year through five years			98,027			97,605
	Due after five years through ten years			216,203			215,401
	Due after ten years			236,568			236,678
	CMOs and MBSs			19,811			19,756
			$	585,160		$	583,880
	The following tables summarize, for all available-for-sale securities in an unrealized loss position, the aggregate fair value and gross unrealized loss by length of time those securities that have continuously been in an unrealized loss position for the periods indicated (in thousands):
			31-Dec-14
			Less than 12 Months						12 Months or Longer				Total
			Fair			Unrealized			Fair		Unrealized		Fair		Unrealized
			Value			Losses			Value		Losses		Value		Losses
	Corporate securities	$	77,868		$	1,473		$	69,498	$	1,841	$	147,366	$	3,314
	CMO’s  - residential		2,062			16			1,562		6		3,624		22
	CMOs - commercial		-			-			953		22		953		22
GSEs		-			-			9,581		86		9,581		86
States and political subdivisions		58,819			744			67,318		1,642		126,137		2,386
Foreign governments		21,148			171			12,229		128		33,377		299
Total fixed maturities		159,897			2,404			161,141		3,725		321,038		6,129
Common stocks		2,007			136			348		11		2,355		147
Total equity securities		2,007			136			348		11		2,355		147
Total temporarily impaired
securities	$	161,904		$	2,540		$	161,489	$	3,736	$	323,393	$	6,276
Number of securities in an
unrealized loss position		70						46				116
		31-Dec-13
		Less than 12 Months						12 Months or Longer				Total
		Fair			Unrealized			Fair		Unrealized		Fair		Unrealized
		Value			Losses			Value		Losses		Value		Losses
Corporate securities	$	124,531		$	5,340		$	21,070	$	2,127	$	145,601	$	7,467
CMO’s  - residential		2,047			8			-		-		2,047		8
CMOs - commercial		-			-			593		382		593		382
U.S. Government obligations		493			6			-		-		493		6
GSEs		22,731			123			5,360		217		28,091		340
States and political subdivisions		149,704			7,312			32,983		2,065		182,687		9,377
Foreign governments		27,587			1,766			3,523		341		31,110		2,107
Redeemable preferred stocks		3,485			278			-		-		3,485		278
Total fixed maturities		330,578			14,833			63,529		5,132		394,107		19,965
Common stocks		2,589			70			-		-		2,589		70
Nonredeemable preferred stocks		2,625			34			-		-		2,625		34
Total equity securities		5,214			104			-		-		5,214		104
Total temporarily impaired
securities	$	335,792		$	14,937		$	63,529	$	5,132	$	399,321	$	20,069
Number of securities in an
unrealized loss position		126						27				153
Substantially all of the unrealized losses on fixed maturities available-for-sale at December 31, 2014 and December 31, 2013 relate to investment grade securities and are attributable to changes in market interest rates. Because the Company does not intend to sell, nor is it more likely than not that the Company will have to sell such investments before recovery of their amortized cost bases, which may be maturity, the Company does not consider these investments to be other-than-temporarily impaired at December 31, 2014.
The following table summarizes the Company’s net investment income for the years indicated (in thousands):
		2014			2013			2012
Fixed maturities	$	18,504		$	22,667		$	27,785
Equity securities		943			1,065			1,967
Short-term investments		74			118			194
Policy loans		813			1,020			1,542
Partnership interests		1,101			2,506			2,027
Other		336			291			5
Investment income, gross		21,771			27,667			33,520
Investment expenses		(79)			(196)			(164)
Net investment income	$	21,692		$	27,471		$	33,356
The following table summarizes the Company’s net realized investment gains (losses) for the years indicated (in thousands):
		2014			2013			2012
Available-for-sale securities:
Fixed maturities	$	7,642		$	17,664		$	5,428
Common stocks		(5)			-			419
Preferred stocks		-			177			(495)
Total available-for-sale securities		7,637			17,841			5,352
Trading securities		506			1,619			79
Total realized gains		8,143			19,460			5,431
Unrealized gains (losses) on trading securities:
Available-for-sale securities transferred
to trading category		-			-			138
Change in unrealized gains (losses) on trading securities		(451)			94			(26)
Total unrealized gains (losses) on trading securities		(451)			94			112
Gains (losses) on other investments		-4			196			(444)
Net realized investment gains	$	7,688		$	19,750		$	5,099
For the years ended December 31, 2014, 2013 and 2012, proceeds from sales of available-for-sale securities were $355,470,000, $563,285,000 and $497,782,000, respectively, and the company realized gross gains of $9,289,000, $21,889,000 and $10,629,000, respectively, and gross losses of $741,000, $2,902,000 and $3,868,000, respectively, on those sales.
On January 1, 2012, the Company transferred equity securities previously classified as available-for-sale into the trading category and, as a result, recognized $287,000 of gross gains and $149,000 of gross losses in net realized investment gains on the accompanying Consolidated Statement of Income. These gains and losses were previously included in accumulated other comprehensive income (loss).
We recognize other-than-temporary impairment losses in earnings in the period that we determine: 1) we intend to sell the security; 2) it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis; or 3) the security has a credit loss. Any non-credit portion of the other-than-temporary impairment loss is recognized in other comprehensive income (loss).
Credit losses were recognized on certain fixed maturities for which each security also had an impairment loss recognized in other comprehensive income (loss). The rollforward of these credit losses were as follows for the years indicated (in thousands):
		2014		2013		2012
Balance at beginning of year	$	473	$	1,976	$	2,555
Credit losses during the period for which an other-
than-temporary loss was not previously recognized		-		-		473
Additional credit losses for which an other-than-temporary
loss was previously recognized		-		-		148
Securities sold		-		(1,503)		(1,200)
Balance at end of period	$	473	$	473	$	1,976
The after-tax portion of other-than-temporary impairments included in accumulated other comprehensive income (loss) at both December 31, 2014 and 2013 consists of $335,000 related to CMO securities.

Note_3_Cash_Flow_Hedge

Note 3. Cash Flow Hedge	12 Months Ended
	Dec. 31, 2014
Notes
Note 3. Cash Flow Hedge	Note 3.                        Cash Flow Hedge
	In connection with its outstanding amortizing term loan, a subsidiary of IHC entered into an interest rate swap on July 1, 2011 with the commercial bank lender, for a notional amount equal to the debt principal amount ($4,000,000 and $6,000,000 December 31, 2014 and December 31, 2013, respectively), under which the Company receives a variable rate equal to the rate on the debt and pays a fixed rate ( 1.60%) in order to manage the risk in overall changes in cash flows attributable to forecasted interest payments. As a result of the interest rate swap, interest payments on this debt are fixed at 4.95%. There was no hedge ineffectiveness on this interest rate swap which was accounted for as a cash flow hedge. At December 31, 2014 and 2013, the fair value of interest rate swap was $83,000 and $204,000, respectively, which is included in other liabilities on the accompanying Consolidated Balance Sheets. See Note 4 for further discussion on the valuation techniques utilized to determine the fair value of the interest rate swap.

Note_4_Fair_Value_Disclosures

Note 4. Fair Value Disclosures	12 Months Ended
	Dec. 31, 2014
Notes
Note 4. Fair Value Disclosures	Note 4.                        Fair Value Disclosures
	For all financial and non-financial assets and liabilities accounted for at fair value on a recurring basis, the Company utilizes valuation techniques based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market expectations. These two types of inputs create the following fair value hierarchy:
	Level 1 - Quoted prices for identical instruments in active markets.
	Level 2 - Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
	Level 3 - Instruments where significant value drivers are unobservable.
	The following section describes the valuation methodologies we use to measure different assets and liabilities at fair value.
	Investments in fixed maturities and equity securities:
	Available-for-sale securities included in Level 1 are equities with quoted market prices. Level 2 is primarily comprised of our portfolio of government securities, agency mortgage-backed securities, corporate fixed income securities, collateralized mortgage obligations, municipals and GSEs that were priced with observable market inputs. Level 3 securities consist primarily of CMO securities backed by commercial mortgages and municipal tax credit strips.  For these securities, we use industry-standard pricing methodologies, including discounted cash flow models, whose inputs are based on management’s assumptions and available market information. Significant unobservable inputs used in the fair value measurement of CMO’s are prepayment rates, probability of default, and loss severity in the event of default. Significant increases (decreases) in any of those inputs in isolation would result in a significantly lower (higher) fair value measurement. Generally, a change in the assumption used for the probability of default is accompanied by a directionally similar change in the assumption used for loss severity and a directionally opposite change in the assumption used for prepayment rates. Further we retain independent pricing vendors to assist in valuing certain instruments.
	Trading securities:
	Trading securities included in Level 1 are equity securities with quoted market prices.
	Interest rate swap:
	The financial liability included in Level 2 consists of an interest rate swap on IHC debt.  It is valued using market observable inputs including market price, interest rate, and volatility within a Black-Scholes model.
	The following tables present our financial assets and liabilities measured at fair value on a recurring basis for the periods indicated (in thousands):
			31-Dec-14
			Level 1			Level 2		Level 3		Total
	FINANCIAL ASSETS:
	Fixed maturities available-for-sale:
	Corporate securities	$	-		$	261,924	$	-	$	261,924
	CMOs – residential		-			5,106		-		5,106
	CMOs – commercial		-			-		953		953
	US Government obligations		-			22,892		-		22,892
	Agency MBS - residential		-			69		-		69
	GSEs		-			14,656		-		14,656
	States and political subdivisions		-			237,067		2,314		239,381
	Foreign government		-			34,700		-		34,700
	Redeemable preferred stocks		4,199			-		-		4,199
	Total fixed maturities		4,199			576,414		3,267		583,880
	Equity securities available-for-sale:
	Common stocks		9,757			-		-		9,757
	Nonredeemable preferred stocks		4,138			-		-		4,138
	Total equity securities		13,895			-		-		13,895
	Trading securities - equities		11,095			-		-		11,095
	Total trading securities		11,095			-		-		11,095
	Total Financial Assets	$	29,189		$	576,414	$	3,267	$	608,870
	FINANCIAL LIABILITIES:
	Interest rate swap	$	-		$	83	$	-	$	83
			31-Dec-13
			Level 1			Level 2		Level 3		Total
	FINANCIAL ASSETS:
	Fixed maturities available-for-sale:
	Corporate securities	$	-		$	209,260	$	-	$	209,260
	CMOs – residential		-			2,457		-		2,457
	CMOs – commercial		-			-		593		593
	US Government obligations		-			15,861		-		15,861
	Agency MBS - residential		-			83		-		83
	GSEs		-			28,148		-		28,148
	States and political subdivisions		-			247,262		2,441		249,703
	Foreign government		-			32,350		-		32,350
	Redeemable preferred stocks		3,832			-		-		3,832
	Total fixed maturities		3,832			535,421		3,034		542,287
	Equity securities available-for-sale:
	Common stocks		7,775			-		-		7,775
	Nonredeemable preferred stocks		4,028			-		-		4,028
	Total equity securities		11,803			-		-		11,803
	Trading securities - equities		7,125			-		-		7,125
	Total trading securities		7,125			-		-		7,125
	Total Financial Assets	$	22,760		$	535,421	$	3,034	$	561,215
	FINANCIAL LIABILITIES:
	Interest rate swap	$	-		$	204	$	-	$	204
	It is the Company’s policy to recognize transfers of assets and liabilities between levels of the fair value hierarchy at the end of a reporting period. The Company does not transfer out of Level 3 and into Level 2 until such time as observable inputs become available and reliable or the range of available independent prices narrow. There were no securities transferred between Level 1, Level 2 or Level 3 in 2014 or 2013. The following table presents the changes in fair value of our Level 3 financial instruments for the periods indicated (in thousands):
			CMOs				States and
							Political
			Residential		Commercial		Subdivisions		Total
	Balance at December 31, 2012	$	14,053	$	570	$	2,558	$	17,181
Gains (losses) included in earnings:
Net realized investment gains		7,133		-		-		7,133
Gains (losses) included in other comprehensive income (loss):
Net unrealized gains (losses)		(7,064)		23		(78)		(7,119)
Sales of securities		(13,108)		-		-		(13,108)
Repayments and amortization of fixed maturities		(1,014)		-		(39)		(1,053)
Balance at December 31, 2013		-		593		2,441		3,034
Gains (losses) included in earnings:
Net realized investment gains		-		-		-		-
Gains (losses) included in other comprehensive income (loss):
Net unrealized gains (losses)		-		360		(58)		302
Sales of securities		-		-		-		-
Repayments and amortization of fixed maturities		-		-		(69)		(69)
Balance at December 31, 2014	$	-	$	953	$	2,314	$	3,267
The following table provides carrying values, fair values and classification in the fair value hierarchy of the Company’s financial instruments, for the periods indicated, that are not carried at fair value but are subject to fair value disclosure requirements, for the periods indicated (in thousands):
		31-Dec-14				31-Dec-13
		Level 2				Level 2
		Fair		Carrying		Fair		Carrying
		Value		Value		Value		Value
FINANCIAL ASSETS:
Policy loans	$	13,356	$	10,667	$	14,177	$	11,328
FINANCIAL LIABILITIES:
Funds on deposit	$	187,213	$	186,782	$	274,773	$	274,826
Debt and junior subordinated
debt securities	$	42,146	$	42,146	$	44,146	$	44,146
The following methods and assumptions were used to estimate the fair value of the financial instruments that are not carried at fair value in the Consolidated Financial Statements:
(A)       Policy Loans
The fair value of policy loans included in Level 2 of the fair value hierarchy is estimated by projecting aggregate loan cash flows to the end of the expected lifetime period of the life insurance business at the average policy loan rates, and discounting them at a current market interest rate.
(B)              Funds on Deposit
The Company has two types of funds on deposit. The first type is credited with a current market interest rate, resulting in a fair value which approximates the carrying amount. The second type carries fixed interest rates which are higher than current market interest rates. The fair value of these deposits was estimated by discounting the payments using current market interest rates. The Company's universal life policies are also credited with current market interest rates, resulting in a fair value which approximates the carrying amount. Both types of funds on deposit are included in Level 2 of the fair value hierarchy.
(C)       Debt
The fair value of debt with variable interest rates approximates its carrying amount and is included in Level 2 of the fair value hierarchy.

Note_5_Other_Investments

Note 5. Other Investments	12 Months Ended
	Dec. 31, 2014
Notes
Note 5. Other Investments	Note 5.                        Other Investments
	Other investments consist of the following for the periods indicated (in thousands):
			December 31,
			2014		2013
	Policy loans	$	10,667	$	11,328
	Partnership interests		12,033		12,149
	Investment in trust subsidiaries		1,146		1,146
	Other		1,405		500
		$	25,251	$	25,123

Note_6_Goodwill_and_Other_Inta

Note 6. Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2014
Notes
Note 6. Goodwill and Other Intangible Assets	Note 6.                        Goodwill and Other Intangible Assets
	The carrying amount of goodwill was $50,318,000 at December 31, 2014 and 2013. See Note 16 for goodwill carrying amounts by segment.
	At December 31, 2014, the Company’s market capitalization was less than its book value indicating a potential impairment of goodwill.  As a result, the Company assessed the factors contributing to the performance of IHC stock in 2014, and concluded that the market capitalization does not represent the fair value of the Company.  The Company noted several factors that have led to a difference between the market capitalization and the fair value of the Company, including (i) the Company’s stock is thinly traded and a sale of even a small number of shares can have a large percentage impact on the price of the stock, (ii) Geneve Corporation and insiders own approximately 57% of the outstanding shares, which has had a significant adverse impact on the number of shares available for sale and therefore the trading potential of IHC stock, and (iii) lack of analyst coverage of the Company. If we experience a sustained decline in our results of operations and cash flows, or other indicators of impairment exist, we may incur a material non-cash charge to earnings relating to impairment of our goodwill, which could have a material adverse effect on our results.
	The Company has net other intangible assets of $12,135,000 and $14,767,000 at December 31, 2014 and 2013, respectively, which are included in other assets in the Consolidated Balance Sheets. These intangible assets consist of: (i) finite-lived intangible assets, principally the fair value of acquired agent and broker relationships, which are subject to amortization; and (ii) indefinite-lived intangible assets which consist of the estimated fair value of insurance licenses that are not subject to amortization. The gross carrying amounts of these other intangible assets are as follows for the periods indicated (in thousands):
			31-Dec-14				31-Dec-13
			Gross				Gross
			Carrying		Accumulated		Carrying		Accumulated
			Amount		Amortization		Amount		Amortization
	Finite-lived Intangible Assets:
	Agent and broker relationships	$	22,725	$	18,567	$	22,725	$	15,935
	Total finite-lived	$	22,725	$	18,567	$	22,725	$	15,935
							December 31,
							2014		2013
	Indefinite-lived Intangible Assets:
	Insurance licenses					$	7,977	$	7,977
	Total indefinite-lived					$	7,977	$	7,977
	Amortization expense was $2,632,000, $3,220,000 and $2,840,000 for the years ended December 31, 2014, 2013 and 2012, respectively. Estimated amortization expense for each of the next five years is as follows (in thousands):
				Amortization
	Year			Expense
	2015		$	1,560
	2016			1,119
	2017			749
	2018			494
	2019			204

Note_7_Reinsurance

Note 7. Reinsurance	12 Months Ended
	Dec. 31, 2014
Notes
Note 7. Reinsurance	Note 7.                        Reinsurance
	The Insurance Group reinsures portions of certain business in order to limit the assumption of disproportionate risks. Amounts not retained are ceded to other companies on an automatic or facultative basis.  In addition, the Insurance Group participates in various coinsurance treaties on a quota share or excess basis. The Company is contingently liable with respect to reinsurance in the unlikely event that the assuming reinsurers are unable to meet their obligations.  The ceding of reinsurance does not discharge the primary liability of the original insurer to the insured.
	The effects of reinsurance on premiums earned and insurance benefits, claims and reserves are shown below for the periods indicated (in thousands). Accident and health products and property and liability products (primarily the new pet insurance line) consist of short-duration contracts. Life and annuity products consist of long-duration contracts.
					ASSUMED		CEDED
			GROSS		FROM OTHER		TO OTHER		NET
			AMOUNT		COMPANIES		COMPANIES		AMOUNT
	Premiums Earned:
	31-Dec-14
	Accident and health	$	482,511	$	52,063	$	116,163	$	418,411
	Life and annuity		44,407		6,128		20,214		30,321
	Property and liability		30,477		-		161		30,316
		$	557,395	$	58,191	$	136,538	$	479,048
	31-Dec-13
	Accident and health	$	461,336	$	85,627	$	102,053	$	444,910
	Life and annuity		46,416		6,654		20,820		32,250
	Property and liability		18,845		-		14		18,831
		$	526,597	$	92,281	$	122,887	$	495,991
	31-Dec-12
	Accident and health	$	396,805	$	60,232	$	140,653	$	316,384
	Life and annuity		47,790		7,538		18,916		36,412
	Property and liability		3,271		-		-		3,271
		$	447,866	$	67,770	$	159,569	$	356,067
	Insurance benefits, claims and reserves:
	31-Dec-14	$	276,634	$	50,441	$	1,040	$	326,035
	31-Dec-13	$	374,865	$	82,337	$	102,412	$	354,790
	31-Dec-12	$	301,734	$	56,405	$	113,348	$	244,791
	Effective May 31, 2013, Madison National Life entered into a coinsurance agreement with an unaffiliated reinsurer, Guggenheim Life and Annuity Company, to cede approximately $218,633,000 of life and annuity reserves and, in accordance with its terms, transferred net cash and other assets, with an aggregate value of $215,137,000, to the reinsurer during the second quarter of 2013. As a result of this transaction, the Company: (i) recorded estimated amounts due from reinsurers of $218,296,000; (ii) recorded $6,643,000 of estimated deferred expenses (included in other assets) which will be amortized over the life of the underlying reinsured contracts; and (iii) wrote-off $9,307,000 of deferred acquisition costs associated with this block of policies. The write-off was more than offset by gains realized by the Company in the transaction, most of which resulted from the required sale and transfer of invested assets. During 2014, a large portion of the reserves were transferred to the reinsurer in accordance with the terms of an assumption agreement.
	Effective January 26, 2012, Standard Security Life entered into a coinsurance agreement with an unaffiliated reinsurer, First Security Benefit Life Insurance and Annuity Company of New York, to cede group annuity reserves. In accordance with the agreement, Standard Security Life transferred $143,537,000 of cash in the first quarter of 2012 and recorded a corresponding amount as due from reinsurers. The Company received final approval from the New York State Insurance Department to convert the transfer from a coinsurance to an assumption agreement which contractually relieves Standard Security Life of liability with regards to the policies. During the third quarter of 2012, a significant portion of the reserves were assumed by the reinsurer.

Note_8_Policy_Benefits_and_Cla

Note 8. Policy Benefits and Claims	12 Months Ended
	Dec. 31, 2014
Notes
Note 8. Policy Benefits and Claims	Note 8.                        Policy Benefits and Claims
	Summarized below are the changes in the liability for policy benefits and claims for the periods indicated (in thousands).
			2014		2013		2012
	Balance at beginning of year	$	237,754	$	194,480	$	192,987
	Less: reinsurance recoverable		72,772		78,629		83,137
	Net balance at beginning of year		164,982		115,851		109,850
	Amount assumed		-		15,384		-
	Amount incurred, related to:
	Current year		303,973		324,040		213,818
	Prior years		(4,552)		(3,230)		(8,908)
	Total incurred		299,421		320,810		204,910
	Amount paid, related to:
	Current year		192,001		207,315		130,386
	Prior years		114,130		79,748		68,523
	Total paid		306,131		287,063		198,909
	Net balance at end of year		158,272		164,982		115,851
	Plus:  reinsurance recoverable		78,531		72,772		78,629
	Balance at end of year	$	236,803	$	237,754	$	194,480
	The preceding schedule reflects:  (i) the due and unpaid; (ii) claims in the course of settlement; (iii) estimated incurred but not reported reserves; and (iv) the present value of amounts not yet due on claims. The incurred and paid data above reflects all activity for the year. The overall net favorable development of $4,552,000 in 2014 related to prior years consists of favorable developments of $3,830,000 in the group disability reserves, $448,000 in other individual accident and health reserves and $378,000 in the Fully Insured Health reserves partially offset by an unfavorable development of $104,000 in Medical Stop-Loss reserves. The overall net favorable development of $3,230,000 in 2013 related to prior years consists of favorable developments of $4,269,000 in the group disability reserves and $1,069,000 in other individual accident and health reserves partially offset by an unfavorable developments of $2,000,000 in Medical Stop-Loss reserves and $108,000 in the Fully Insured Health reserves. The net favorable development in 2012 for prior years of $8,908,000 is primarily the result of $2,968,000 of net favorable developments in Medical Stop-Loss reserves, $375,000 in the Fully Insured Health reserves, $4,508,000 in the group disability reserves and $1,057,000 in all other reserves.
	These changes in reserve estimates are generally the result of on-going analysis of recent loss development trends.  Medical stop-loss business is excess coverage with a short duration. Predicting ultimate claims and estimating reserves in medical stop-loss is especially complicated due to the “excess of loss” nature of these products with very high deductibles applying to specific claims on any individual claimant and in the aggregate for a given group. Fluctuations in results for specific coverage are primarily due to the severity and frequency of individual claims. Due to the short-term nature of medical stop-loss, redundancies and deficiencies will typically emerge during the following year rather than over a number of years.

Note_9_Debt_and_Junior_Subordi

Note 9. Debt and Junior Subordinated Debt Securities	12 Months Ended
	Dec. 31, 2014
Notes
Note 9. Debt and Junior Subordinated Debt Securities	Note 9.                        Debt and Junior Subordinated Debt Securities
	(A)       Debt
	In July 2011, a subsidiary of IHC amended its amortizing term loan with a commercial bank and increased its outstanding debt to $10,000,000. The amortizing term loan, as amended: (i) matures on July 1, 2016; (ii) bears a variable interest rate of Libor plus 3.35%; and (iii) requires principal payments in the amount of $2,000,000 annually, commencing on July 1, 2012 through maturity. The Company simultaneously entered into an interest rate swap with the commercial bank lender effectively fixing the rate at 4.95%. See Note 3 for further discussion pertaining to the interest rate swap. As to such subsidiary, the line of credit (i) contains restrictions with respect to, among other things, the creation of additional indebtedness, the consolidation or merger with or into certain corporations, the payment of dividends and the retirement of capital stock; (ii) requires the maintenance of minimum amounts of net worth, as defined, certain financial ratios, and certain investment restrictions; and (iii) is secured by the stock of Madison National Life, Standard Security Life and the assets of such subsidiary of IHC. At December 31, 2014 and 2013, there was $4,000,000 and $6,000,000, respectively, of outstanding debt under this amortizing term loan.
	(B)       Junior Subordinated Debt Issued to Trust Preferred Subsidiaries
	Junior subordinated debt consisted of the following at both December 31, 2014 and 2013 (in thousands):
	Independence Preferred Trust I - Trust Preferred	$	10,000
	Independence Preferred Trust I - Common Stock		310
	Junior subordinated debt security -Trust I		10,310
	Independence Preferred Trust II -Trust Preferred		12,000
	Independence Preferred Trust II - Common Stock		372
	Junior subordinated debt security - Trust II		12,372
	Independence Preferred Trust III – Trust Preferred		15,000
	Independence Preferred Trust III – Common Stock		464
	Junior subordinated debt security – Trust III		15,464
	Total junior subordinated debt securities	$	38,146
	The Company has three statutory business trusts that were formed for the purpose of issuing trust preferred securities, totaling $37,000,000, to institutional investors in pooled issuances. Although the Company owns all of the trusts' common securities, it is not the primary beneficiary and, therefore, the trusts are unconsolidated subsidiaries for financial reporting purposes. As a result, the Company recorded liabilities of $38,146,000 for junior subordinated debt and assets of $1,146,000 for the investments in trust subsidiaries (included in other investments on the accompanying Consolidated Balance Sheets) at both December 31, 2014 and 2013. The Company's subordinated debt securities, which are the sole assets of the subsidiary trusts, are unsecured obligations of the Company and are subordinate and junior in right of payment to all present and future senior indebtedness of the Company. The Company has provided a full and unconditional guarantee of amounts due on the trust preferred securities. The terms of the junior subordinated debt securities, including interest rates and maturities, are the same as the related trust preferred securities.
	The distributions payable on the capital securities are cumulative and payable quarterly in arrears. The Company has the right, subject to events of default, to defer payments of interest for a period not to exceed 20 consecutive quarters, provided that no extension period may extend beyond the maturity dates which range from April 2033 to December 2034. The Company has no current intention to exercise its right to defer interest payments. The rates on the capital securities are as follows: Independence Preferred Trust I, 400 basis points over the three-month LIBOR, (4.23% at December 31, 2014); Independence Preferred Trust II, 390 basis points over the three-month LIBOR, (4.13% at December 31, 2014); and Independence Preferred Trust III, 350 basis points over the three-month LIBOR (3.74% at December 31, 2014).
	The capital securities are mandatorily redeemable upon maturity. The Company has the right to redeem the capital securities, in whole or in part without penalties with respect to Independence Preferred Trust I, Independence Preferred Trust II and Independence Preferred Trust III. The redemption price would be 100% (without penalty) of the principal amount plus accrued and unpaid interest.
	Cash payments for interest on debt and junior subordinated debt securities were $1,804,000 $1,923,000 and $2,107,000 for the years ended December 31, 2014, 2013 and 2012, respectively.

Note_10_Income_Taxes

Note 10. Income Taxes	12 Months Ended
	Dec. 31, 2014
Notes
Note 10. Income Taxes	Note 10.          Income Taxes
	IHC and its subsidiaries file a consolidated Federal income tax return on a June 30 fiscal year. Prior to January 15, 2013, AMIC and its subsidiaries filed a separate consolidated Federal income tax return on a September 30 fiscal year. The provision for income tax expense (benefit) attributable to income from operations, as shown in the Consolidated Statements of Income, is as follows for the years indicated (in thousands):
					2014				2013		2012
	CURRENT:
	U.S. Federal			$	20			$	(1,500)	$	2,555
	State and Local				743				1,206		648
					763				(294)		3,203
	DEFERRED:
	U.S. Federal				5,317				8,805		(1,188)
	State and Local				311				(113)		(12)
					5,628				8,692		(1,200)
				$	6,391			$	8,398	$	2,003
	Taxes computed at the Federal statutory rate of 35% in 2014, 2013 and 2012, attributable to pretax income, are reconciled to the Company's actual income tax expense as follows for the years indicated (in thousands):
			2014			2013			2012
	Tax computed at the statutory rate	$	8,159		$	8,279		$	8,615
	Dividends received deduction and tax
	exempt interest		(1,384)			(849)			(1,336)
	State and local income taxes, net of Federal effect		685			710			414
	Health insurance excise tax		696			-			-
	Health insurer compensation limit		661			-			-
	AMIC valuation allowance adjustment		(2,500)			-			(5,900)
	Other, net		74			258			210
	Income tax expense	$	6,391		$	8,398		$	2,003
	Temporary differences between the Consolidated Financial Statement carrying amounts and tax bases of assets and liabilities that give rise to the deferred tax assets and liabilities at December 31, 2014 and 2013 are summarized below (in thousands). The net deferred tax asset or liability is included in Other Assets or Other Liabilities, as appropriate, in the Consolidated Balance Sheets. IHC and its subsidiaries, excluding AMIC, have certain tax-planning strategies that were used in determining that a valuation allowance was not necessary on its deferred tax assets at December 31, 2014 or 2013. The net deferred tax asset relative to AMIC included in other assets on IHC’s Consolidated Balance Sheets at December 31, 2014 and 2013 was $11,517,000 and $10,689,000, respectively.
				2014			2013
	DEFERRED TAX ASSETS:
	Deferred insurance policy acquisition costs		$	754		$	484
	Unrealized losses on investment securities			54			5,398
	Investment write-downs			222			222
	Loss carryforwards			102,478			109,463
	Insurance reserves			366			392
	Other			5,790			7,222
	Total gross deferred tax assets			109,664			123,181
	Less AMIC valuation allowance			(73,849)			(76,911)
	Net deferred tax assets			35,815			46,270
	DEFERRED TAX LIABILITIES:
	Deferred insurance policy acquisition costs			(10,712)			(10,376)
	Insurance reserves			(6,856)			(6,183)
	Unrealized gains on investment securities			(78)			-
	Other			(12,702)			(13,805)
	Total gross deferred tax liabilities			(30,348)			(30,364)
	Net deferred tax asset		$	5,467		$	15,906
	As of December 31, 2014, IHC and its non-life subsidiaries, excluding AMIC, had NOL carryforwards arising from limitations on offsetting non-life insurance company losses against life insurance company income. The non-life insurance company Federal NOL carryforwards amount to approximately $24,418,000 at December 31, 2014, which expire in varying amounts between 2029 and 2032. Madison National Life had Federal NOL carryforwards of approximately $4,392,000 at December 31, 2014 expiring in 2033 and 2034.
	At December 31, 2014, AMIC had Federal NOL carryforwards of approximately $263,985,000 which expire in varying amounts through the year 2028 with a significant portion expiring in 2020.
	AMIC’s valuation allowance at December 31, 2014 and 2013 was primarily related to net operating loss carryforwards that, in the judgment of management, were not considered realizable. During the years ended December 31, 2014 and 2013, AMIC decreased its valuation allowance by $3,062,000 and $1,661,000, respectively. The valuation allowance decrease in the year ended December 31, 2014 included $2,500,000 for the projected utilization of Federal net operating losses allocated to operations.
	In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Management believes that it is more likely than not that IHC and its subsidiaries, and AMIC, will realize the benefits of these net deferred tax assets recorded at December 31, 2014. As of December 31, 2014, IHC and its subsidiaries, and AMIC, believe there were no material uncertain tax positions that would require disclosure under U.S. GAAP.
	Interest expense and penalties for the years ended December 31, 2014, 2013 and 2012 are insignificant.
	Net cash payments (receipts) for income taxes were $(2,448,000), $(387,000) and $550,000 in 2014, 2013 and 2012, respectively.

Note_11_Stockholders_Equity

Note 11. Stockholders' Equity	12 Months Ended
	Dec. 31, 2014
Notes
Note 11. Stockholders' Equity	Note 11.          Stockholders’ Equity
	Preferred Stock
	IHC has 100,000 authorized shares of preferred stock, par value $1.00 per share, none of which was issued as of December 31, 2014 and 2013.
	Common Stock
	In 2012, IHC issued 1,638,849 shares of common stock, net of treasury shares, in connection with a special stock dividend payable to shareholders of record on February 17, 2012 with a distribution date of March 5, 2012. Accordingly, IHC charged retained earnings $15,799,000, representing the fair value of such shares on the distribution date, and recorded a credit to common stock for the par value of such shares and a credit to paid-in capital for the remaining difference. Fractional shares were paid in cash in-lieu of stock. All references to number of common shares and earnings per share amounts have been adjusted retroactively for all periods presented to reflect the change in capital structure.
	In June 2012, the stockholders of the Company approved an amendment to the Company’s restated certificate of incorporation to increase the number of authorized shares of common stock from 20,000,000 shares to 23,000,000 shares.
	Treasury Stock
	In 1991, IHC initiated a program of repurchasing shares of its common stock. In August 2014, the Board of Directors authorized the repurchase of up to 500,000 shares of IHC’s common stock, in addition to prior authorizations, under the 1991 plan. The Company has repurchased 296,775, 334,305 and 100,246 shares in 2014, 2013 and 2012, respectively.  All of the shares repurchased have been either retired, reissued, or have become treasury shares. At December 31, 2014, there were 468,218 shares still authorized to be repurchased under the plan authorized by the Board of Directors.
	Accumulated Other Comprehensive Income (Loss)
	The components of other comprehensive income (loss) include (i) the after-tax net unrealized gains and losses on investment securities available-for-sale, including the subsequent increases and decreases in fair value of available-for-sale securities previously impaired and the non-credit related component of other-than-temporary impairments of fixed maturities and (ii) the after-tax unrealized gains and losses on a cash flow hedge.
	Changes in the balances for each component of accumulated other comprehensive income (loss), shown net of taxes, for the years indicated were as follows (in thousands):
			Unrealized
			Gains (Losses) on
			Available-for Sale			Cash Flow
			Securities			Hedge			Total
	Balance at December 31, 2011	$	8,150		$	(297)		$	7,853
	Other comprehensive income (loss) before reclassifications		10,480			79			10,559
	Amounts reclassified from accumulated OCI		(3,284)			-			(3,284)
	Net other comprehensive income (loss)		7,196			79			7,275
	Less: Other comprehensive income attributable
	to noncontrolling interests		(118)			-			(118)
	Acquired from noncontrolling interests		3			-			3
	Balance at December 31, 2012		15,231			(218)			15,013
	Other comprehensive income (loss) before reclassifications		(14,361)			96			(14,265)
	Amounts reclassified from accumulated OCI		(11,826)			-			(11,826)
	Net other comprehensive income (loss)		(26,187)			96			(26,091)
	Less: Other comprehensive loss attributable
	to noncontrolling interests		665			-			665
	Acquired from noncontrolling interests		(59)			-			(59)
	Balance at December 31, 2013		(10,350)			(122)			(10,472)
	Other comprehensive income (loss) before reclassifications		15,872			72			15,944
	Amounts reclassified from accumulated OCI		(5,251)			-			(5,251)
	Net other comprehensive income (loss)		10,621			72			10,693
	Less: Other comprehensive loss attributable
	to noncontrolling interests		(199)			-			(199)
	Balance at December 31, 2014	$	72		$	(50)		$	22
	Presented below are the amounts reclassified out of accumulated other comprehensive income (loss) and recognized in earnings for each of the years indicated (in thousands):
			2014		2013		2012
	Unrealized gains (losses) on available-for-sale securities
	reclassified during the period to the following income
	statement line items:
	Net realized investment gains	$	7,637	$	17,841	$	5,490
	Net impairment losses recognized in earnings		-		-		(704)
	Income before income tax		7,637		17,841		4,786
	Tax effect		2,386		6,015		1,502
	Net income	$	5,251	$	11,826	$	3,284

Note_12_Sharebased_Compensatio

Note 12. Share-based Compensation	12 Months Ended
	Dec. 31, 2014
Notes
Note 12. Share-based Compensation	Note 12.          Share-Based Compensation
	IHC and AMIC each have a share-based compensation plan. The following is a summary of the activity pertaining to each of these plans.
	A)                IHC Share-Based Compensation Plan
	In June 2006, the stockholders approved the Independence Holding Company 2006 Stock Incentive Plan (the “2006 Plan"). Under the terms of the 2006 Plan, option exercise prices are more than or equal to the quoted market price of the shares at the date of grant; option terms are generally five years; and vesting periods are generally three years. The fair value of an option award is estimated on the date of grant using the Black-Scholes option valuation model. In addition to stock options, the Company has also granted restricted stock units, share appreciation rights (“SARs”) and share-based performance awards under the 2006 Plan. Restricted share units are valued at the quoted market price of the shares at the date of grant and have a three year vesting period. Compensation costs for options and restricted share units are recognized over the stated vesting periods on a straight-line basis. Exercise prices of SARs are more than or equal to the quoted market price of IHC shares at the date of the grant and have three year vesting periods. The fair value of SARs is calculated using the Black-Scholes valuation model at the grant date and each subsequent reporting period until settlement. Compensation cost is based on the proportionate amount of the requisite service that has been rendered to date. Once fully vested, changes in fair value of the SARs continue to be recognized as compensation expense in the period of the change until settlement. Compensation costs for share-based performance awards are recognized and accrued as performance conditions are met, based on the current share price. IHC discontinued these award programs in 2013.
	At December 31, 2014, there were 377,286 shares available for future stock-based compensation grants under IHC’s stock incentive plans. The following table summarizes share-based compensation expense, which is included in selling, general and administrative expenses on the Consolidated Statements of Income, applicable to the IHC plans  by award type for each of the years indicated (in thousands):
				2014		2013		2012
	IHC’s Share-based Compensation Plan:
	Stock options		$	669	$	210	$	237
	Restricted stock units			85		66		45
	SARs			14		698		428
	Performance awards			-		(15)		89
	Share-based compensation expense, pre-tax			768		959		799
	Tax benefits			306		382		319
	Share-based compensation expense, net		$	462	$	577	$	480
	Stock Options
	The Company’s stock option activity during 2014 was as follows:
			Shares		Weighted- Average
			Under Option		Exercise Price
	31-Dec-13		616,858		$	9.35
	Expired		-2,178		14.75
	31-Dec-14		614,680		$	9.33
	No options were granted in 2014, 2013 or 2012. In May 2014, option agreements affecting 15 employees were modified to extend the expirations of their terms from 2015 to 2017 and as a result, the Company recorded incremental compensation costs of $405,000. In 2013, the Company received $430,000 in cash from the exercise of stock options with an aggregate intrinsic value of $243,000 and realized $85,000 of tax benefits. In March 2013, option agreements affecting 5 employees were modified to extend the expiration term 5 years. The incremental cost of the modified awards was $618,000, which is being recognized over the new 2-year vesting period starting from the date of the modification.
	The following table summarizes information regarding outstanding and exercisable options:
			31-Dec-14
			Outstanding		Exercisable
	Number of options		614,680		532,180
	Weighted average exercise price per share	$	9.33	$	9.23
	Aggregate intrinsic value for all options (in thousands)	$	2,838	$	2,512
	Weighted average contractual term remaining		2.3 years		2.2 years
	As of December 31, 2014, the total unrecognized compensation expense related to non-vested stock options was $55,000, which is expected to be recognized over the remaining requisite weighted average service period of 0.21 years.
	Restricted Stock
	The following table summarizes IHC’s restricted stock activity for the year ended December 31, 2014:
			No. of		Weighted-Average
			Non-vested		Grant-Date
			Shares		Fair Value
	31-Dec-13		14,850		$	10.6
	Granted		7,425			13.27
	Vested		(7,425)			10.3
	31-Dec-14		14,850		$	12.09
	IHC granted 7,425 restricted stock units during each of the years ended December 31, 2014, 2013 and 2012, with weighted-average grant-date fair values of $13.27, $11.66 and $9.39 per share, respectively. The total fair value of restricted stock that vested in 2014, 2013 and 2012 was $103,000, $69,000 and $40,000, respectively.
	At December 31, 2014, the total unrecognized compensation cost related to non-vested restricted stock awards was $131,000 which is expected to be recognized as compensation expense over a weighted average period of 1.8 years.
	SARs and Share-Based Performance Awards
	IHC had 136,850 and 251,800 SAR awards outstanding at December 31, 2014 and 2013, respectively. During 2014, 112,200 SARs were exercised with an aggregate intrinsic value of $529,000; and 2,750 SARs were forfeited. During 2013, 14,850 SARs were exercised with an aggregate intrinsic value of $74,000; and 3,300 SARs were forfeited. During 2012, the Company granted 56,000 SAR awards; 13,750 SARs were exercised with an aggregate intrinsic value of $33,000; and 2,750 SARs were forfeited.  Included in Other Liabilities in the Company’s Consolidated Balance Sheets at December 31, 2014 and December 31, 2013 are liabilities of $791,000 and $1,307,000, respectively, pertaining to SARs.
	In the past, other share-based compensation awards have included performance awards. These programs were discontinued in 2013. The intrinsic value of share-based performance awards paid during the years ended December 31, 2013 and 2012 was $83,000 and $57,000, respectively.
	B)        AMIC Share-Based Compensation Plans
	Effective July 1, 2009, AMIC implemented the 2009 Stock Incentive Plan (“AMIC 2009 Plan”), which the AMIC stockholders approved on June 19, 2009.  The AMIC 2009 Plan was preceded by the 1988 Stock Incentive Plan which expired by its terms in 2008. The AMIC 2009 Plan provided for the grants of non-statutory and incentive stock options, stock appreciation rights, restricted stock awards, performance shares, and other awards to officers, employee and other individuals.  Under the terms of the AMIC 2009 Plan, stock options have a maximum term of ten years from the date of grant, and have various vesting criteria depending on the grant with most grants vesting ratably over four years. At December 31, 2014, stock options for 166,616 common stock shares were outstanding, stock options for 148,837 common stock shares were vested, and 6,490,553 common stock shares that had not been issued remained available for future stock options grants and other awards.  Awards made under AMIC’s 1998 Plan prior to its expiration are still in effect.
	The following table summarizes share-based compensation expense, which is included in selling, general and administrative expenses on the Consolidated Statements of Income, applicable to the AMIC share-based compensation plans, by award type for each of the years indicated (in thousands):
				2014		2013		2012
	AMIC’s Share-based Compensation Plans:
	Stock options		$	52	$	42	$	33
	Share-based compensation expense, pre-tax			52		42		33
	Tax benefits			18		15		11
	Share-based compensation expense, net		$	34	$	27	$	22
	Stock Options
	AMIC’s stock option activity during 2014 was as follows:
			Shares		Weighted- Average
			Under Option		Exercise Price
	31-Dec-13		222,285		$	11.46
	Granted		13,334			10.8
	Exercised		(6,667)			4.87
	Expired		(62,336)			14.58
	31-Dec-14		166,616		$	10.5
	The following table summarizes information regarding AMIC’s outstanding and exercisable options:
			31-Dec-14
		Outstanding		Exercisable
Number of options		166,616		148,837
Weighted average exercise price per share	$	10.5	$	10.64
Aggregate intrinsic value for all options (in thousands)	$	217	$	196
Weighted average contractual term remaining		3.18 years		2.48 years
The fair value of an option award is estimated on the date of grant using the Black-Scholes option valuation model. The weighted average grant-date fair-value of options granted during the years ended December 31, 2014 and 2013 was $5.70 and $4.04. No options were granted in 2012. The assumptions set forth in the table below were used to value the stock options granted during the periods:
		2014		2013
Weighted-average risk-free interest rate		2.72%		2.30%
Annual dividend rate per share		-		-
Weighted-average volatility factor of the Company's common stock		38.27%		45.00%
Weighted-average expected term of options		5 years		5 years
During 2014, AMIC received $33,000 in cash from the exercise of stock options with an aggregate intrinsic value of $38,000. No options were exercised during the years ended December 31, 2013 or 2012.
As of December 31, 2014, the total unrecognized compensation expense related to AMIC’s non-vested options was $83,000 which will be recognized over the remaining requisite service periods.

Note_13_Commitments_and_Contin

Note 13. Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Notes
Note 13. Commitments and Contingencies	Note 13.          Commitments and Contingencies
	Certain subsidiaries of the Company are obligated under non-cancelable operating lease agreements for office space. Total rental expense for the years 2014, 2013 and 2012 for operating leases was $3,403,000, $3,470,000 and $3,750,000, respectively.
	The approximate minimum annual rental payments under operating leases that have remaining non-cancelable lease terms in excess of one year at December 31, 2014 are as follows (in thousands):
	2015	$	3,291
	2016		2,723
	2017		1,206
	2018		790
	2019		118
	2020 and thereafter		29
	Total	$	8,157
	We are involved in legal proceedings and claims that arise in the ordinary course of our businesses. We have established reserves that we believe are sufficient given information presently available relating to our outstanding legal proceedings and claims.  We do not anticipate that the result of any pending legal proceeding or claim will have a material adverse effect on our financial condition or cash flows, although there could be such an effect on our results of operations for any particular period.
	On September 1, 2013, Madison National Life entered into an agreement with a former policyholder for a return of premium in connection with health insurance business written during 2007.  The agreement was entered into in response to a potential lawsuit. In April 2014, the Company fulfilled its obligation under the terms of the agreement with a payment of $1,541,000 representing return of premium reserves (net of recoveries). The Company terminated the MGU that produced this business in 2008.

Note_14_Concentration_of_Credi

Note 14. Concentration of Credit Risk	12 Months Ended
	Dec. 31, 2014
Notes
Note 14. Concentration of Credit Risk	Note 14.          Concentration of Credit Risk
	At December 31, 2014, the Company had no investment securities of any one issuer or in any one industry which exceeded 10% of stockholders' equity, except for investments in obligations of the U.S. Government and its agencies and mortgage-backed securities issued by GSEs, as summarized in Note 2.
	Fixed maturities with a carrying value of $12,523,000 and $12,637,000 were on deposit with various state insurance departments at December 31, 2014 and 2013, respectively.
	At December 31, 2014, the Company had net receivables of $115,188,000, $40,581,000 and $42,534,000 from three different reinsurers, Guggenheim Life and Annuity Company, Markel Bermuda, Ltd. and RGA Reinsurance Company, respectively, which are rated B++, A and A+, respectively, by A.M. Best.  These are the only reinsurers with net receivables that individually exceed 10% of the stockholders' equity of the Company. The Company believes that these receivables are fully collectible.

Note_15_Dividend_Payment_Restr

Note 15. Dividend Payment Restrictions and Statutory Information	12 Months Ended
	Dec. 31, 2014
Notes
Note 15. Dividend Payment Restrictions and Statutory Information	Note 15.          Dividend Payment Restrictions and Statutory Information
	Our insurance subsidiaries are restricted by state laws and regulations as to the amount of dividends they may pay to their parent without regulatory approval in any year. Any dividends in excess of limits are deemed “extraordinary” and require approval. Based on statutory results as of December 31, 2014, in accordance with applicable dividend restrictions, our insurance subsidiaries could pay dividends of approximately $25,507,000 in 2015 without obtaining regulatory approval. There are no regulatory restrictions on the ability of our holding company, IHC, to pay dividends. Under Delaware law, IHC is permitted to pay dividends from surplus or net profits for the fiscal year in which the dividend is declared and/or the preceding fiscal year. Dividends to shareholders are paid from funds available at the corporate holding company level.
	Non-“extraordinary” dividend payments were as follows:  (i) Madison National Life declared and paid cash dividends of $4,000,000, $3,950,000 and $3,450,000 to its parent in 2014, 2013 and 2012, respectively; (ii) Standard Security Life declared and paid dividends of $6,000,000, $8,000,000 and $7,980,000 to its parent in 2014, 2013 and 2012, respectively; and (iii)  Independence American declared and paid dividends of $0, $0 and $2,000,000 to its parent in 2014, 2013 and 2012, respectively. In February 2012, IHC announced a special 10% stock dividend payable to shareholders. See Note 11 for more information regarding the stock dividend. IHC declared cash dividends of $1,223,000 in 2014, $1,241,000 in 2013 and $1,271,000 in 2012.
	The Company’s insurance subsidiaries are required to prepare statutory financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of their state of domicile. Statutory accounting practices differ from U.S. GAAP in several respects causing differences in reported net income and stockholder’s equity. The Company’s insurance subsidiaries have no permitted accounting practices, which encompass all accounting practices not so prescribed that have been specifically allowed by the state insurance authorities.
	The statutory net income and statutory capital and surplus for each of the Company’s insurance subsidiaries are as follows for the periods indicated (in thousands):
			Years Ended December 31,
			2014		2013		2012
	Statutory net income:
	Madison National Life	$	9,876	$	11,704	$	11,903
	Standard Security Life		12,074		9,180		15,805
	Independence American		3,127		3,176		3,271
			December 31,
			2014		2013
	Statutory capital and surplus:
	Madison National Life	$	81,534	$	77,969
	Standard Security Life		116,525		113,972
	Independence American		60,168		57,875
	The insurance subsidiaries are also required to maintain certain minimum amounts of statutory surplus to satisfy their various state insurance departments of domicile. Risk-based capital (“RBC”) requirements are designed to assess capital adequacy and to raise the level of protection that statutory surplus provides for policyholders. At December 31, 2014 and 2013, the statutory capital of our insurance subsidiaries is significantly in excess of their regulatory RBC requirements.

Note_16_Segment_Reporting

Note 16. Segment Reporting	12 Months Ended
	Dec. 31, 2014
Notes
Note 16. Segment Reporting	Note 16.          Segment Reporting
	The Insurance Group principally engages in the life and health insurance business. Interest expense, taxes, and general expenses associated with parent company activities are included in Corporate. Identifiable assets by segment are those assets that are utilized in each segment and are allocated based upon the mean reserves and liabilities of each such segment. Corporate assets are composed principally of cash equivalents, resale agreements, fixed maturities, equity securities, partnership interests and certain other investments.
	Information by business segment is presented below for the years indicated (in thousands).
			2014		2013		2012
	Revenues:
	Medical Stop-Loss	$	184,775	$	171,963	$	146,378
	Fully Insured Health		239,101		278,105		171,492
	Group disability; life, annuities and DBL		67,641		63,155		52,049
	Individual life, annuities and other		34,551		41,966		53,207
	Corporate		177		105		540
			526,245		555,294		423,666
	Net realized investment gains		7,688		19,750		5,099
	Other-than-temporary impairment losses		-		-		-704
	Total revenues	$	533,933	$	575,044	$	428,061
	Income before income taxes:
	Medical Stop-Loss	$	21,933	$	12,677	$	15,818
	Fully Insured Health (A)		(1,987)		832		4,360
	Group disability; life, annuities and DBL		12,168		8,647		8,607
	Individual life, annuities and other		(6,618)		-10,396		905
	Corporate		(8,075)		-5,941		-7,380
			17,421		-5,819		22,310
	Interest expense		(1,797)		-1,915		-2,091
	Net realized investment gains		7,688		19,750		5,099
	Other-than-temporary impairment losses		-		-		-704
	Income before income taxes	$	23,312	$	23,654	$	24,614
	(A)    The Fully Insured Health segment includes amortization of intangible assets recorded as a result of purchase accounting for previous acquisitions. Total amortization expense was $1,948,000, $2,393,000 and $2,453,000 for the years ended December 31, 2014, 2013 and 2012, respectively. Amortization expense for the other segments is not material.
			December 31,
			2014		2013
	IDENTIFIABLE ASSETS AT YEAR END
	Medical Stop-Loss (A)	$	235,429	$	200,991
	Fully Insured Health (B)		170,522		198,000
	Group disability; life, annuities and DBL		231,109		213,952
	Individual life, annuities and other		525,519		620,891
	Corporate		25,138		35,201
		$	1,187,717	$	1,269,035
	(A)    The Medical Stop-Loss segment includes allocated goodwill of $5,664,000 at both December 31, 2014 and 2013.
	(B)     The Fully Insured Health segment includes allocated goodwill of $44,654,000 at both December 31, 2014 and 2013.

Note_17_Quarterly_Data_unaudit

Note 17. Quarterly Data (unaudited)	12 Months Ended
	Dec. 31, 2014
Notes
Note 17. Quarterly Data (unaudited)	Note 17.          Quarterly Data   (Unaudited)
	The quarterly results of operations for the years indicated are summarized below (in thousands, except per share data):
			FIRST		SECOND		THIRD		FOURTH
			QUARTER		QUARTER		QUARTER		QUARTER
	2014
	Total revenues	$	141,072	$	136,019	$	129,752	$	127,090
	Net income	$	4,005	$	3,880	$	4,824	$	4,212
	Less income from  noncontrolling interests
	in subsidiaries		-304		-32		-114		-178
	Net income attributable to IHC	$	3,701	$	3,848	$	4,710	$	4,034
	Basic income per common share	$	0.21	$	0.22	$	0.27	$	0.23
	Diluted income per share	$	0.21	$	0.22	$	0.27	$	0.23
			FIRST		SECOND		THIRD		FOURTH
			QUARTER		QUARTER		QUARTER		QUARTER
	2013
	Total revenues	$	137,882	$	151,900	$	141,644	$	143,618
	Net income	$	5,040	$	4,158	$	3,916	$	2,142
	Less income from  noncontrolling interests
	in subsidiaries		-339		-467		-277		-394
	Net income attributable to IHC	$	4,701	$	3,691	$	3,639	$	1,748
	Basic income per common share	$	0.26	$	0.21	$	0.21	$	0.1
	Diluted income per share	$	0.26	$	0.21	$	0.21	$	0.1

Summary_of_Investments_Other_T

Summary of Investments, Other Than Investments in Related Parties	12 Months Ended
	Dec. 31, 2014
Notes
Summary of Investments, Other Than Investments in Related Parties
	SCHEDULE I
	INDEPENDENCE HOLDING COMPANY AND SUBSIDIARIES
	SUMMARY OF INVESTMENTS – OTHER THAN INVESTMENTS IN RELATED PARTIES
	31-Dec-14
	(In thousands)
							AMOUNT
							SHOWN IN
							BALANCE
	TYPE OF INVESTMENT		COST		VALUE		SHEET
	FIXED MATURITIES - AVAILABLE-FOR-SALE:
	Bonds:
	United States Government and Government
	agencies and authorities	$	37,537	$	37,617	$	37,617
	States, municipalities and political subdivisions		238,514		239,381		239,381
	Foreign governments		34,863		34,700		34,700
	Public utilities		42,977		42,380		42,380
	All other corporate bonds		227,233		225,603		225,603
	Redeemable preferred stock		4,036		4,199		4,199
	TOTAL FIXED MATURITIES		585,160		583,880		583,880
	EQUITY SECURITIES - AVAILABLE-FOR-SALE
	AND TRADING:
	Common stocks:
	Public utilities		868		861		861
	Banks, trust and insurance companies		752		764		764
	Industrial, miscellaneous and all other		18,172		19,227		19,227
	Non-redeemable preferred stocks		4,004		4,138		4,138
	TOTAL EQUITY SECURITIES		23,796		24,990		24,990
	Policy loans		10,667		10,667		10,667
	Short-term investments and resale agreements		16,840		16,840		16,840
	Other long-term investments		14,584		14,584		14,584
	TOTAL INVESTMENTS	$	651,047	$	650,961	$	650,961

Condensed_Financial_Informatio

Condensed Financial Information of Parent Company Only Disclosure	12 Months Ended
	Dec. 31, 2014
Notes
Condensed Financial Information of Parent Company Only Disclosure
	SCHEDULE II
	INDEPENDENCE HOLDING COMPANY
	CONDENSED BALANCE SHEETS (In thousands, except share data)
	(PARENT COMPANY ONLY)
				DECEMBER 31,
				2014			2013
	ASSETS:
	Cash and cash equivalents		$	389		$	61
	Fixed maturities, available-for-sale			9,647			2,406
	Trading securities			1,916			944
	Other investments			1,146			1,146
	Investments in consolidated subsidiaries			387,270			356,378
	Deferred tax assets, net			11,414			13,347
	Goodwill			228			228
	Other assets			97			69
	TOTAL ASSETS		$	412,107		$	374,579
	LIABILITIES AND STOCKHOLDERS' EQUITY
	LIABILITIES:
	Accounts payable and other liabilities		$	7,140		$	6,403
	Amounts due to consolidated subsidiaries, net			57,220			45,000
	Income taxes payable			7,871			6,096
	Junior subordinated debt securities			38,146			38,146
	Dividends payable			628			628
	TOTAL LIABILITIES			111,005			96,273
	STOCKHOLDERS' EQUITY:
	Preferred stock (none issued)			-			-
	Common stock (A)			18,531			18,524
	Paid-in capital			127,098			126,239
	Accumulated other comprehensive income (loss)			22			(10,472)
	Treasury stock, at cost (B)			(12,141)			(8,169)
	Retained earnings			157,667			142,669
	TOTAL IHC’S STOCKHOLDERS' EQUITY			291,177			268,791
	NONCONTROLLING INTERESTS IN SUBSIDIARIES			9,925			9,515
	TOTAL EQUITY			301,102			278,306
	TOTAL LIABILITIES AND EQUITY		$	412,107		$	374,579
	(A)    Common stock $1.00 par value, 23,000,000 shares authorized; 18,531,158 and 18,523,733 shares issued, respectively, 17,371,040 and 17,660,390 shares outstanding, respectively.
	(B)    Treasury stock, at cost; 1,160,118 and 863,343 shares, respectively, outstanding.
	The financial information of Independence Holding Company (Parent Company Only) should be read in conjunction with the Consolidated Financial Statements and Notes.
	SCHEDULE II
	(Continued)
	INDEPENDENCE HOLDING COMPANY
	CONDENSED STATEMENTS OF INCOME (In thousands)
	(PARENT COMPANY ONLY)
			2014			2013			2012
	REVENUES:
	Net investment income	$	112		$	61		$	491
	Net realized investment gains (losses)		(78)			349			2
	Other income		2,129			2,327			2,251
			2,163			2,737			2,744
	EXPENSES:
	Interest expense on debt		1,546			1,563			1,638
	General and administrative expenses		5,606			4,301			5,125
			7,152			5,864			6,763
	Loss before tax benefit and equity in net income of subsidiaries		(4,989)			(3,127)			(4,019)
	Income taxes (benefits)		(2,389)			(1,228)			(1,528)
	Equity in net income of subsidiaries		19,521			17,155			25,102
	Net income		16,921			15,256			22,611
	Less income from noncontrolling interests in
	subsidiaries		(628)			(1,477)			(2,950)
	Net income attributable to IHC	$	16,293		$	13,779		$	19,661
	The financial information of Independence Holding Company (Parent Company Only) should be read in conjunction with the Consolidated Financial Statements and Notes thereto.
	SCHEDULE II
	(Continued)
INDEPENDENCE HOLDING COMPANY
CONDENSED STATEMENTS OF CASH FLOWS (In thousands)
(PARENT COMPANY ONLY)
		2014			2013			2012
CASH FLOWS PROVIDED BY (USED BY)
OPERATING ACTIVITIES:
Net income	$	16,921		$	15,256		$	22,611
Adjustments to net income:
Equity in net income of subsidiaries		(19,521)			(17,155)			(25,102)
Other		3,748			4,398			604
Changes in other assets and liabilities		440			(1,609)			(439)
Net change in cash from operating activities		1,588			890			(2,326)
CASH FLOWS PROVIDED BY (USED BY)
INVESTING ACTIVITIES:
Change in investments in and advances to subsidiaries		11,138			6,708			5,109
Purchases of fixed maturities		(9,953)			-			(11,781)
Sales of fixed maturities		2,751			3,260			6,109
Change in other  investments		-			-			3,152
Net change in cash  from investing activities		3,936			9,968			2,589
CASH FLOWS PROVIDED BY (USED BY)
FINANCING ACTIVITIES:
Repurchases of common stock		(3,972)			(3,636)			(941)
Cash paid in acquisitions of noncontrolling interests		-			(7,626)			(58)
Dividends paid		(1,233)			(620)			(1,681)
Proceeds from exercise of stock options		-			430			-
Other financing activities		9			66			(92)
Net change in cash from financing activities		(5,196)			(11,386)			(2,772)
Net change in cash and cash equivalents		328			(528)			(2,509)
Cash and cash equivalents, beginning of year		61			589			3,098
Cash and cash equivalents, end of year	$	389		$	61		$	589
The financial information of Independence Holding Company (Parent Company Only) should be read in conjunction with the Consolidated Financial Statements and Notes thereto.

Supplementary_Insurance_Inform

Supplementary Insurance Information, for Insurance Companies Disclosure	12 Months Ended
	Dec. 31, 2014
Notes
Supplementary Insurance Information, for Insurance Companies Disclosure
	SCHEDULE III
	INDEPENDENCE HOLDING COMPANY
	SUPPLEMENTARY INSURANCE INFORMATION
	(in thousands)
				FUTURE
				POLICY				INSURANCE	AMORTIZATION	SELLING
			DEFERRED	BENEFITS,		NET	NET	BENEFITS,	OF DEFERRED	GENERAL &		NET
			ACQUISITION	LOSSES &	UNEARNED	PREMIUMS	INVESTMENT	CLAIMS &	ACQUISTION	ADMINISTRATIVE		PREMIUMS
			COSTS	CLAIMS	PREMIUMS	EARNED	INCOME (1)	RESERVES	COSTS	EXPENSES (2)		WRITTEN
	31-Dec-14
	Medical Stop-Loss	$	-	80,128	-	176,941	4,327	122,469	-	40,373	$	176,941
	Fully Insured Health		624	50,767	6,568	218,949	2,202	146,431	482	94,175		215,844
	Group disability; life,
	annuities and DBL		-	147,823	2,700	64,260	3,156	37,537	-	17,936		64,632
	Individual life, annuities
	and other		30,182	421,908	187	18,898	11,830	19,598	4,459	17,112		18,894
	Corporate		-	-	-	-	177	-	-	8,252		-
		$	30,806	700,626	9,455	479,048	21,692	326,035	4,941	177,848	$	476,311
	31-Dec-13
	Medical Stop-Loss	$	-	72,307	-	166,302	5,055	115,599	-	43,687	$	166,302
	Fully Insured Health		361	57,323	9,828	248,870	2,711	177,290	22	99,961		253,569
	Group disability; life,
	annuities and DBL		-	147,426	2,398	60,004	2,763	37,463	-	17,045		60,227
	Individual life, annuities
	and other		29,416	522,973	197	20,815	16,837	24,438	15,110	12,814		20,810
	Corporate		-	-	-	-	105	-	-	6,046		-
		$	29,777	800,029	12,423	495,991	27,471	354,790	15,132	179,553	$	500,908
	31-Dec-12
	Medical Stop-Loss	$	-	59,029	-	139,724	4,990	90,406	-	40,154	$	139,724
	Fully Insured Health		48	41,034	6,897	141,546	1,733	94,700	17	72,415		145,202
	Group disability; life,
	annuities and DBL		-	126,840	1,347	49,315	2,618	27,663	-	15,779		49,212
	Individual life, annuities
	and other		33,353	535,899	209	25,482	23,475	32,022	6,549	13,731		25,479
	Corporate		-	-	-	-	540	-	-	7,920		-
		$	33,401	762,802	8,453	356,067	33,356	244,791	6,566	149,999	$	359,617
	(1)         Net investment income is allocated between product lines based on the mean reserve method.
	(2)         Where possible, direct operating expenses are specifically identified and charged to product lines. Indirect expenses are allocated based on time studies; however, other acceptable methods of allocation might produce different results.

Supplemental_Schedule_of_Reins

Supplemental Schedule of Reinsurance Premiums for Insurance Companies	12 Months Ended
	Dec. 31, 2014
Notes
Supplemental Schedule of Reinsurance Premiums for Insurance Companies
	SCHEDULE IV
	INDEPENDENCE HOLDING COMPANY
	REINSURANCE
	(In thousands)
										PERCENTAGE
					ASSUMED		CEDED			OF AMOUNT
			GROSS		FROM OTHER		TO OTHER		NET	ASSUMED
			AMOUNT		COMPANIES		COMPANIES		AMOUNT	TO NET
	Life Insurance In-Force:
	31-Dec-14	$	11,054,484	$	418,775	$	6,128,608	$	5,344,651	7.80%
	31-Dec-13	$	11,415,328	$	333,200	$	6,493,122	$	5,255,406	6.30%
	31-Dec-12	$	11,293,128	$	213,041	$	6,004,459	$	5,501,710	3.90%
	Premiums Earned:
	31-Dec-14
	Accident and health	$	482,511	$	52,063	$	116,163	$	418,411	12.40%
	Life and annuity		44,407		6,128		20,214		30,321	20.20%
	Property and liability (1)		30,477		-		161		30,316	0.00%
		$	557,395	$	58,191	$	136,538	$	479,048	12.10%
	31-Dec-13
	Accident and health	$	461,336	$	85,627	$	102,053	$	444,910	19.20%
	Life and annuity		46,416		6,654		20,820		32,250	20.60%
	Property and liability (1)		18,845		-		14		18,831	0.00%
		$	526,597	$	92,281	$	122,887	$	495,991	18.60%
	31-Dec-12
	Accident and health	$	396,805	$	60,232	$	140,653	$	316,384	19.00%
	Life and annuity		47,790		7,538		18,916		36,412	20.70%
	Property and liability (1)		3,271		-		-		3,271	0.00%
		$	447,866	$	67,770	$	159,569	$	356,067	19.00%
	(1)     Property and liability products consist primarily of our new pet insurance line.

Note_1_Organization_Consolidat1

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Basis of Presentation (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Basis of Presentation	The Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect:  (i) the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements; and (ii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Note_1_Organization_Consolidat2

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Reclassification Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Reclassification Policy	Certain amounts in prior year’s Consolidated Financial Statements and Notes thereto have been reclassified to conform to the 2014 presentation.

Note_1_Organization_Consolidat3

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Cash and Cash Equivalents, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Cash and Cash Equivalents, Policy	Cash equivalents are carried at cost which approximates fair value and include principally interest-bearing deposits at brokers, money market instruments and U.S. Treasury securities with original maturities of less than 91 days.  Investments with original maturities of 91 days to one year are considered short-term investments and are carried at cost which approximates fair value.

Note_1_Organization_Consolidat4

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Repurchase and Resale Agreements Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Repurchase and Resale Agreements Policy	Securities purchased under agreements to resell ("resale agreements") are carried at the amounts at which the securities will be subsequently resold as specified in the agreements. Resale agreements are utilized to invest excess funds on a short-term basis. At December 31, 2014, the Company had $16,790,000 invested in resale agreements, all of which settled on January 2, 2015 and were subsequently reinvested. The Company maintains control of securities purchased under resale agreements, values the collateral on a daily basis and obtains additional collateral, if necessary, to protect the Company in the event of default by the counterparties.

Note_1_Organization_Consolidat5

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Investment Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Investment Policy	(G)        Investment Securities
	(i) Investments in fixed maturities, redeemable preferred securities and equity securities are accounted for as follows:
	(a) Securities which are held for trading purposes are carried at estimated fair value ("fair value").  Changes in fair value are credited or charged, as appropriate, to net realized investment gains (losses) in the Consolidated Statements of Income.
	(b) Securities not held for trading purposes which may or may not be held to maturity ("available-for-sale securities") are carried at fair value. Unrealized gains and losses deemed temporary, net of deferred income taxes and adjustments to deferred policy acquisition costs, are credited or charged, as appropriate, to other comprehensive income or loss. Premiums and discounts on debt securities purchased at other than par value are amortized and accreted, respectively, to interest income in the Consolidated Statements of Income, using the constant yield method over the period to maturity.
	(ii) Gains or losses on sales of securities are determined on the basis of specific identification and are recorded in net realized investment gains (losses) in the Consolidated Statements of Income on the trade date.
	(iii) Fair value is determined using quoted market prices when available. In some cases, we use quoted market prices for similar instruments in active markets and/or model-derived valuations where inputs are observable in active markets. When there are limited or inactive trading markets, we use industry-standard pricing methodologies, including discounted cash flow models, whose inputs are based on management assumptions and available current market information. Further, we retain independent pricing vendors to assist in valuing certain instruments. Most of the securities in our portfolio are classified in either Level 1 or Level 2 of the Fair Value Hierarchy.
	The Company periodically reviews and assesses the vendor’s qualifications and the design and appropriateness of its pricing methodologies.  Management will on occasion challenge pricing information on certain individual securities and, through communications with the vendor, obtain information about the assumptions, inputs and methodologies used in pricing those securities, and corroborate it against documented pricing methodologies. Validation procedures are in place to determine completeness and accuracy of pricing information, including, but not limited to: (i) review of exception reports that (a) identify any zero or un-priced securities; (b) identify securities with no price change; and (c) identify securities with significant price changes; (ii) performance of trend analyses; (iii) periodic comparison of pricing to alternative pricing sources; and (iv) comparison of pricing changes to expectations based on rating changes, benchmarks or control groups.  In certain circumstances, pricing is unavailable from the vendor and broker pricing information is used to determine fair value. In these instances, management will assess the quality of the data sources, the underlying assumptions and the reasonableness of the broker quotes based on the current market information available. To determine if an exception represents an error, management will often have to exercise judgment. Procedures to resolve an exception vary depending on the significance of the security and its related class, the frequency of the exception, the risk of material misstatement, and the availability of information for the security. These procedures include, but are not limited to; (i) a price challenge process with the vendor; (ii) pricing from a different vendor; (iii) a reasonableness review;  and (iv) a change in price based on better information, such as an actual market trade, among other things.  Management considers all facts and relevant information obtained during the above procedures to determine the proper classification of each security in the Fair Value Hierarchy.
	(iv) The Company reviews its investment securities regularly and determines whether other-than-temporary impairments have occurred. The factors considered by management in its regular review to identify and recognize other-than-temporary impairment losses on fixed maturities include, but are not limited to:  the length of time and extent to which the fair value has been less than cost; the Company's intent to sell, or be required to sell, the debt security before the anticipated recovery of its remaining amortized cost basis; the financial condition and near-term prospects of the issuer; adverse changes in ratings announced by one or more rating agencies; subordinated credit support; whether the issuer of a debt security has remained current on principal and interest payments; current expected cash flows; whether the decline in fair value appears to be issuer specific or, alternatively, a reflection of general market or industry conditions including the effect of changes in market interest rates. If the Company intends to sell a debt security, or it is more likely than not that it would be required to sell a debt security before the recovery of its amortized cost basis, the entire difference between the security's amortized cost basis and its fair value at the balance sheet date would be recognized by a charge to total other-than-temporary impairment losses in the Consolidated Statement of Income.  If a decline in fair value of a debt security is judged by management to be other-than-temporary and; (i) the Company does not intend to sell the security; and (ii) it is not more likely than not that it will be required to sell the security prior to recovery of the security’s amortized cost, the Company assesses whether the present value of the cash flows to be collected from the security is less than its amortized cost basis. To the extent that the present value of the cash flows generated by a debt security is less than the amortized cost basis, a credit loss exists. For any such security, the impairment is bifurcated into (a) the amount of the total impairment related to the credit loss, and (b) the amount of the total impairment related to all other factors. The amount of the other-than-temporary impairment related to the credit loss is recognized by a charge to total other-than-temporary impairment losses in the Consolidated Statement of Income, establishing a new cost basis for the security. The amount of the other-than-temporary impairment related to all other factors is recognized in other comprehensive income (loss). It is reasonably possible that further declines in estimated fair values of such investments, or changes in assumptions or estimates of anticipated recoveries and/or cash flows, may cause further other-than-temporary impairments in the near term, which could be significant.
	In assessing corporate debt securities for other-than-temporary impairment, the Company evaluates the ability of the issuer to meet its debt obligations and the value of the company or specific collateral securing the debt position. For mortgage-backed securities where loan level data is not available, the Company uses a cash flow model based on the collateral characteristics. Assumptions about loss severity and defaults used in the model are primarily based on actual losses experienced and defaults in the collateral pool. Prepayment speeds, both actual and estimated, are also considered. The cash flows generated by the collateral securing these securities are then determined with these default, loss severity and prepayment assumptions. These collateral cash flows are then utilized, along with consideration for the issue’s position in the overall structure, to determine the cash flows associated with the mortgage-backed security held by the Company. In addition, the Company evaluates other asset-backed securities for other-than-temporary impairment by examining similar characteristics referenced above for mortgage-backed securities.  The Company evaluates U.S. Treasury securities and obligations of U.S. Government corporations, U.S. Government agencies, and obligations of states and political subdivisions for other-than-temporary impairment by examining the terms and collateral of the security.
	Equity securities may experience other-than-temporary impairment in the future based on the prospects for full recovery in value in a reasonable period of time and the Company’s ability and intent to hold the security to recovery. If a decline in fair value is judged by management to be other-than-temporary or management does not have the intent or ability to hold a security, a loss is recognized by a charge to total other-than-temporary impairment losses in the Consolidated Statement of Income. For the purpose of other-than-temporary impairment evaluations, redeemable preferred stocks are evaluated in a manner similar to debt securities. Declines in the creditworthiness of the issuer of debt securities with both debt and equity-like features are evaluated using the equity model in consideration of other-than-temporary impairment.
	Subsequent increases and decreases, if not an other-than-temporary impairment, in the fair value of available-for-sale securities that were previously impaired, are recorded in other comprehensive income (loss).
	(H)       Other Investments
	Investment partnership interests relate to limited investment partnerships that are relatively insensitive to interest rates. All securities held by these partnerships are carried at fair value with changes in fair value credited or charged, as appropriate, to the Consolidated Statements of Income. The Company's investment partnership interests are carried at a value which approximates the Company's equity in the underlying net assets of the partnerships or the equivalent of the net asset value per share. Operating partnership interests relate to insurance related limited operating partnerships. The Company's operating partnership interests are carried on the equity method which approximates the Company's equity in the underlying net assets of the partnership. Equity income or loss on partnership interests are credited or charged, as appropriate, to the Consolidated Statements of Income.
	Policy loans are stated at their aggregate unpaid balances.

Note_1_Organization_Consolidat6

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Deferred Policy Acquisition Costs, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Deferred Policy Acquisition Costs, Policy	Costs that vary with and are primarily related to the successful acquisition of insurance policies and investment type contracts are deferred and recorded as deferred policy acquisition costs ("DAC").  These costs are principally broker fees, agent commissions, and the purchase prices of the acquired blocks of insurance policies and investment type policies. DAC is amortized to expense and reported separately in the Consolidated Statements of Income. All DAC within a particular product type is amortized on the same basis using the following methods:
	For traditional life insurance and other premium paying policies, amortization of DAC is charged to expense over the related premium revenue recognition period.  Assumptions used in the amortization of DAC are determined based upon the conditions as of the date of policy issue or assumption and are not generally revised during the life of the policy.
	For long duration type contracts, such as annuities and universal life business, amortization of DAC is charged to expense over the life of the underlying contracts based on the present value of the estimated gross profits ("EGPs") expected to be realized over the life of the book of contracts.  EGPs consist of margins based on expected mortality rates, persistency rates, interest rate spreads, and other revenues and expenses. The Company regularly evaluates its EGPs to determine if actual experience or other evidence suggests that earlier estimates should be revised. If the Company determines that the current assumptions underlying the EGPs are no longer the best estimate for the future due to changes in actual versus expected mortality rates, persistency rates,  interest rate spreads, or other revenues and expenses,  the future EGPs are updated using the new assumptions and prospective unlocking occurs.  These updated EGPs are utilized for future amortization calculations.   The total amortization recorded to date is adjusted through a current charge or credit to the Consolidated Statements of Income.
	Internal replacements of insurance and investment contracts determined to result in a  replacement contract that is substantially changed from the original contract will be accounted for as an extinguishment of the original contract, resulting in a release of the unamortized deferred acquisition costs, unearned revenue, and deferral of sales inducements associated with the replaced contract.
	Deferred acquisition costs have been increased (decreased) by $(323,000), $5,681,000 and $(2,930,000) in 2014, 2013 and 2012 respectively, representing the amortization of DAC due to unrealized gains and losses on investment securities available-for-sale. A corresponding increase or decrease was recorded in other comprehensive income or loss.

Note_1_Organization_Consolidat7

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Property, Plant and Equipment, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Property, Plant and Equipment, Policy	Improvements are capitalized while repair and maintenance costs are charged to operations as incurred. Depreciation of property and equipment has been provided on the straight-line method over the estimated useful lives of the respective assets. Amortization of leasehold improvements has been provided on the straight-line method over the shorter of the lease term or the estimated useful life of the asset.

Note_1_Organization_Consolidat8

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Goodwill and Intangible Assets, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Goodwill and Intangible Assets, Policy	Goodwill carrying amounts are evaluated for impairment at the reporting unit level, which is equivalent to an operating segment, at least annually. If the fair value of a reporting unit is less than its carrying amount, further evaluation is required to determine if a write-down of goodwill is required. In determining the fair value of each reporting unit, we used an income approach, applying a discounted cash flow method which included a residual value.  Based on historical experience, we make assumptions as to: (i) expected future performance and future economic conditions, (ii) projected operating earnings, (iii) projected new and renewal business as well as profit margins on such business, and (iv) a discount rate that incorporated an appropriate risk level for the reporting unit. Any impairment of goodwill would be charged to expense.
	Other intangible assets are amortized to expense over their estimated useful lives and are subject to impairment testing. Any impairment of other intangible assets would be charged to expense.

Note_1_Organization_Consolidat9

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Liability Reserve Estimate, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Liability Reserve Estimate, Policy	The Company maintains loss reserves to cover its estimated liability for unpaid losses and loss adjustment expenses, where material, including legal, other fees, and costs not associated with specific claims but related to the claims payment function), for reported and unreported claims incurred as of the end of each accounting period.  These loss reserves are based on actuarial assumptions and are maintained at levels that are in accordance with U.S. GAAP.  Many factors could affect these reserves, including economic and social conditions, frequency and severity of claims, medical trend resulting from the influences of underlying cost inflation, changes in utilization and demand for medical services, and changes in doctrines of legal liability and damage awards in litigation. Therefore, the Company’s reserves are necessarily based on estimates, assumptions and analysis of historical experience. The Company’s results depend upon the variation between actual claims experience and the assumptions used in determining reserves and pricing products. Reserve assumptions and estimates require significant judgment and, therefore, are inherently uncertain. The Company cannot determine with precision the ultimate amounts that will be paid for actual claims or the timing of those payments. The Company's estimate of loss represents management's best estimate of the Company's liability at the balance sheet date.
	Loss reserves differ for short-duration and long-duration insurance policies, including annuities. Reserves are based on approved actuarial methods, but necessarily include assumptions about expenses, mortality, morbidity, lapse rates and future yield on related investments.

Recovered_Sheet1

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Unpaid Policy Claims and Claims Adjustment Expense, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Unpaid Policy Claims and Claims Adjustment Expense, Policy	All of the Company’s short-duration contracts are generated from its accident, health, disability and pet insurance business, and are accounted for based on actuarial estimates of the amount of loss inherent in that period’s claims, including losses incurred for which claims have not been reported. Short-duration contract loss estimates rely on actuarial observations of ultimate loss experience for similar historical events.
	Medical Stop-Loss
	Liabilities for policy benefits and claims on medical stop-loss coverage are computed using completion factors and expected Net Loss Ratios derived from actual historical premium and claim data. Policy benefits and claims for medical stop-loss insurance are more volatile in nature than those for fully insured medical insurance.  This is primarily due to the excess nature of medical stop-loss, with very high deductibles applying to specific claims on any individual claimant and in the aggregate for a given group.  The level of these deductibles makes it more difficult to predict the amount and payment pattern of such claims.  Furthermore, these excess claims are highly sensitive to changes in factors such as medical trend, provider contracts and medical treatment protocols, adding to the difficulty in predicting claim values and estimating reserves.  Also, because medical stop-loss is in excess of an underlying benefit plan, there is an additional layer of claim reporting and processing that can affect claim payment patterns.  Finally, changes in the distribution of business by effective month can affect reserve estimates due to the timing of claim occurrences and the time required to accumulate claims against the stop-loss deductible.
	The two “primary” or “key” assumptions underlying the calculation of policy benefits and claims for Medical Stop-Loss business are (i) projected Net Loss Ratio, and (ii) claim development patterns.  The projected Net Loss Ratio is set at expected levels consistent with the underlying assumptions (“Projected Net Loss Ratio”). Claim development patterns are set quarterly as reserve estimates are developed and are based on recent claim development history (“Claim Development Patterns”).  The Company uses the Projected Net Loss Ratio to establish reserves until developing losses provide a better indication of ultimate results and it is feasible to set reserves based on Claim Development Patterns. The Company has concluded that a reasonably likely change in the Projected Net Loss Ratio assumption could have a material effect on the Company’s financial condition, results of operations, or liquidity (“Material Effect”) but a reasonably likely change in the Claim Development Pattern would not have a Material Effect.
	Projected Net Loss Ratio
	Generally, during the first twelve months of an underwriting year, policy benefits for Medical Stop-Loss are first set at the Projected Net Loss Ratio, which is set using assumptions developed using completed prior experience trended forward. The Projected Net Loss Ratio is the Company’s best estimate of future performance until such time as developing losses provide a better indication of ultimate results.
	Major factors that affect the Projected Net Loss Ratio assumption in reserving for Medical Stop-Loss relate to: (i) frequency and severity of claims; (ii) changes in medical trend resulting from the influences of underlying cost inflation, changes in utilization and demand for medical services, the impact of new medical technology and changes in medical treatment protocols; and (iii) the adherence to the Company’s underwriting guidelines.
	Claim Development Patterns
	Subsequent to the first twelve months of an underwriting year, the Company’s developing losses provide a better indication of ultimate losses. At this point, claims have developed to a level where Claim Development Patterns can be applied to generate reasonably reliable estimates of ultimate claim levels.  Development factors based on historical patterns are applied to paid and reported claims to estimate fully developed claims. Claim Development Patterns are reviewed quarterly as reserve estimates are developed and are based on recent claim development history. The Company must determine whether changes in development represent true indications of emerging experience or are simply due to random claim fluctuations.
	The Company also establishes its best estimates of claim development factors to be applied to more developed treaty year experience.  While these factors are based on historical Claim Development Patterns, actual claim development may vary from these estimates.
	Predicting ultimate claims and estimating reserves in Medical Stop-Loss is more complex than fully insured medical and disability business due to the “excess of loss” nature of these products with very high deductibles applying to specific claims on any individual claimant and in the aggregate for a given group.  The level of these deductibles makes it more difficult to predict the amount and payment pattern of such claims.  Fluctuations in results for specific coverage are primarily due to the severity and frequency of individual claims, whereas fluctuations in aggregate coverage are largely attributable to frequency of underlying claims rather than severity. Liabilities for first dollar medical reserves and disability coverages are computed using completion factors and expected Net Loss Ratios derived from actual historical premium and claim data.
	Due to the short-term nature of Medical Stop-Loss, redundancies or deficiencies will typically emerge during the course of the following year rather than over a number of years.  For Employer Stop-Loss, as noted above, the Company maintains its reserves based on underlying assumptions until it determines that an adjustment is appropriate based on emerging experience from all of its MGUs for prior underwriting years.
	Fully Insured Health
	Policy benefits and claims for Fully Insured Health business are established to provide for the liability for incurred but not paid claims.  Policy benefits and claims are calculated using standard actuarial methods and practices. The “primary” assumption in the determination of Fully Insured Health reserves is that historical Claim Development Patterns are representative of future Claim Development Patterns. Factors which may affect this assumption include changes in claim payment processing times and procedures, changes in time delay in submission of claims, and the incidence of unusually large claims. Liabilities for policy benefits and claims for fully insured medical and disability coverage are computed using completion factors and expected Net Loss Ratios derived from actual historical premium and claim data.  The reserving analysis includes a review of claim processing statistical measures and large claim early notifications; the potential impacts of any changes in these factors are not material. The delay in submission of claims tends to be stable over time and not subject to significant volatility.
	While these calculations are based on standard methodologies, they are estimates based on historical patterns.  To the extent that actual claim payment patterns differ from historical patterns, such estimated reserves may be redundant or inadequate.  The effects of such deviations are evaluated by considering claim backlog statistics and reviewing the reasonableness of projected claim ratios.  Other factors which may affect the accuracy of policy benefits and claim estimates include the proportion of large claims which may take longer to adjudicate, changes in billing patterns by providers and changes in claim management practices such as hospital bill audits.
	Long Term Disability
	Policy benefits and claims for the Company’s long term disability products are developed using actuarial principles and assumptions that consider, among other things, future offsets and recoveries, elimination periods, interest rates, probability of rehabilitation or mortality, incidence and termination rates based on the Company’s experience.  The liability for policy benefits and claims is made up of case reserves, incurred but not reported reserves, reopen reserves, and loss adjustment expense.  Incurred but not reported and reopen reserves are calculated by a hind-sight study, which takes historical experience and develops the reserve as a percentage of premiums from prior years.
	The two “primary” assumptions on which long term disability reserves are based are: (i) morbidity levels; and (ii) recovery rates. If morbidity levels increase, for example due to an epidemic or a recessionary environment, the Company would increase reserves because there would be more new claims than expected.  In regard to the assumed recovery rate, if disabled lives recover more quickly than anticipated then the existing claims reserves would be reduced; if less quickly, the existing claims reserves would be increased.
	Management believes that the Company's methods of estimating the liabilities for policy benefits and claims provided appropriate levels of reserves at December 31, 2014 and 2013. Changes in the Company's policy benefits and claims estimates are generally recorded through a charge or credit to its earnings.

Recovered_Sheet2

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Future Policy Benefits Liability, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Future Policy Benefits Liability, Policy	The liability for future policy benefits consists of the liabilities associated with the Company’s long-duration contracts, primarily its life and annuity products. For traditional life insurance products, the Company computes the liability for future policy benefits primarily using the net premium method based on anticipated investment yield, mortality, and withdrawals. These methods are widely used in the life insurance industry to estimate the liabilities for future policy benefits. Inherent in these calculations are management and actuarial judgments and estimates that could significantly impact the ending reserve liabilities and, consequently, operating results.  Actual results may differ, and these estimates are subject to interpretation and change.
	Management believes that the Company's methods of estimating the liabilities for future policy benefits provided appropriate levels of reserves at December 31, 2014 and 2013. Changes in the Company's future policy benefits estimates are recorded through a charge or credit to its earnings.

Recovered_Sheet3

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Deposit Contracts, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Deposit Contracts, Policy	Funds received (net of mortality and expense charges) for certain long-duration contracts (principally deferred annuities and universal life policies) are credited directly to a policyholder liability account, funds on deposit. Withdrawals are recorded directly as a reduction of respective policyholders' funds on deposit. Amounts on deposit were credited at annual rates ranging from 3.0% to 8.0% in 2014, 2.5% to 8.0% in 2013, and 2.7% to 8.0% in 2012.

Recovered_Sheet4

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Policyholder Accounts, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Policyholder Accounts, Policy	Other policyholders’ funds represent interest-bearing liabilities arising from the sale of products, such as universal life, interest-sensitive life and annuities.  Policyholder funds are primarily comprised of deposits received and interest credited to the benefit of the policyholder less surrenders and withdrawals, mortality charges and administrative expenses.
	Interest credited to policyholder funds represents interest accrued or paid on interest-sensitive life policies and investment policies.  These amounts are reported in insurance benefits, claims and reserves on the Consolidated Statements of Income.  Credit rates for certain annuities and interest-sensitive life policies are adjusted periodically by the Company to reflect current market conditions, subject to contractually guaranteed minimum rates.

Recovered_Sheet5

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Derivatives, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Derivatives, Policy	All derivatives, whether designated in hedging relationships or not, are required to be recorded in the balance sheet as assets or liabilities at fair value. Hedge accounting is permitted only if certain criteria are met, including a requirement that a highly effective relationship exist between the derivative instrument and the hedged item, both at inception of the hedge and on an ongoing basis. Results of effective hedges are recognized in other comprehensive income or loss for cash flow hedges. The ineffective portions of hedge results are recognized in current earnings.
	At December 31, 2014, the Company had an interest rate swap agreement that converts an outstanding term loan from a variable rate to a fixed rate. This agreement was designated and effective as a cash flow hedge. The objective of the swap is to reduce the variability in cash flows associated with the re-pricing of interest rates on certain variable rate debt. Changes in fair value of the swap were recorded through other comprehensive income or loss.

Recovered_Sheet6

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Income Tax, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Income Tax, Policy	The provision for deferred income taxes is based on the asset and liability method of accounting for income taxes. Under this method, deferred income taxes are recognized by applying enacted statutory tax rates to temporary differences between amounts reported in the Consolidated Financial Statements and the tax bases of existing assets and liabilities in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is recognized for the portion of deferred tax assets that, in management's judgment, is not likely to be realized.  A liability for uncertain tax positions is recorded when it is more likely than not that a tax position will not be sustained upon examination by taxing authorities. The effect on deferred income taxes of a change in tax rates or laws is recognized in income tax expense in the period that includes the enactment date.
	Interest and penalties are classified as other interest expense and are included in selling, general and administrative expenses in the Consolidated Statements of Income.

Recovered_Sheet7

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Reinsurance Accounting Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Reinsurance Accounting Policy	Amounts paid for or recoverable under reinsurance contracts are included in total assets or total liabilities as due from reinsurers or due to reinsurers. The cost of reinsurance related to long-duration contracts is accounted for over the life of the underlying reinsured policies using assumptions consistent with those used to account for the underlying policies.

Recovered_Sheet8

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Insurance Premiums Revenue Recognition, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Insurance Premiums Revenue Recognition, Policy	Premiums from short-duration medical insurance contracts are intended to cover expected claim costs resulting from insured events that occur during a fixed period of short duration.  The Company has the ability to not renew the contract or to revise the premium rates at the end of each annual contract period to cover future insured events.  Insurance premiums from annual health contracts are collected monthly and are recognized as revenue evenly as insurance protection is provided.
	Premiums related to long-term and short-term disability contracts are recognized on a pro rata basis over the applicable contract term.
	Traditional life insurance products consist principally of products with fixed and guaranteed premiums and benefits, primarily term and whole life insurance products.  Revenue from these products are recognized as premium when due.
	Annuities and interest-sensitive life contracts, such as universal life and interest sensitive whole life, are contracts whose terms are not fixed and guaranteed.  Premiums from these policies are reported as funds on deposit.  Policy charges consist of fees assessed against the policyholder for cost of insurance (mortality risk), policy administration and early surrender.  These revenues are recognized when assessed against the policyholder account balance.
	Policies that do not subject the Company to significant risk arising from mortality or morbidity are considered investment contracts. Deposits received for such contracts are reported as other policyholder funds.  Policy charges for investment contracts consist of fees assessed against the policyholder account for maintenance, administration and surrender of the policy prior to contractually specified dates, and are recognized when assessed against the policyholder account balance.

Recovered_Sheet9

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Policyholders' Dividend, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Policyholders' Dividend, Policy	Dividends to policyholders are determined annually and are payable only upon declaration by the Board of Directors of the insurance companies.

Recovered_Sheet10

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Earnings Per Share, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Earnings Per Share, Policy	Included in the diluted earnings per share calculation for 2014, 2013 and 2012 are 165,000, 113,000 and 109,000 incremental common shares, respectively, primarily from the dilutive effect of share-based payment awards, computed using the treasury stock method.

Recovered_Sheet11

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Compensation Related Costs, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Compensation Related Costs, Policy	Compensation costs for equity awards, such as stock options and non-vested stock, are measured based on grant-date fair value and are recognized in the Consolidated Statements of Income over the requisite service period (which is usually the vesting period). For such awards with only service conditions, the Company recognizes the compensation cost on a straight-line basis over the requisite service period for the entire award.
	Compensation costs for liability-classified awards, such as share appreciation rights (“SARs”) and share-based performance awards, are measured and accrued each reporting period in the Consolidated Statements of Income as the requisite service or performance conditions are met.

Recovered_Sheet12

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: New Accounting Pronouncements (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
New Accounting Pronouncements	Recently Adopted Accounting Standards
	In July 2013, the Financial Accounting Standards Board (“FASB”) issued guidance for the presentation of unrecognized tax benefits to better reflect the manner in which an entity would settle, at the reporting date, any additional income taxes that would result from the disallowance of a tax position when net operating loss carryforwards, similar tax losses, or tax credit carryforwards exist. The adoption of this guidance, effective January 1, 2014, did not have an effect on the Company’s consolidated financial statements.
	In July 2011, the FASB issued guidance specifying that the liability for the fees paid to the Federal Government by health insurers as a result of recent healthcare reform legislation should be estimated and recorded in full once the entity provides qualifying health insurance in the applicable calendar year in which the fee is payable with a corresponding deferred cost that is amortized to expense using a straight-line method of allocation unless another method better allocates the fee over the calendar year that it is payable. The amendments in this Update became effective January 1, 2014 and in accordance with the provisions, IHC recorded the estimated gross liability for the mandated fees payable to the Federal Government of $1,500,000 and the corresponding deferred cost in the first quarter of 2014. The amounts were recorded in accounts payable, accruals and other liabilities and in other assets, respectively, on the Consolidated Balance Sheet. Upon final assessment in June 2014, the Company increased its gross liability for the mandated fees payable to the Federal Government to $1,816,000. The deferred asset was amortized ratably over the calendar year to selling, general and administrative expense in the Consolidated Statement of Income.
	Recently Issued Accounting Standards Not Yet Adopted
	In February 2015, the FASB issued guidance that modifies the evaluation of whether limited partnerships and similar legal entities are variable interest entities or voting interest entities for the purpose of consolidation. For public entities, this guidance is effective for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years. Early adoption is permitted. Management has not yet determined the impact that the adoption of this guidance will have on the Company’s consolidated financial statements.
	In June 2014, the FASB issued explicit guidance for entities that grant their employees share-based payments in which the terms of the award include a performance target that affects vesting and could be achieved after the requisite service period.  This guidance is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2015. Earlier adoption is permitted. The guidance may be applied either prospectively to all awards granted or modified after the effective date or retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements.
	In May 2014, the FASB issued revenue recognition guidance for entities that either enter into contracts with customers to transfer goods or services or enter into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards such as insurance contracts or lease contracts. The amendment provides specific steps that an entity should apply in order to achieve its main objective which is recognizing revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For public entities, this guidance is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period, and requires one of two specified retrospective methods of application. Early application is prohibited. Management has not yet determined the impact that the adoption of this guidance will have on the Company’s consolidated financial statements.
	In April 2014, the FASB issued guidance: (i) improving the definition of discontinued operations by limiting the reporting of discontinued operations to disposals of components that represent strategic shifts that have (or will have) a major effect on an entity’s operations and financial results; and (ii) requiring expanded disclosures for discontinued operations. Public entities are required to apply this guidance to: (i) all disposals (or classifications as held for sale) of components of the entity that occur within annual periods beginning on or after December 15, 2014, and interim periods within those years; and (ii) to all businesses that, on acquisition, are classified as held for sale that occur within annual periods beginning on or after December 15, 2014, and interim periods within those years. Early adoption is permitted, but only for disposals (or classifications as held for sale) that have not been reported in previously issued financial statements. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements.

Note_4_Fair_Value_Disclosures_

Note 4. Fair Value Disclosures: Fair Value of Financial Instruments, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Fair Value of Financial Instruments, Policy	For all financial and non-financial assets and liabilities accounted for at fair value on a recurring basis, the Company utilizes valuation techniques based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market expectations. These two types of inputs create the following fair value hierarchy:
	Level 1 - Quoted prices for identical instruments in active markets.
	Level 2 - Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
	Level 3 - Instruments where significant value drivers are unobservable.

Note_4_Fair_Value_Disclosures_1

Note 4. Fair Value Disclosures: Fair Value Transfer, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Fair Value Transfer, Policy	It is the Company’s policy to recognize transfers of assets and liabilities between levels of the fair value hierarchy at the end of a reporting period. The Company does not transfer out of Level 3 and into Level 2 until such time as observable inputs become available and reliable or the range of available independent prices narrow.

Note_12_Sharebased_Compensatio1

Note 12. Share-based Compensation: Share-based Compensation, Option and Incentive Plans Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Independence Holding Company Share Based Plans Total Member
Share-based Compensation, Option and Incentive Plans Policy	In June 2006, the stockholders approved the Independence Holding Company 2006 Stock Incentive Plan (the “2006 Plan"). Under the terms of the 2006 Plan, option exercise prices are more than or equal to the quoted market price of the shares at the date of grant; option terms are generally five years; and vesting periods are generally three years. The fair value of an option award is estimated on the date of grant using the Black-Scholes option valuation model. In addition to stock options, the Company has also granted restricted stock units, share appreciation rights (“SARs”) and share-based performance awards under the 2006 Plan. Restricted share units are valued at the quoted market price of the shares at the date of grant and have a three year vesting period. Compensation costs for options and restricted share units are recognized over the stated vesting periods on a straight-line basis. Exercise prices of SARs are more than or equal to the quoted market price of IHC shares at the date of the grant and have three year vesting periods. The fair value of SARs is calculated using the Black-Scholes valuation model at the grant date and each subsequent reporting period until settlement. Compensation cost is based on the proportionate amount of the requisite service that has been rendered to date. Once fully vested, changes in fair value of the SARs continue to be recognized as compensation expense in the period of the change until settlement. Compensation costs for share-based performance awards are recognized and accrued as performance conditions are met, based on the current share price. IHC discontinued these award programs in 2013.
American Independence Corp Share Based Plans Total Member
Share-based Compensation, Option and Incentive Plans Policy	Effective July 1, 2009, AMIC implemented the 2009 Stock Incentive Plan (“AMIC 2009 Plan”), which the AMIC stockholders approved on June 19, 2009.  The AMIC 2009 Plan was preceded by the 1988 Stock Incentive Plan which expired by its terms in 2008. The AMIC 2009 Plan provided for the grants of non-statutory and incentive stock options, stock appreciation rights, restricted stock awards, performance shares, and other awards to officers, employee and other individuals.  Under the terms of the AMIC 2009 Plan, stock options have a maximum term of ten years from the date of grant, and have various vesting criteria depending on the grant with most grants vesting ratably over four years. At December 31, 2014, stock options for 166,616 common stock shares were outstanding, stock options for 148,837 common stock shares were vested, and 6,490,553 common stock shares that had not been issued remained available for future stock options grants and other awards.  Awards made under AMIC’s 1998 Plan prior to its expiration are still in effect.

Note_16_Segment_Reporting_Segm

Note 16. Segment Reporting: Segment Reporting, Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Segment Reporting, Policy	The Insurance Group principally engages in the life and health insurance business. Interest expense, taxes, and general expenses associated with parent company activities are included in Corporate. Identifiable assets by segment are those assets that are utilized in each segment and are allocated based upon the mean reserves and liabilities of each such segment. Corporate assets are composed principally of cash equivalents, resale agreements, fixed maturities, equity securities, partnership interests and certain other investments.

Recovered_Sheet13

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net
			2014		2013		2012
	Changes in IHC’s paid-in capital:
	Purchases of AMIC shares	$	-	$	(1,571)	$	29
	Repurchases of shares by AMIC		-		403		-
	Net transfers from noncontrolling interests	$	-	$	(1,168)	$	29

Note_2_Investment_Securities_S

Note 2. Investment Securities: Schedule of Available-for-sale Securities Reconciliation (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Available-for-sale Securities Reconciliation
			December 31, 2014
					GROSS		GROSS
			AMORTIZED		UNREALIZED		UNREALIZED		FAIR
			COST		GAINS		LOSSES		VALUE
	FIXED MATURITIES
	AVAILABLE-FOR-SALE:
	Corporate securities	$	264,162	$	1,076	$	(3,314)	$	261,924
	CMOs - residential (1)		5,073		55		(22)		5,106
	CMOs - commercial		975		-		(22)		953
	U.S. Government obligations		22,766		126		-		22,892
	Agency MBS - residential (2)		65		4		-		69
	GSEs (3)		14,706		36		(86)		14,656
	States and political subdivisions		238,514		3,253		(2,386)		239,381
	Foreign governments		34,863		136		(299)		34,700
	Redeemable preferred stocks		4,036		163		-		4,199
	Total fixed maturities	$	585,160	$	4,849	$	(6,129)	$	583,880
	EQUITY SECURITIES
	AVAILABLE-FOR-SALE:
	Common stocks	$	8,452	$	1,452	$	(147)	$	9,757
	Nonredeemable preferred stocks		4,004		134		-		4,138
	Total equity securities	$	12,456	$	1,586	$	(147)	$	13,895
			December 31, 2013
					GROSS		GROSS
			AMORTIZED		UNREALIZED		UNREALIZED		FAIR
			COST		GAINS		LOSSES		VALUE
	FIXED MATURITIES
	AVAILABLE-FOR-SALE:
	Corporate securities	$	215,412	$	1,315	$	(7,467)	$	209,260
	CMOs - residential (1)		2,457		8		(8)		2,457
	CMOs - commercial		975		-		(382)		593
	U.S. Government obligations		15,596		271		(6)		15,861
	Agency MBS - residential (2)		79		4		-		83
	GSEs (3)		28,484		4		(340)		28,148
	States and political subdivisions		256,645		2,435		(9,377)		249,703
	Foreign governments		34,437		20		(2,107)		32,350
	Redeemable preferred stocks		4,036		74		(278)		3,832
	Total fixed maturities	$	558,121	$	4,131	$	(19,965)	$	542,287
	EQUITY SECURITIES
	AVAILABLE-FOR-SALE:
	Common stocks	$	7,517	$	328	$	(70)	$	7,775
	Nonredeemable preferred stocks		4,004		58		(34)		4,028
	Total equity securities	$	11,521	$	386	$	(104)	$	11,803
	(1)         Collateralized mortgage obligations (“CMOs”).
	(2)         Mortgage-backed securities (“MBS”).
	(3)         Government-sponsored enterprises (“GSEs’) are private enterprises established and chartered by the Federal Government or its various insurance and lease programs which carry the full faith and credit obligation of the U.S. Government.

Note_2_Investment_Securities_I

Note 2. Investment Securities: Investments Classified by Contractual Maturity Date (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Investments Classified by Contractual Maturity Date
			AMORTIZED		FAIR
			COST		VALUE
	Due in one year or less	$	14,551	$	14,440
	Due after one year through five years		98,027		97,605
	Due after five years through ten years		216,203		215,401
	Due after ten years		236,568		236,678
	CMOs and MBSs		19,811		19,756
		$	585,160	$	583,880

Note_2_Investment_Securities_A

Note 2. Investment Securities: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
			31-Dec-14
			Less than 12 Months				12 Months or Longer				Total
			Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
			Value		Losses		Value		Losses		Value		Losses
	Corporate securities	$	77,868	$	1,473	$	69,498	$	1,841	$	147,366	$	3,314
	CMO’s  - residential		2,062		16		1,562		6		3,624		22
	CMOs - commercial		-		-		953		22		953		22
	GSEs		-		-		9,581		86		9,581		86
	States and political subdivisions		58,819		744		67,318		1,642		126,137		2,386
	Foreign governments		21,148		171		12,229		128		33,377		299
	Total fixed maturities		159,897		2,404		161,141		3,725		321,038		6,129
	Common stocks		2,007		136		348		11		2,355		147
	Total equity securities		2,007		136		348		11		2,355		147
	Total temporarily impaired
	securities	$	161,904	$	2,540	$	161,489	$	3,736	$	323,393	$	6,276
	Number of securities in an
	unrealized loss position		70				46				116
			31-Dec-13
			Less than 12 Months				12 Months or Longer				Total
			Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
			Value		Losses		Value		Losses		Value		Losses
	Corporate securities	$	124,531	$	5,340	$	21,070	$	2,127	$	145,601	$	7,467
	CMO’s  - residential		2,047		8		-		-		2,047		8
	CMOs - commercial		-		-		593		382		593		382
	U.S. Government obligations		493		6		-		-		493		6
	GSEs		22,731		123		5,360		217		28,091		340
	States and political subdivisions		149,704		7,312		32,983		2,065		182,687		9,377
	Foreign governments		27,587		1,766		3,523		341		31,110		2,107
	Redeemable preferred stocks		3,485		278		-		-		3,485		278
	Total fixed maturities		330,578		14,833		63,529		5,132		394,107		19,965
	Common stocks		2,589		70		-		-		2,589		70
	Nonredeemable preferred stocks		2,625		34		-		-		2,625		34
	Total equity securities		5,214		104		-		-		5,214		104
	Total temporarily impaired
	securities	$	335,792	$	14,937	$	63,529	$	5,132	$	399,321	$	20,069
	Number of securities in an
	unrealized loss position		126				27				153

Note_2_Investment_Securities_I1

Note 2. Investment Securities: Investment Income (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Investment Income
			2014		2013		2012
	Fixed maturities	$	18,504	$	22,667	$	27,785
	Equity securities		943		1,065		1,967
	Short-term investments		74		118		194
	Policy loans		813		1,020		1,542
	Partnership interests		1,101		2,506		2,027
	Other		336		291		5
	Investment income, gross		21,771		27,667		33,520
	Investment expenses		(79)		(196)		(164)
	Net investment income	$	21,692	$	27,471	$	33,356

Note_2_Investment_Securities_R

Note 2. Investment Securities: Realized Gain (Loss) on Investments (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Realized Gain (Loss) on Investments
			2014		2013		2012
	Available-for-sale securities:
	Fixed maturities	$	7,642	$	17,664	$	5,428
	Common stocks		(5)		-		419
	Preferred stocks		-		177		(495)
	Total available-for-sale securities		7,637		17,841		5,352
	Trading securities		506		1,619		79
	Total realized gains		8,143		19,460		5,431
	Unrealized gains (losses) on trading securities:
	Available-for-sale securities transferred
	to trading category		-		-		138
	Change in unrealized gains (losses) on trading securities		(451)		94		(26)
	Total unrealized gains (losses) on trading securities		(451)		94		112
	Gains (losses) on other investments		-4		196		(444)
	Net realized investment gains	$	7,688	$	19,750	$	5,099

Note_2_Investment_Securities_O

Note 2. Investment Securities: Other than Temporary Impairment, Credit Losses Recognized in Earnings (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Other than Temporary Impairment, Credit Losses Recognized in Earnings
			2014		2013		2012
	Balance at beginning of year	$	473	$	1,976	$	2,555
	Credit losses during the period for which an other-
	than-temporary loss was not previously recognized		-		-		473
	Additional credit losses for which an other-than-temporary
	loss was previously recognized		-		-		148
	Securities sold		-		(1,503)		(1,200)
	Balance at end of period	$	473	$	473	$	1,976

Note_4_Fair_Value_Disclosures_2

Note 4. Fair Value Disclosures: Fair Value Measurements, Recurring and Nonrecurring (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Fair Value Measurements, Recurring and Nonrecurring
			31-Dec-14
			Level 1		Level 2		Level 3		Total
	FINANCIAL ASSETS:
	Fixed maturities available-for-sale:
	Corporate securities	$	-	$	261,924	$	-	$	261,924
	CMOs – residential		-		5,106		-		5,106
	CMOs – commercial		-		-		953		953
	US Government obligations		-		22,892		-		22,892
	Agency MBS - residential		-		69		-		69
	GSEs		-		14,656		-		14,656
	States and political subdivisions		-		237,067		2,314		239,381
	Foreign government		-		34,700		-		34,700
	Redeemable preferred stocks		4,199		-		-		4,199
	Total fixed maturities		4,199		576,414		3,267		583,880
	Equity securities available-for-sale:
	Common stocks		9,757		-		-		9,757
	Nonredeemable preferred stocks		4,138		-		-		4,138
	Total equity securities		13,895		-		-		13,895
	Trading securities - equities		11,095		-		-		11,095
	Total trading securities		11,095		-		-		11,095
	Total Financial Assets	$	29,189	$	576,414	$	3,267	$	608,870
	FINANCIAL LIABILITIES:
	Interest rate swap	$	-	$	83	$	-	$	83
			31-Dec-13
			Level 1		Level 2		Level 3		Total
	FINANCIAL ASSETS:
	Fixed maturities available-for-sale:
	Corporate securities	$	-	$	209,260	$	-	$	209,260
	CMOs – residential		-		2,457		-		2,457
	CMOs – commercial		-		-		593		593
	US Government obligations		-		15,861		-		15,861
	Agency MBS - residential		-		83		-		83
	GSEs		-		28,148		-		28,148
	States and political subdivisions		-		247,262		2,441		249,703
	Foreign government		-		32,350		-		32,350
	Redeemable preferred stocks		3,832		-		-		3,832
	Total fixed maturities		3,832		535,421		3,034		542,287
	Equity securities available-for-sale:
	Common stocks		7,775		-		-		7,775
	Nonredeemable preferred stocks		4,028		-		-		4,028
	Total equity securities		11,803		-		-		11,803
	Trading securities - equities		7,125		-		-		7,125
	Total trading securities		7,125		-		-		7,125
	Total Financial Assets	$	22,760	$	535,421	$	3,034	$	561,215
	FINANCIAL LIABILITIES:
	Interest rate swap	$	-	$	204	$	-	$	204

Note_4_Fair_Value_Disclosures_3

Note 4. Fair Value Disclosures: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
			CMOs				States and
							Political
			Residential		Commercial		Subdivisions		Total
	Balance at December 31, 2012	$	14,053	$	570	$	2,558	$	17,181
	Gains (losses) included in earnings:
	Net realized investment gains		7,133		-		-		7,133
	Gains (losses) included in other comprehensive income (loss):
	Net unrealized gains (losses)		(7,064)		23		(78)		(7,119)
	Sales of securities		(13,108)		-		-		(13,108)
	Repayments and amortization of fixed maturities		(1,014)		-		(39)		(1,053)
	Balance at December 31, 2013		-		593		2,441		3,034
	Gains (losses) included in earnings:
	Net realized investment gains		-		-		-		-
	Gains (losses) included in other comprehensive income (loss):
	Net unrealized gains (losses)		-		360		(58)		302
	Sales of securities		-		-		-		-
	Repayments and amortization of fixed maturities		-		-		(69)		(69)
	Balance at December 31, 2014	$	-	$	953	$	2,314	$	3,267

Note_4_Fair_Value_Disclosures_4

Note 4. Fair Value Disclosures: Fair Value, by Balance Sheet Grouping (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Fair Value, by Balance Sheet Grouping
			31-Dec-14				31-Dec-13
			Level 2				Level 2
			Fair		Carrying		Fair		Carrying
			Value		Value		Value		Value
	FINANCIAL ASSETS:
	Policy loans	$	13,356	$	10,667	$	14,177	$	11,328
	FINANCIAL LIABILITIES:
	Funds on deposit	$	187,213	$	186,782	$	274,773	$	274,826
	Debt and junior subordinated
	debt securities	$	42,146	$	42,146	$	44,146	$	44,146

Note_5_Other_Investments_Other

Note 5. Other Investments: Other Investments Table Text Block (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Other Investments Table Text Block
			December 31,
			2014		2013
	Policy loans	$	10,667	$	11,328
	Partnership interests		12,033		12,149
	Investment in trust subsidiaries		1,146		1,146
	Other		1,405		500
		$	25,251	$	25,123

Note_6_Goodwill_and_Other_Inta1

Note 6. Goodwill and Other Intangible Assets: Schedule of Finite-Lived Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Finite-Lived Intangible Assets
			31-Dec-14				31-Dec-13
			Gross				Gross
			Carrying		Accumulated		Carrying		Accumulated
			Amount		Amortization		Amount		Amortization
	Finite-lived Intangible Assets:
	Agent and broker relationships	$	22,725	$	18,567	$	22,725	$	15,935
	Total finite-lived	$	22,725	$	18,567	$	22,725	$	15,935

Note_6_Goodwill_and_Other_Inta2

Note 6. Goodwill and Other Intangible Assets: Schedule of Indefinite-Lived Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Indefinite-Lived Intangible Assets
			December 31,
			2014		2013
	Indefinite-lived Intangible Assets:
	Insurance licenses	$	7,977	$	7,977
	Total indefinite-lived	$	7,977	$	7,977

Note_6_Goodwill_and_Other_Inta3

Note 6. Goodwill and Other Intangible Assets: Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
			Amortization
	Year		Expense
	2015	$	1,560
	2016		1,119
	2017		749
	2018		494
	2019		204

Note_7_Reinsurance_Effects_of_

Note 7. Reinsurance: Effects of Reinsurance (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Effects of Reinsurance
					ASSUMED		CEDED
			GROSS		FROM OTHER		TO OTHER		NET
			AMOUNT		COMPANIES		COMPANIES		AMOUNT
	Premiums Earned:
	31-Dec-14
	Accident and health	$	482,511	$	52,063	$	116,163	$	418,411
	Life and annuity		44,407		6,128		20,214		30,321
	Property and liability		30,477		-		161		30,316
		$	557,395	$	58,191	$	136,538	$	479,048
	31-Dec-13
	Accident and health	$	461,336	$	85,627	$	102,053	$	444,910
	Life and annuity		46,416		6,654		20,820		32,250
	Property and liability		18,845		-		14		18,831
		$	526,597	$	92,281	$	122,887	$	495,991
	31-Dec-12
	Accident and health	$	396,805	$	60,232	$	140,653	$	316,384
	Life and annuity		47,790		7,538		18,916		36,412
	Property and liability		3,271		-		-		3,271
		$	447,866	$	67,770	$	159,569	$	356,067
	Insurance benefits, claims and reserves:
	31-Dec-14	$	276,634	$	50,441	$	1,040	$	326,035
	31-Dec-13	$	374,865	$	82,337	$	102,412	$	354,790
	31-Dec-12	$	301,734	$	56,405	$	113,348	$	244,791

Note_8_Policy_Benefits_and_Cla1

Note 8. Policy Benefits and Claims: Schedule of Liability for Unpaid Claims and Claims Adjustment Expense (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense
			2014		2013		2012
	Balance at beginning of year	$	237,754	$	194,480	$	192,987
	Less: reinsurance recoverable		72,772		78,629		83,137
	Net balance at beginning of year		164,982		115,851		109,850
	Amount assumed		-		15,384		-
	Amount incurred, related to:
	Current year		303,973		324,040		213,818
	Prior years		(4,552)		(3,230)		(8,908)
	Total incurred		299,421		320,810		204,910
	Amount paid, related to:
	Current year		192,001		207,315		130,386
	Prior years		114,130		79,748		68,523
	Total paid		306,131		287,063		198,909
	Net balance at end of year		158,272		164,982		115,851
	Plus:  reinsurance recoverable		78,531		72,772		78,629
	Balance at end of year	$	236,803	$	237,754	$	194,480

Note_9_Debt_and_Junior_Subordi1

Note 9. Debt and Junior Subordinated Debt Securities: Schedule of Long-term Debt Instruments (Tables) (Junior Subordinated Debt)	12 Months Ended
	Dec. 31, 2014
Junior Subordinated Debt
Schedule of Long-term Debt Instruments
	Independence Preferred Trust I - Trust Preferred	$	10,000
	Independence Preferred Trust I - Common Stock		310
	Junior subordinated debt security -Trust I		10,310
	Independence Preferred Trust II -Trust Preferred		12,000
	Independence Preferred Trust II - Common Stock		372
	Junior subordinated debt security - Trust II		12,372
	Independence Preferred Trust III – Trust Preferred		15,000
	Independence Preferred Trust III – Common Stock		464
	Junior subordinated debt security – Trust III		15,464
	Total junior subordinated debt securities	$	38,146

Note_10_Income_Taxes_Schedule_

Note 10. Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Components of Income Tax Expense (Benefit)
			2014		2013		2012
	CURRENT:
	U.S. Federal	$	20	$	(1,500)	$	2,555
	State and Local		743		1,206		648
			763		(294)		3,203
	DEFERRED:
	U.S. Federal		5,317		8,805		(1,188)
	State and Local		311		(113)		(12)
			5,628		8,692		(1,200)
		$	6,391	$	8,398	$	2,003

Note_10_Income_Taxes_Schedule_1

Note 10. Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Effective Income Tax Rate Reconciliation
			2014		2013		2012
	Tax computed at the statutory rate	$	8,159	$	8,279	$	8,615
	Dividends received deduction and tax
	exempt interest		(1,384)		(849)		(1,336)
	State and local income taxes, net of Federal effect		685		710		414
	Health insurance excise tax		696		-		-
	Health insurer compensation limit		661		-		-
	AMIC valuation allowance adjustment		(2,500)		-		(5,900)
	Other, net		74		258		210
	Income tax expense	$	6,391	$	8,398	$	2,003

Note_10_Income_Taxes_Schedule_2

Note 10. Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Deferred Tax Assets and Liabilities
			2014		2013
	DEFERRED TAX ASSETS:
	Deferred insurance policy acquisition costs	$	754	$	484
	Unrealized losses on investment securities		54		5,398
	Investment write-downs		222		222
	Loss carryforwards		102,478		109,463
	Insurance reserves		366		392
	Other		5,790		7,222
	Total gross deferred tax assets		109,664		123,181
	Less AMIC valuation allowance		(73,849)		(76,911)
	Net deferred tax assets		35,815		46,270
	DEFERRED TAX LIABILITIES:
	Deferred insurance policy acquisition costs		(10,712)		(10,376)
	Insurance reserves		(6,856)		(6,183)
	Unrealized gains on investment securities		(78)		-
	Other		(12,702)		(13,805)
	Total gross deferred tax liabilities		(30,348)		(30,364)
	Net deferred tax asset	$	5,467	$	15,906

Note_11_Stockholders_Equity_Sc

Note 11. Stockholders' Equity: Schedule of Accumulated Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Accumulated Other Comprehensive Income (Loss)
			Unrealized
			Gains (Losses) on
			Available-for Sale		Cash Flow
			Securities		Hedge		Total
	Balance at December 31, 2011	$	8,150	$	(297)	$	7,853
	Other comprehensive income (loss) before reclassifications		10,480		79		10,559
	Amounts reclassified from accumulated OCI		(3,284)		-		(3,284)
	Net other comprehensive income (loss)		7,196		79		7,275
	Less: Other comprehensive income attributable
	to noncontrolling interests		(118)		-		(118)
	Acquired from noncontrolling interests		3		-		3
	Balance at December 31, 2012		15,231		(218)		15,013
	Other comprehensive income (loss) before reclassifications		(14,361)		96		(14,265)
	Amounts reclassified from accumulated OCI		(11,826)		-		(11,826)
	Net other comprehensive income (loss)		(26,187)		96		(26,091)
	Less: Other comprehensive loss attributable
	to noncontrolling interests		665		-		665
	Acquired from noncontrolling interests		(59)		-		(59)
	Balance at December 31, 2013		(10,350)		(122)		(10,472)
	Other comprehensive income (loss) before reclassifications		15,872		72		15,944
	Amounts reclassified from accumulated OCI		(5,251)		-		(5,251)
	Net other comprehensive income (loss)		10,621		72		10,693
	Less: Other comprehensive loss attributable
	to noncontrolling interests		(199)		-		(199)
	Balance at December 31, 2014	$	72	$	(50)	$	22

Note_11_Stockholders_Equity_Re

Note 11. Stockholders' Equity: Reclassification out of Accumulated Other Comprehensive Income (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Reclassification out of Accumulated Other Comprehensive Income
			2014		2013		2012
	Unrealized gains (losses) on available-for-sale securities
	reclassified during the period to the following income
	statement line items:
	Net realized investment gains	$	7,637	$	17,841	$	5,490
	Net impairment losses recognized in earnings		-		-		(704)
	Income before income tax		7,637		17,841		4,786
	Tax effect		2,386		6,015		1,502
	Net income	$	5,251	$	11,826	$	3,284

Note_12_Sharebased_Compensatio2

Note 12. Share-based Compensation: Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan (Tables)	12 Months Ended
	Dec. 31, 2014
Independence Holding Company Share Based Plans Total Member
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
			2014		2013		2012
	IHC’s Share-based Compensation Plan:
	Stock options	$	669	$	210	$	237
	Restricted stock units		85		66		45
	SARs		14		698		428
	Performance awards		-		(15)		89
	Share-based compensation expense, pre-tax		768		959		799
	Tax benefits		306		382		319
	Share-based compensation expense, net	$	462	$	577	$	480
American Independence Corp Share Based Plans Total Member
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
			2014		2013		2012
	AMIC’s Share-based Compensation Plans:
	Stock options	$	52	$	42	$	33
	Share-based compensation expense, pre-tax		52		42		33
	Tax benefits		18		15		11
	Share-based compensation expense, net	$	34	$	27	$	22

Note_12_Sharebased_Compensatio3

Note 12. Share-based Compensation: Schedule of Share-based Compensation, Stock Options, Activity (Tables)	12 Months Ended
	Dec. 31, 2014
Independence Holding Company Share Based Plans Total Member
Schedule of Share-based Compensation, Stock Options, Activity
		Shares	Weighted- Average
		Under Option	Exercise Price
	31-Dec-13	616,858	$	9.35
	Expired	-2,178	14.75
	31-Dec-14	614,680	$	9.33
American Independence Corp Share Based Plans Total Member
Schedule of Share-based Compensation, Stock Options, Activity
		Shares	Weighted- Average
		Under Option	Exercise Price
	31-Dec-13	222,285	$	11.46
	Granted	13,334		10.8
	Exercised	(6,667)		4.87
	Expired	(62,336)		14.58
	31-Dec-14	166,616	$	10.5

Note_12_Sharebased_Compensatio4

Note 12. Share-based Compensation: Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding (Tables)	12 Months Ended
	Dec. 31, 2014
Independence Holding Company Share Based Plans Total Member
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding
			31-Dec-14
			Outstanding		Exercisable
	Number of options		614,680		532,180
	Weighted average exercise price per share	$	9.33	$	9.23
	Aggregate intrinsic value for all options (in thousands)	$	2,838	$	2,512
	Weighted average contractual term remaining		2.3 years		2.2 years
American Independence Corp Share Based Plans Total Member
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding
			31-Dec-14
			Outstanding		Exercisable
	Number of options		166,616		148,837
	Weighted average exercise price per share	$	10.5	$	10.64
	Aggregate intrinsic value for all options (in thousands)	$	217	$	196
	Weighted average contractual term remaining		3.18 years		2.48 years

Note_12_Sharebased_Compensatio5

Note 12. Share-based Compensation: Schedule of Share-based Compensation, Restricted Stock Units Award Activity (Tables) (Independence Holding Company Share Based Plans Total Member)	12 Months Ended
	Dec. 31, 2014
Independence Holding Company Share Based Plans Total Member
Schedule of Share-based Compensation, Restricted Stock Units Award Activity
		No. of	Weighted-Average
		Non-vested	Grant-Date
		Shares	Fair Value
	31-Dec-13	14,850	$	10.6
	Granted	7,425		13.27
	Vested	(7,425)		10.3
	31-Dec-14	14,850	$	12.09

Note_12_Sharebased_Compensatio6

Note 12. Share-based Compensation: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Tables) (American Independence Corp Share Based Plans Total Member)	12 Months Ended
	Dec. 31, 2014
American Independence Corp Share Based Plans Total Member
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
		2014	2013
	Weighted-average risk-free interest rate	2.72%	2.30%
	Annual dividend rate per share	-	-
	Weighted-average volatility factor of the Company's common stock	38.27%	45.00%
	Weighted-average expected term of options	5 years	5 years

Note_13_Commitments_and_Contin1

Note 13. Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Future Minimum Rental Payments for Operating Leases
	2015	$	3,291
	2016		2,723
	2017		1,206
	2018		790
	2019		118
	2020 and thereafter		29
	Total	$	8,157

Note_15_Dividend_Payment_Restr1

Note 15. Dividend Payment Restrictions and Statutory Information: Statutory Accounting Practices Disclosure (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Statutory Accounting Practices Disclosure
			Years Ended December 31,
			2014		2013		2012
	Statutory net income:
	Madison National Life	$	9,876	$	11,704	$	11,903
	Standard Security Life		12,074		9,180		15,805
	Independence American		3,127		3,176		3,271
			December 31,
			2014		2013
	Statutory capital and surplus:
	Madison National Life	$	81,534	$	77,969
	Standard Security Life		116,525		113,972
	Independence American		60,168		57,875

Note_16_Segment_Reporting_Sche

Note 16. Segment Reporting: Schedule of Segment Reporting Information, by Segment (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Segment Reporting Information, by Segment
			2014		2013		2012
	Revenues:
	Medical Stop-Loss	$	184,775	$	171,963	$	146,378
	Fully Insured Health		239,101		278,105		171,492
	Group disability; life, annuities and DBL		67,641		63,155		52,049
	Individual life, annuities and other		34,551		41,966		53,207
	Corporate		177		105		540
			526,245		555,294		423,666
	Net realized investment gains		7,688		19,750		5,099
	Other-than-temporary impairment losses		-		-		-704
	Total revenues	$	533,933	$	575,044	$	428,061
	Income before income taxes:
	Medical Stop-Loss	$	21,933	$	12,677	$	15,818
	Fully Insured Health (A)		(1,987)		832		4,360
	Group disability; life, annuities and DBL		12,168		8,647		8,607
	Individual life, annuities and other		(6,618)		-10,396		905
	Corporate		(8,075)		-5,941		-7,380
			17,421		-5,819		22,310
	Interest expense		(1,797)		-1,915		-2,091
	Net realized investment gains		7,688		19,750		5,099
	Other-than-temporary impairment losses		-		-		-704
	Income before income taxes	$	23,312	$	23,654	$	24,614
	(A)    The Fully Insured Health segment includes amortization of intangible assets recorded as a result of purchase accounting for previous acquisitions. Total amortization expense was $1,948,000, $2,393,000 and $2,453,000 for the years ended December 31, 2014, 2013 and 2012, respectively. Amortization expense for the other segments is not material.
			December 31,
			2014		2013
	IDENTIFIABLE ASSETS AT YEAR END
	Medical Stop-Loss (A)	$	235,429	$	200,991
	Fully Insured Health (B)		170,522		198,000
	Group disability; life, annuities and DBL		231,109		213,952
	Individual life, annuities and other		525,519		620,891
	Corporate		25,138		35,201
		$	1,187,717	$	1,269,035
	(A)    The Medical Stop-Loss segment includes allocated goodwill of $5,664,000 at both December 31, 2014 and 2013.
	(B)     The Fully Insured Health segment includes allocated goodwill of $44,654,000 at both December 31, 2014 and 2013.

Note_17_Quarterly_Data_unaudit1

Note 17. Quarterly Data (unaudited): Schedule of Quarterly Financial Information (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Quarterly Financial Information
			FIRST		SECOND		THIRD		FOURTH
			QUARTER		QUARTER		QUARTER		QUARTER
	2014
	Total revenues	$	141,072	$	136,019	$	129,752	$	127,090
	Net income	$	4,005	$	3,880	$	4,824	$	4,212
	Less income from  noncontrolling interests
	in subsidiaries		-304		-32		-114		-178
	Net income attributable to IHC	$	3,701	$	3,848	$	4,710	$	4,034
	Basic income per common share	$	0.21	$	0.22	$	0.27	$	0.23
	Diluted income per share	$	0.21	$	0.22	$	0.27	$	0.23
			FIRST		SECOND		THIRD		FOURTH
			QUARTER		QUARTER		QUARTER		QUARTER
	2013
	Total revenues	$	137,882	$	151,900	$	141,644	$	143,618
	Net income	$	5,040	$	4,158	$	3,916	$	2,142
	Less income from  noncontrolling interests
	in subsidiaries		-339		-467		-277		-394
	Net income attributable to IHC	$	4,701	$	3,691	$	3,639	$	1,748
	Basic income per common share	$	0.26	$	0.21	$	0.21	$	0.1
	Diluted income per share	$	0.26	$	0.21	$	0.21	$	0.1

Summary_of_Investments_Other_T1

Summary of Investments, Other Than Investments in Related Parties: Summary of Investments-Other Than Investments in Related Parties Table Text Block (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Summary of Investments-Other Than Investments in Related Parties Table Text Block
	SCHEDULE I
	INDEPENDENCE HOLDING COMPANY AND SUBSIDIARIES
	SUMMARY OF INVESTMENTS – OTHER THAN INVESTMENTS IN RELATED PARTIES
	31-Dec-14
	(In thousands)
							AMOUNT
							SHOWN IN
							BALANCE
	TYPE OF INVESTMENT		COST		VALUE		SHEET
	FIXED MATURITIES - AVAILABLE-FOR-SALE:
	Bonds:
	United States Government and Government
	agencies and authorities	$	37,537	$	37,617	$	37,617
	States, municipalities and political subdivisions		238,514		239,381		239,381
	Foreign governments		34,863		34,700		34,700
	Public utilities		42,977		42,380		42,380
	All other corporate bonds		227,233		225,603		225,603
	Redeemable preferred stock		4,036		4,199		4,199
	TOTAL FIXED MATURITIES		585,160		583,880		583,880
	EQUITY SECURITIES - AVAILABLE-FOR-SALE
	AND TRADING:
	Common stocks:
	Public utilities		868		861		861
	Banks, trust and insurance companies		752		764		764
	Industrial, miscellaneous and all other		18,172		19,227		19,227
	Non-redeemable preferred stocks		4,004		4,138		4,138
	TOTAL EQUITY SECURITIES		23,796		24,990		24,990
	Policy loans		10,667		10,667		10,667
	Short-term investments and resale agreements		16,840		16,840		16,840
	Other long-term investments		14,584		14,584		14,584
	TOTAL INVESTMENTS	$	651,047	$	650,961	$	650,961

Condensed_Financial_Informatio1

Condensed Financial Information of Parent Company Only Disclosure: Condensed Balance Sheet (Parent Company Only) (Tables) (Parent Company)	12 Months Ended
	Dec. 31, 2014
Parent Company
Condensed Balance Sheet (Parent Company Only)
	SCHEDULE II
	INDEPENDENCE HOLDING COMPANY
	CONDENSED BALANCE SHEETS (In thousands, except share data)
	(PARENT COMPANY ONLY)
			DECEMBER 31,
			2014		2013
	ASSETS:
	Cash and cash equivalents	$	389	$	61
	Fixed maturities, available-for-sale		9,647		2,406
	Trading securities		1,916		944
	Other investments		1,146		1,146
	Investments in consolidated subsidiaries		387,270		356,378
	Deferred tax assets, net		11,414		13,347
	Goodwill		228		228
	Other assets		97		69
	TOTAL ASSETS	$	412,107	$	374,579
	LIABILITIES AND STOCKHOLDERS' EQUITY
	LIABILITIES:
	Accounts payable and other liabilities	$	7,140	$	6,403
	Amounts due to consolidated subsidiaries, net		57,220		45,000
	Income taxes payable		7,871		6,096
	Junior subordinated debt securities		38,146		38,146
	Dividends payable		628		628
	TOTAL LIABILITIES		111,005		96,273
	STOCKHOLDERS' EQUITY:
	Preferred stock (none issued)		-		-
	Common stock (A)		18,531		18,524
	Paid-in capital		127,098		126,239
	Accumulated other comprehensive income (loss)		22		(10,472)
	Treasury stock, at cost (B)		(12,141)		(8,169)
	Retained earnings		157,667		142,669
	TOTAL IHC’S STOCKHOLDERS' EQUITY		291,177		268,791
	NONCONTROLLING INTERESTS IN SUBSIDIARIES		9,925		9,515
	TOTAL EQUITY		301,102		278,306
	TOTAL LIABILITIES AND EQUITY	$	412,107	$	374,579

Condensed_Financial_Informatio2

Condensed Financial Information of Parent Company Only Disclosure: Condensed Income Statement (Parent Company Only) (Tables) (Parent Company)	12 Months Ended
	Dec. 31, 2014
Parent Company
Condensed Income Statement (Parent Company Only)
	SCHEDULE II
	(Continued)
	INDEPENDENCE HOLDING COMPANY
	CONDENSED STATEMENTS OF INCOME (In thousands)
	(PARENT COMPANY ONLY)
			2014		2013		2012
	REVENUES:
	Net investment income	$	112	$	61	$	491
	Net realized investment gains (losses)		(78)		349		2
	Other income		2,129		2,327		2,251
			2,163		2,737		2,744
	EXPENSES:
	Interest expense on debt		1,546		1,563		1,638
	General and administrative expenses		5,606		4,301		5,125
			7,152		5,864		6,763
	Loss before tax benefit and equity in net income of subsidiaries		(4,989)		(3,127)		(4,019)
	Income taxes (benefits)		(2,389)		(1,228)		(1,528)
	Equity in net income of subsidiaries		19,521		17,155		25,102
	Net income		16,921		15,256		22,611
	Less income from noncontrolling interests in
	subsidiaries		(628)		(1,477)		(2,950)
	Net income attributable to IHC	$	16,293	$	13,779	$	19,661

Condensed_Financial_Informatio3

Condensed Financial Information of Parent Company Only Disclosure: Condensed Cash Flow Statement (Parent Company Only) (Tables) (Parent Company)	12 Months Ended
	Dec. 31, 2014
Parent Company
Condensed Cash Flow Statement (Parent Company Only)
	SCHEDULE II
	(Continued)
	INDEPENDENCE HOLDING COMPANY
	CONDENSED STATEMENTS OF CASH FLOWS (In thousands)
	(PARENT COMPANY ONLY)
			2014		2013		2012
	CASH FLOWS PROVIDED BY (USED BY)
	OPERATING ACTIVITIES:
	Net income	$	16,921	$	15,256	$	22,611
	Adjustments to net income:
	Equity in net income of subsidiaries		(19,521)		(17,155)		(25,102)
	Other		3,748		4,398		604
	Changes in other assets and liabilities		440		(1,609)		(439)
	Net change in cash from operating activities		1,588		890		(2,326)
	CASH FLOWS PROVIDED BY (USED BY)
	INVESTING ACTIVITIES:
	Change in investments in and advances to subsidiaries		11,138		6,708		5,109
	Purchases of fixed maturities		(9,953)		-		(11,781)
	Sales of fixed maturities		2,751		3,260		6,109
	Change in other  investments		-		-		3,152
	Net change in cash  from investing activities		3,936		9,968		2,589
	CASH FLOWS PROVIDED BY (USED BY)
	FINANCING ACTIVITIES:
	Repurchases of common stock		(3,972)		(3,636)		(941)
	Cash paid in acquisitions of noncontrolling interests		-		(7,626)		(58)
	Dividends paid		(1,233)		(620)		(1,681)
	Proceeds from exercise of stock options		-		430		-
	Other financing activities		9		66		(92)
	Net change in cash from financing activities		(5,196)		(11,386)		(2,772)
	Net change in cash and cash equivalents		328		(528)		(2,509)
	Cash and cash equivalents, beginning of year		61		589		3,098
	Cash and cash equivalents, end of year	$	389	$	61	$	589

Supplementary_Insurance_Inform1

Supplementary Insurance Information, for Insurance Companies Disclosure: Supplementary Insurance Information for Insurance Companies Disclosure Table Text Block (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Supplementary Insurance Information for Insurance Companies Disclosure Table Text Block
	SCHEDULE III
	INDEPENDENCE HOLDING COMPANY
	SUPPLEMENTARY INSURANCE INFORMATION
	(in thousands)
				FUTURE
				POLICY				INSURANCE	AMORTIZATION	SELLING
			DEFERRED	BENEFITS,		NET	NET	BENEFITS,	OF DEFERRED	GENERAL &		NET
			ACQUISITION	LOSSES &	UNEARNED	PREMIUMS	INVESTMENT	CLAIMS &	ACQUISTION	ADMINISTRATIVE		PREMIUMS
			COSTS	CLAIMS	PREMIUMS	EARNED	INCOME (1)	RESERVES	COSTS	EXPENSES (2)		WRITTEN
	31-Dec-14
	Medical Stop-Loss	$	-	80,128	-	176,941	4,327	122,469	-	40,373	$	176,941
	Fully Insured Health		624	50,767	6,568	218,949	2,202	146,431	482	94,175		215,844
	Group disability; life,
	annuities and DBL		-	147,823	2,700	64,260	3,156	37,537	-	17,936		64,632
	Individual life, annuities
	and other		30,182	421,908	187	18,898	11,830	19,598	4,459	17,112		18,894
	Corporate		-	-	-	-	177	-	-	8,252		-
		$	30,806	700,626	9,455	479,048	21,692	326,035	4,941	177,848	$	476,311
	31-Dec-13
	Medical Stop-Loss	$	-	72,307	-	166,302	5,055	115,599	-	43,687	$	166,302
	Fully Insured Health		361	57,323	9,828	248,870	2,711	177,290	22	99,961		253,569
	Group disability; life,
	annuities and DBL		-	147,426	2,398	60,004	2,763	37,463	-	17,045		60,227
	Individual life, annuities
	and other		29,416	522,973	197	20,815	16,837	24,438	15,110	12,814		20,810
	Corporate		-	-	-	-	105	-	-	6,046		-
		$	29,777	800,029	12,423	495,991	27,471	354,790	15,132	179,553	$	500,908
	31-Dec-12
	Medical Stop-Loss	$	-	59,029	-	139,724	4,990	90,406	-	40,154	$	139,724
	Fully Insured Health		48	41,034	6,897	141,546	1,733	94,700	17	72,415		145,202
	Group disability; life,
	annuities and DBL		-	126,840	1,347	49,315	2,618	27,663	-	15,779		49,212
	Individual life, annuities
	and other		33,353	535,899	209	25,482	23,475	32,022	6,549	13,731		25,479
	Corporate		-	-	-	-	540	-	-	7,920		-
		$	33,401	762,802	8,453	356,067	33,356	244,791	6,566	149,999	$	359,617

Supplemental_Schedule_of_Reins1

Supplemental Schedule of Reinsurance Premiums for Insurance Companies: Supplemental Schedule of Reinsurance Premiums for Insurance Companies Disclosure Table Text Block (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Supplemental Schedule of Reinsurance Premiums for Insurance Companies Disclosure Table Text Block
	SCHEDULE IV
	INDEPENDENCE HOLDING COMPANY
	REINSURANCE
	(In thousands)
										PERCENTAGE
					ASSUMED		CEDED			OF AMOUNT
			GROSS		FROM OTHER		TO OTHER		NET	ASSUMED
			AMOUNT		COMPANIES		COMPANIES		AMOUNT	TO NET
	Life Insurance In-Force:
	31-Dec-14	$	11,054,484	$	418,775	$	6,128,608	$	5,344,651	7.80%
	31-Dec-13	$	11,415,328	$	333,200	$	6,493,122	$	5,255,406	6.30%
	31-Dec-12	$	11,293,128	$	213,041	$	6,004,459	$	5,501,710	3.90%
	Premiums Earned:
	31-Dec-14
	Accident and health	$	482,511	$	52,063	$	116,163	$	418,411	12.40%
	Life and annuity		44,407		6,128		20,214		30,321	20.20%
	Property and liability (1)		30,477		-		161		30,316	0.00%
		$	557,395	$	58,191	$	136,538	$	479,048	12.10%
	31-Dec-13
	Accident and health	$	461,336	$	85,627	$	102,053	$	444,910	19.20%
	Life and annuity		46,416		6,654		20,820		32,250	20.60%
	Property and liability (1)		18,845		-		14		18,831	0.00%
		$	526,597	$	92,281	$	122,887	$	495,991	18.60%
	31-Dec-12
	Accident and health	$	396,805	$	60,232	$	140,653	$	316,384	19.00%
	Life and annuity		47,790		7,538		18,916		36,412	20.70%
	Property and liability (1)		3,271		-		-		3,271	0.00%
		$	447,866	$	67,770	$	159,569	$	356,067	19.00%

Recovered_Sheet14

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$14,030	$13,090
Participating Policies as Percentage of Gross Insurance in Force	13.70%	11.70%	11.40%
Other Assets
Property, Plant and Equipment, Net	$3,086	$3,815
GeneveAffiliatedEntityMember
EntityCommonStockOutstandingOwnershipPercent	52.70%
AMICSubsidiariesMember
Noncontrolling Interest, Ownership Percentage by Parent	90.00%	90.00%	78.60%

Recovered_Sheet15

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net	($1,168)	$29
AMICSubsidiariesMember
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent	-1,571	29
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Repurchase of Shares by Subsidiary	$403

Recovered_Sheet16

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Repurchase and Resale Agreements Policy (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Details
Securities purchased under agreements to resell	$16,790	$22,594

Recovered_Sheet17

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Deferred Policy Acquisition Costs, Policy (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Details
Deferred Policy Acquisition Cost, Amortization Expense, Unrealized Investment Gains (Losses)	($323)	$5,681	($2,930)

Recovered_Sheet18

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Deposit Contracts, Policy (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Details
Liability for Policyholder Contract Deposits, Interest Rate, Deferred Annuity, Low End	3.00%	2.50%	2.70%
Liability for Policyholder Contract Deposits, Interest Rate, Deferred Annuity, High End	8.00%	8.00%	8.00%

Recovered_Sheet19

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: Earnings Per Share, Policy (Details)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Details
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	165	113	109

Recovered_Sheet20

Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies: New Accounting Pronouncements (Details) (USD $)	Jun. 30, 2014	Mar. 31, 2014
In Thousands, unless otherwise specified
Details
Mandatory Fees Under Affordable Care Act	$1,816	$1,500

Note_2_Investment_Securities_S1

Note 2. Investment Securities: Schedule of Available-for-sale Securities Reconciliation (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Available For Sale Debt Securities Amortized Cost Basis	$585,160	$558,121
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	4,849	4,131
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax	6,129	19,965
Fixed maturities, available-for-sale	583,880	542,287
Available For Sale Equity Securities Amortized Cost Basis	12,456	11,521
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax	1,586	386
Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax	147	104
Equity securities, available-for-sale	13,895	11,803
Corporate Debt Securities
Available For Sale Debt Securities Amortized Cost Basis	264,162	215,412
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	1,076	1,315
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax	3,314	7,467
Fixed maturities, available-for-sale	261,924	209,260
Residential Mortgage Backed Securities Member
Available For Sale Debt Securities Amortized Cost Basis	5,073	2,457
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	55	8
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax	22	8
Fixed maturities, available-for-sale	5,106	2,457
Commercial Mortgage Backed Securities
Available For Sale Debt Securities Amortized Cost Basis	975	975
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax	22	382
Fixed maturities, available-for-sale	953	593
US Treasury Securities
Available For Sale Debt Securities Amortized Cost Basis	22,766	15,596
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	126	271
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax		6
Fixed maturities, available-for-sale	22,892	15,861
US Government Agencies Debt Securities
Available For Sale Debt Securities Amortized Cost Basis	65	79
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	4	4
Fixed maturities, available-for-sale	69	83
US Government-sponsored Enterprises Debt Securities
Available For Sale Debt Securities Amortized Cost Basis	14,706	28,484
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	36	4
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax	86	340
Fixed maturities, available-for-sale	14,656	28,148
US States and Political Subdivisions Debt Securities
Available For Sale Debt Securities Amortized Cost Basis	238,514	256,645
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	3,253	2,435
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax	2,386	9,377
Fixed maturities, available-for-sale	239,381	249,703
Foreign Government Debt
Available For Sale Debt Securities Amortized Cost Basis	34,863	34,437
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	136	20
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax	299	2,107
Fixed maturities, available-for-sale	34,700	32,350
Redeemable Preferred Stock
Available For Sale Debt Securities Amortized Cost Basis	4,036	4,036
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax	163	74
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax		278
Fixed maturities, available-for-sale	4,199	3,832
COMMON STOCK
Available For Sale Equity Securities Amortized Cost Basis	8,452	7,517
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax	1,452	328
Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax	147	70
Equity securities, available-for-sale	9,757	7,775
Nonredeemable Preferred Stock
Available For Sale Equity Securities Amortized Cost Basis	4,004	4,004
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax	134	58
Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax		34
Equity securities, available-for-sale	$4,138	$4,028

Note_2_Investment_Securities_I2

Note 2. Investment Securities: Investments Classified by Contractual Maturity Date (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Details
Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis	$14,551
Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value	14,440
Available-for-sale Securities, Debt Maturities, Year Two Through Five, Amortized Cost Basis	98,027
Available-for-sale Securities, Debt Maturities, Year Two Through Five, Fair Value	97,605
Available-for-sale Securities, Debt Maturities, Year Six Through Ten, Amortized Cost Basis	216,203
Available-for-sale Securities, Debt Maturities, Year Six Through Ten, Fair Value	215,401
Available-for-sale Securities, Debt Maturities, after Ten Years, Amortized Cost Basis	236,568
Available-for-sale Securities, Debt Maturities, after Ten Years, Fair Value	236,678
Available-for-sale Securities, Debt Maturities, without Single Maturity Date, Amortized Cost Basis	19,811
Available-for-sale Securities, Debt Maturities, without Single Maturity Date, Fair Value	19,756
Available For Sale Debt Securities Amortized Cost Basis	585,160	558,121
Fixed maturities, available-for-sale	$583,880	$542,287

Note_2_Investment_Securities_A1

Note 2. Investment Securities: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value	$161,904	$335,792
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	2,540	14,937
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	161,489	63,529
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	3,736	5,132
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	323,393	399,321
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	6,276	20,069
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Less than One Year	70	126
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year	46	27
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions	116	153
Corporate Debt Securities
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value	77,868	124,531
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	1,473	5,340
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	69,498	21,070
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	1,841	2,127
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	147,366	145,601
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	3,314	7,467
Residential Mortgage Backed Securities Member
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value	2,062	2,047
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	16	8
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	1,562
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	6
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	3,624	2,047
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	22	8
Commercial Mortgage Backed Securities
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	953	593
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	22	382
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	953	593
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	22	382
US Government-sponsored Enterprises Debt Securities
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value		22,731
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss		123
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	9,581	5,360
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	86	217
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	9,581	28,091
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	86	340
US States and Political Subdivisions Debt Securities
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value	58,819	149,704
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	744	7,312
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	67,318	32,983
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	1,642	2,065
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	126,137	182,687
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	2,386	9,377
Foreign Government Debt
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value	21,148	27,587
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	171	1,766
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	12,229	3,523
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	128	341
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	33,377	31,110
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	299	2,107
Debt Securities
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value	159,897	330,578
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	2,404	14,833
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	161,141	63,529
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	3,725	5,132
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	321,038	394,107
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	6,129	19,965
COMMON STOCK
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value	2,007	2,589
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	136	70
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	348
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	11
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	2,355	2,589
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	147	70
Equity Securities
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value	2,007	5,214
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	136	104
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	348
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	11
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	2,355	5,214
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	147	104
US Treasury Securities
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value		493
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss		6
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value		493
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss		6
Redeemable Preferred Stock
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value		3,485
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss		278
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value		3,485
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss		278
Nonredeemable Preferred Stock
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value		2,625
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss		34
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value		2,625
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss		$34

Note_2_Investment_Securities_I3

Note 2. Investment Securities: Investment Income (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Gross Investment Income, Operating	$21,771	$27,667	$33,520
Investment Income, Investment Expense	79	196	164
Net investment income	21,692	27,471	33,356
Fixed Maturities
Gross Investment Income, Operating	18,504	22,667	27,785
Equity Securities
Gross Investment Income, Operating	943	1,065	1,967
Short-term Investments
Gross Investment Income, Operating	74	118	194
Policy Loans
Gross Investment Income, Operating	813	1,020	1,542
Partnership Interest
Gross Investment Income, Operating	1,101	2,506	2,027
Other Long-term Investments
Gross Investment Income, Operating	$336	$291	$5

Note_2_Investment_Securities_R1

Note 2. Investment Securities: Realized Gain (Loss) on Investments (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Available for sale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments	$7,637	$17,841	$5,352
Trading Securities, Realized Gain (Loss)	506	1,619	79
Marketable Securities, Realized Gain (Loss), Excluding Other than Temporary Impairments	8,143	19,460	5,431
Available for sale Securities Transfers To Trading Gains Losses Excluding Other Than Temporary Impairments			138
Trading Securities, Change in Unrealized Holding Gain (Loss)	-451	94	-26
Marketable Securities, Unrealized Gain (Loss), Excluding Other than Temporary Impairments	-451	94	112
Gain (Loss) on Sale of Other Investments	-4	196	-444
Net realized investment gains	7,688	19,750	5,099
Debt Securities
Available for sale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments	7,642	17,664	5,428
COMMON STOCK
Available for sale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments	-5		419
Preferred Stock
Available for sale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments		$177	($495)

Note_2_Investment_Securities_D

Note 2. Investment Securities (Details) (USD $)	1 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds		$355,470	$563,285	$497,782
Available-for-sale Securities, Gross Realized Gains		9,289	21,889	10,629
Available-for-sale Securities, Gross Realized Losses		741	2,902	3,868
Available-for-sale Securities, Transfers to Trading, Gross Gains	287
Available-for-sale Securities, Transfers to Trading, Gross Losses	149
Collateralized Mortgage Backed Securities
Accumulated Other Comprehensive Income (Loss), Other than Temporary Impairment, Not Credit Loss, Net of Tax, Available-for-sale, Debt Securities		$335	$335

Note_2_Investment_Securities_O1

Note 2. Investment Securities: Other than Temporary Impairment, Credit Losses Recognized in Earnings (Details) (Available-for-sale Securities, USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014
Available-for-sale Securities
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held	$1,976	$2,555	$473
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Additions, No Previous Impairment		473
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Additions, Additional Credit Losses		148
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold	1,503	1,200
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held	$473	$1,976	$473

Note_3_Cash_Flow_Hedge_Details

Note 3. Cash Flow Hedge (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Notes Payable to Banks
Long Term Debt Percentage Bearing Fixed Interest Rate	4.95%	4.95%
Interest Rate Swap | Designated as Hedging Instrument
Derivative Liability Notional Amount	4,000	6,000
Derivative Fixed Interest Rate	1.60%	1.60%
Interest Rate Swap | Designated as Hedging Instrument | Accounts Payable and Accrued Liabilities
Derivative Liability, Fair Value, Gross Liability	83	204

Note_4_Fair_Value_Disclosures_5

Note 4. Fair Value Disclosures: Fair Value Measurements, Recurring and Nonrecurring (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Fixed maturities, available-for-sale	$583,880	$542,287
Equity securities, available-for-sale	13,895	11,803
Trading securities	11,095	7,125
Corporate Debt Securities
Fixed maturities, available-for-sale	261,924	209,260
Residential Mortgage Backed Securities Member
Fixed maturities, available-for-sale	5,106	2,457
Commercial Mortgage Backed Securities
Fixed maturities, available-for-sale	953	593
US Treasury Securities
Fixed maturities, available-for-sale	22,892	15,861
US Government Agencies Debt Securities
Fixed maturities, available-for-sale	69	83
US Government-sponsored Enterprises Debt Securities
Fixed maturities, available-for-sale	14,656	28,148
US States and Political Subdivisions Debt Securities
Fixed maturities, available-for-sale	239,381	249,703
Foreign Government Debt
Fixed maturities, available-for-sale	34,700	32,350
Redeemable Preferred Stock
Fixed maturities, available-for-sale	4,199	3,832
COMMON STOCK
Equity securities, available-for-sale	9,757	7,775
Nonredeemable Preferred Stock
Equity securities, available-for-sale	4,138	4,028
Fair Value, Measurements, Recurring
Fixed maturities, available-for-sale	583,880	542,287
Equity securities, available-for-sale	13,895	11,803
Trading securities	11,095	7,125
Financial Assets, Fair Value Disclosure	608,870	561,215
Fair Value, Measurements, Recurring | Interest Rate Swap
Derivative Liability, Fair Value, Gross Liability	83	204
Fair Value, Measurements, Recurring | Corporate Debt Securities
Fixed maturities, available-for-sale	261,924	209,260
Fair Value, Measurements, Recurring | Residential Mortgage Backed Securities Member
Fixed maturities, available-for-sale	5,106	2,457
Fair Value, Measurements, Recurring | Commercial Mortgage Backed Securities
Fixed maturities, available-for-sale	953	593
Fair Value, Measurements, Recurring | US Treasury Securities
Fixed maturities, available-for-sale	22,892	15,861
Fair Value, Measurements, Recurring | US Government Agencies Debt Securities
Fixed maturities, available-for-sale	69	83
Fair Value, Measurements, Recurring | US Government-sponsored Enterprises Debt Securities
Fixed maturities, available-for-sale	14,656	28,148
Fair Value, Measurements, Recurring | US States and Political Subdivisions Debt Securities
Fixed maturities, available-for-sale	239,381	249,703
Fair Value, Measurements, Recurring | Foreign Government Debt
Fixed maturities, available-for-sale	34,700	32,350
Fair Value, Measurements, Recurring | Redeemable Preferred Stock
Fixed maturities, available-for-sale	4,199	3,832
Fair Value, Measurements, Recurring | COMMON STOCK
Equity securities, available-for-sale	9,757	7,775
Fair Value, Measurements, Recurring | Nonredeemable Preferred Stock
Equity securities, available-for-sale	4,138	4,028
Fair Value, Measurements, Recurring | Equity Securities
Trading securities	11,095	7,125
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring
Fixed maturities, available-for-sale	4,199	3,832
Equity securities, available-for-sale	13,895	11,803
Trading securities	11,095	7,125
Financial Assets, Fair Value Disclosure	29,189	22,760
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Redeemable Preferred Stock
Fixed maturities, available-for-sale	4,199	3,832
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | COMMON STOCK
Equity securities, available-for-sale	9,757	7,775
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Nonredeemable Preferred Stock
Equity securities, available-for-sale	4,138	4,028
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Equity Securities
Trading securities	11,095	7,125
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring
Fixed maturities, available-for-sale	576,414	535,421
Financial Assets, Fair Value Disclosure	576,414	535,421
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Interest Rate Swap
Derivative Liability, Fair Value, Gross Liability	83	204
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Corporate Debt Securities
Fixed maturities, available-for-sale	261,924	209,260
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Residential Mortgage Backed Securities Member
Fixed maturities, available-for-sale	5,106	2,457
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | US Treasury Securities
Fixed maturities, available-for-sale	22,892	15,861
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | US Government Agencies Debt Securities
Fixed maturities, available-for-sale	69	83
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | US Government-sponsored Enterprises Debt Securities
Fixed maturities, available-for-sale	14,656	28,148
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | US States and Political Subdivisions Debt Securities
Fixed maturities, available-for-sale	237,067	247,262
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Foreign Government Debt
Fixed maturities, available-for-sale	34,700	32,350
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring
Fixed maturities, available-for-sale	3,267	3,034
Financial Assets, Fair Value Disclosure	3,267	3,034
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Commercial Mortgage Backed Securities
Fixed maturities, available-for-sale	953	593
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | US States and Political Subdivisions Debt Securities
Fixed maturities, available-for-sale	$2,314	$2,441

Note_4_Fair_Value_Disclosures_6

Note 4. Fair Value Disclosures: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	$3,034	$17,181
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		7,133
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	302	-7,119
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales		-13,108
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	-69	-1,053
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	3,267	3,034
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	3,267	3,034
Residential Mortgage Backed Securities Member
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value		14,053
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		7,133
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)		-7,064
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales		-13,108
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements		-1,014
Commercial Mortgage Backed Securities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	593	570
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	360	23
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	953	593
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	953	593
US States and Political Subdivisions Debt Securities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	2,441	2,558
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	-58	-78
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	-69	-39
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	2,314	2,441
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	$2,314	$2,441

Note_4_Fair_Value_Disclosures_7

Note 4. Fair Value Disclosures: Fair Value, by Balance Sheet Grouping (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Funds on deposit	$186,782	$274,826
Estimate of Fair Value, Fair Value Disclosure | Fair Value, Inputs, Level 2
Policy Loans Receivable	13,356	14,177
Funds on deposit	187,213	274,773
Long-term Debt	42,146	44,146
Carrying (Reported) Amount, Fair Value Disclosure
Policy Loans Receivable	10,667	11,328
Funds on deposit	186,782	274,826
Long-term Debt	$42,146	$44,146

Note_5_Other_Investments_Other1

Note 5. Other Investments: Other Investments Table Text Block (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Other investments	$25,251	$25,123
Policy Loans
Other investments	10,667	11,328
Partnership Interest
Other investments	12,033	12,149
Variable Interest Entity, Not Primary Beneficiary
Other investments	1,146	1,146
Other Long-term Investments
Other investments	$1,405	$500

Note_6_Goodwill_and_Other_Inta4

Note 6. Goodwill and Other Intangible Assets (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Goodwill	$50,318	$50,318
Intangible Assets, Net (Excluding Goodwill)	12,135	14,767
Amortization of Intangible Assets	2,632	3,220	2,840
Other Assets
Intangible Assets, Net (Excluding Goodwill)	$12,135	$14,767
GeneveAndAffiliatedInsidersMember
EntityCommonStockOutstandingOwnershipPercent	57.00%

Note_6_Goodwill_and_Other_Inta5

Note 6. Goodwill and Other Intangible Assets: Schedule of Finite-Lived Intangible Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets, Gross	$22,725	$22,725
Finite-Lived Intangible Assets, Accumulated Amortization	18,567	15,935
Customer Relationships
Finite-Lived Intangible Assets, Gross	22,725	22,725
Finite-Lived Intangible Assets, Accumulated Amortization	$18,567	$15,935

Note_6_Goodwill_and_Other_Inta6

Note 6. Goodwill and Other Intangible Assets: Schedule of Indefinite-Lived Intangible Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Indefinite-Lived Intangible Assets (Excluding Goodwill)	$7,977	$7,977
Licensing Agreements
Indefinite-Lived Intangible Assets (Excluding Goodwill)	$7,977	$7,977

Note_6_Goodwill_and_Other_Inta7

Note 6. Goodwill and Other Intangible Assets: Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Details
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	$1,560
Finite-Lived Intangible Assets, Amortization Expense, Year Two	1,119
Finite-Lived Intangible Assets, Amortization Expense, Year Three	749
Finite-Lived Intangible Assets, Amortization Expense, Year Four	494
Finite-Lived Intangible Assets, Amortization Expense, Year Five	$204

Note_7_Reinsurance_Effects_of_1

Note 7. Reinsurance: Effects of Reinsurance (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Direct Premiums Earned	$557,395	$526,597	$447,866
Assumed Premiums Earned	58,191	92,281	67,770
Ceded Premiums Earned	136,538	122,887	159,569
Premiums earned	479,048	495,991	356,067
Policyholder Benefits and Claims Incurred, Direct	276,634	374,865	301,734
Policyholder Benefits and Claims Incurred, Assumed	50,441	82,337	56,405
Policyholder Benefits and Claims Incurred, Ceded	1,040	102,412	113,348
Insurance benefits, claims and reserves	326,035	354,790	244,791
Accident and Health Insurance Product Line
Direct Premiums Earned	482,511	461,336	396,805
Assumed Premiums Earned	52,063	85,627	60,232
Ceded Premiums Earned	116,163	102,053	140,653
Premiums earned	418,411	444,910	316,384
Life and Annuity Insurance Product Line
Direct Premiums Earned	44,407	46,416	47,790
Assumed Premiums Earned	6,128	6,654	7,538
Ceded Premiums Earned	20,214	20,820	18,916
Premiums earned	30,321	32,250	36,412
Property, Liability and Casualty Insurance Product Line
Direct Premiums Earned	30,477	18,845	3,271
Ceded Premiums Earned	161	14
Premiums earned	$30,316	$18,831	$3,271

Note_7_Reinsurance_Details

Note 7. Reinsurance (Details) (USD $)	1 Months Ended	3 Months Ended	1 Months Ended	3 Months Ended
In Thousands, unless otherwise specified	31-May-13	Jun. 30, 2013	Jan. 31, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013
Due from reinsurers					$278,242	$380,229
Other assets					57,126	78,712
Madison National Life Subsidiaries Member | Madison National Life Coinsurance Transaction With Guggenheim Life and Annuity
Material Nonrecurring Reinsurance Transactions	Effective May 31, 2013, Madison National Life entered into a coinsurance agreement with an unaffiliated reinsurer, Guggenheim Life and Annuity Company, to cede approximately $218,633,000 of life and annuity reserves and, in accordance with its terms, transferred net cash and other assets, with an aggregate value of $215,137,000, to the reinsurer during the second quarter of 2013. As a result of this transaction, the Company: (i) recorded estimated amounts due from reinsurers of $218,296,000; (ii) recorded $6,643,000 of estimated deferred expenses (included in other assets) which will be amortized over the life of the underlying reinsured contracts; and (iii) wrote-off $9,307,000 of deferred acquisition costs associated with this block of policies. The write-off was more than offset by gains realized by the Company in the transaction, most of which resulted from the required sale and transfer of invested assets. During 2014, a large portion of the reserves were transferred to the reinsurer in accordance with the terms of an assumption agreement.
Madison National Life Subsidiaries Member | Madison National Life Coinsurance Transaction With Guggenheim Life and Annuity | Life and Annuity Insurance Product Line
Liability for Future Policy Benefits, Portion Ceded	218,633
Payments For Reinsurance Under Coinsurance Agreement		215,137
Due from reinsurers	218,296
Other assets	6,643
Deferred Policy Acquisition Cost, Amortization Expense, Effect of Adjustments to Estimated Gross Profit	9,307
Standard Security Life Subsidiaries Member | Standard Security Life Coinsurance Transaction with First Security Benefit
Material Nonrecurring Reinsurance Transactions			Effective January 26, 2012, Standard Security Life entered into a coinsurance agreement with an unaffiliated reinsurer, First Security Benefit Life Insurance and Annuity Company of New York, to cede group annuity reserves. In accordance with the agreement, Standard Security Life transferred $143,537,000 of cash in the first quarter of 2012 and recorded a corresponding amount as due from reinsurers. The Company received final approval from the New York State Insurance Department to convert the transfer from a coinsurance to an assumption agreement which contractually relieves Standard Security Life of liability with regards to the policies. During the third quarter of 2012, a significant portion of the reserves were assumed by the reinsurer.
Standard Security Life Subsidiaries Member | Standard Security Life Coinsurance Transaction with First Security Benefit | Life and Annuity Insurance Product Line
Payments For Reinsurance Under Coinsurance Agreement				$143,537

Note_8_Policy_Benefits_and_Cla2

Note 8. Policy Benefits and Claims: Schedule of Liability for Unpaid Claims and Claims Adjustment Expense (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Details
Liability for Claims and Claims Adjustment Expense, Beginning Balance	$237,754	$194,480	$192,987
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance	72,772	78,629	83,137
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance	164,982	115,851	109,850
Claims and Claims Adjustment Expenses Assumed		15,384
Current Year Claims and Claims Adjustment Expense	303,973	324,040	213,818
Prior Year Claims and Claims Adjustment Expense	-4,552	-3,230	-8,908
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	299,421	320,810	204,910
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year	192,001	207,315	130,386
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years	114,130	79,748	68,523
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid	306,131	287,063	198,909
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance	158,272	164,982	115,851
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance	78,531	72,772	78,629
Liability for Claims and Claims Adjustment Expense, Ending Balance	$236,803	$237,754	$194,480

Note_8_Policy_Benefits_and_Cla3

Note 8. Policy Benefits and Claims (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Prior Year Claims and Claims Adjustment Expense	($4,552)	($3,230)	($8,908)
Group disability, life annuities and DBL Segment Member
Prior Year Claims and Claims Adjustment Expense	-3,830	-4,269	-4,508
Individual life annuities and other Segment Member
Prior Year Claims and Claims Adjustment Expense	-448	-1,069	-1,057
Fully Insured Segment Member
Prior Year Claims and Claims Adjustment Expense	-378	108	-375
Medical Stop-Loss Segment Member
Prior Year Claims and Claims Adjustment Expense	$104	$2,000	($2,968)

Note_9_Debt_and_Junior_Subordi2

Note 9. Debt and Junior Subordinated Debt Securities (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013	Dec. 31, 2012	Jul. 31, 2011
Debt	$4,000		$6,000
Interest Paid	1,804		1,923	2,107
Notes Payable to Banks
Long Term Debt Percentage Bearing Fixed Interest Rate	4.95%		4.95%
Junior Subordinated Debt
Debt Instrument, Maturity Date Range, Start	30-Apr-33
Debt Instrument, Maturity Date Range, End	31-Dec-34
Debt Instrument, Redemption Price, Percentage	100.00%
Junior Subordinated Debt | Junior Subordinated Debt - Trust I
Debt Instrument, Basis Spread on Variable Rate	4.00%
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate	4.23%
Junior Subordinated Debt | Junior Subordinated Debt - Trust II
Debt Instrument, Basis Spread on Variable Rate	3.90%
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate	4.13%
Junior Subordinated Debt | Junior Subordinated Debt - Trust III
Debt Instrument, Basis Spread on Variable Rate	3.50%
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate	3.74%
Consolidated Entity Excluding Variable Interest Entities (VIE) | Notes Payable to Banks
Debt	4,000		6,000		10,000
Debt Instrument, Maturity Date	1-Jul-16
Debt Instrument, Basis Spread on Variable Rate	3.35%
Debt Instrument, Periodic Payment, Principal	2,000	[1]
Debt Instrument, Date of First Required Payment	1-Jul-12
Long Term Debt Percentage Bearing Fixed Interest Rate	4.95%		4.95%
Variable Interest Entity, Not Primary Beneficiary, Aggregated Disclosure
Trust Preferred Securities Issued Aggregate	37,000		37,000
Variable Interest Entity, Not Primary Beneficiary, Aggregated Disclosure | Other Investments
Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets	1,146		1,146
Variable Interest Entity, Not Primary Beneficiary, Aggregated Disclosure | Junior Subordinated Debt
Variable Interest Entity, Nonconsolidated, Carrying Amount, Liabilities	$38,146		$38,146
[1]	Annually from July 1, 2012 through maturity.

Note_9_Debt_and_Junior_Subordi3

Note 9. Debt and Junior Subordinated Debt Securities: Schedule of Long-term Debt Instruments (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Junior subordinated debt securities	$38,146	$38,146
Junior Subordinated Debt
Junior subordinated debt securities	38,146	38,146
Junior Subordinated Debt | Junior Subordinated Debt - Trust I
Junior subordinated debt securities	10,310	10,310
Junior Subordinated Debt | Junior Subordinated Debt - Trust II
Junior subordinated debt securities	12,372	12,372
Junior Subordinated Debt | Junior Subordinated Debt - Trust III
Junior subordinated debt securities	15,464	15,464
Independence Preferred Trust I Member
Trust Preferred Securities Issued Aggregate	10,000	10,000
Common Securities Issued By Unconsolidated Subsidiary Trusts	310	310
Independence Preferred Trust II Member
Trust Preferred Securities Issued Aggregate	12,000	12,000
Common Securities Issued By Unconsolidated Subsidiary Trusts	372	372
Independence Preferred Trust III Member
Trust Preferred Securities Issued Aggregate	15,000	15,000
Common Securities Issued By Unconsolidated Subsidiary Trusts	$464	$464

Note_10_Income_Taxes_Schedule_3

Note 10. Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Details
Current Federal Tax Expense (Benefit)	$20	($1,500)	$2,555
Current State and Local Tax Expense (Benefit)	743	1,206	648
Current Income Tax Expense (Benefit)	763	-294	3,203
Deferred Federal Income Tax Expense (Benefit)	5,317	8,805	-1,188
Deferred State and Local Income Tax Expense (Benefit)	311	-113	-12
Deferred tax expense (benefits)	5,628	8,692	-1,200
Income taxes (benefits)	$6,391	$8,398	$2,003

Note_10_Income_Taxes_Details

Note 10. Income Taxes (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013	Dec. 31, 2012
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	35.00%		35.00%	35.00%
Deferred Tax Assets, Net	$5,467		$15,906
Income Taxes Paid (Refunds), Net	-2,448		-387	550
IHC And NonLIfe Subsidiaries Excluding AMIC | Domestic Tax Authority
Operating Loss Carryforwards	24,418	[1]
Madison National Life Subsidiary | Domestic Tax Authority
Operating Loss Carryforwards	4,392	[2]
AMIC | Domestic Tax Authority
Operating Loss Carryforwards	263,985	[3]
AMICSubsidiariesMember
Deferred Tax Assets, Net	11,517		10,689
Valuation Allowance, Deferred Tax Asset, Change in Amount	-3,062		-1,661
AMICSubsidiariesMember | Valuation Allowance, Operating Loss Carryforwards
Valuation Allowance, Deferred Tax Asset, Change in Amount	($2,500)
[1]	Which expire in varying amounts between 2029 and 2032.
[2]	Which expire in 2033 and 2034.
[3]	Which expire in varying amounts through 2028, a significant portion expires in 2020.

Note_10_Income_Taxes_Schedule_4

Note 10. Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Details
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	$8,159	$8,279	$8,615
Income Tax Reconciliation, Tax Exempt Income and Dividends Received Deduction	1,384	849	1,336
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	685	710	414
Effective Income Tax Rate Reconciliation, Health Insurance Excise Tax	696
Effective Income Tax Rate Reconciliation, Health Insurer Compensation Limit	661
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	-2,500		-5,900
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	74	258	210
Income taxes (benefits)	$6,391	$8,398	$2,003

Note_10_Income_Taxes_Schedule_5

Note 10. Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Deferred Tax Assets, Deferred Expense, Deferred Policy Acquisition Cost	$754	$484
Deferred Tax Assets, Investments	54	5,398
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses	222	222
Deferred Tax Assets, Operating Loss Carryforwards, Domestic	102,478	109,463
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Policyholder Liabilities	366	392
Deferred Tax Assets, Other	5,790	7,222
Deferred Tax Assets, Gross	109,664	123,181
Deferred Tax Assets, Net of Valuation Allowance	35,815	46,270
Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost	10,712	10,376
Deferred Tax Liabilities, Tax Deferred Expense, Reserves and Accruals, Policyholder Liabilities	6,856	6,183
Deferred Tax Liabilities, Investments	78
Deferred Tax Liabilities, Other	12,702	13,805
Deferred Tax Liabilities, Gross	30,348	30,364
Deferred Tax Assets, Net	5,467	15,906
AMICSubsidiariesMember
Deferred Tax Assets, Valuation Allowance	73,849	76,911
Deferred Tax Assets, Net	$11,517	$10,689

Note_11_Stockholders_Equity_De

Note 11. Stockholders' Equity (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2012		Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2011	Aug. 31, 2014
Preferred Stock, Shares Authorized			100,000	100,000
Preferred Stock, Par or Stated Value Per Share			1	1
Common Stock Dividends, Shares	1,638,849	[1]
Stock Issued During Period, Value, Stock Dividend	$15,799	[1]
Common Stock, shares authorized	23,000,000		23,000,000	23,000,000	20,000,000
IhcShareRepurchaseProgramMember
Stock Repurchase Program, Number of Shares Authorized to be Repurchased						500,000
Treasury Stock, Shares, Acquired	100,246		296,775	334,305
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased			468,218
[1]	Stock dividend payable to shareholders of record on 2/17/2012 with a distribution date of 3/5/2012.

Note_11_Stockholders_Equity_Sc1

Note 11. Stockholders' Equity: Schedule of Accumulated Other Comprehensive Income (Loss) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Accumulated other comprehensive income (loss)	$22	($10,472)	$15,013	$7,853
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	15,944	-14,265	10,559
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	5,251	11,826	3,284
Other comprehensive income (loss), net of tax	10,693	-26,091	7,275
Other comprehensive (income) loss, net of tax, attributable to noncontrolling interests	-199	665	-118
Unrealized Gains/Losses Purchased from Noncontrolling Interests		-59	3
Accumulated Net Unrealized Investment Gain (Loss)
Accumulated other comprehensive income (loss)	72	-10,350	15,231	8,150
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	15,872	-14,361	10,480
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	5,251	11,826	3,284
Other comprehensive income (loss), net of tax	10,621	-26,187	7,196
Other comprehensive (income) loss, net of tax, attributable to noncontrolling interests	-199	665	-118
Unrealized Gains/Losses Purchased from Noncontrolling Interests		-59	3
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges
Accumulated other comprehensive income (loss)	-50	-122	-218	-297
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	72	96	79
Other comprehensive income (loss), net of tax	$72	$96	$79

Note_11_Stockholders_Equity_Re1

Note 11. Stockholders' Equity: Reclassification out of Accumulated Other Comprehensive Income (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Net realized investment gains									$7,688	$19,750	$5,099
Net impairment losses recognized in earnings											-704
Income (loss) from continuing operations before income taxes									23,312	23,654	24,614
Income taxes (benefits)									6,391	8,398	2,003
Net income (loss)	4,212	4,824	3,880	4,005	2,142	3,916	4,158	5,040	16,921	15,256	22,611
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Unrealized Investment Gain (Loss)
Net realized investment gains									7,637	17,841	5,490
Net impairment losses recognized in earnings											-704
Income (loss) from continuing operations before income taxes									7,637	17,841	4,786
Income taxes (benefits)									2,386	6,015	1,502
Net income (loss)									$5,251	$11,826	$3,284

Note_12_Sharebased_Compensatio7

Note 12. Share-based Compensation: Share-based Compensation, Option and Incentive Plans Policy (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Independence Holding Company Share Based Plans Total Member
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	377,286
Independence Holding Company Share Based Plans Total Member | Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	5 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number	614,680	616,858
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number	532,180
Independence Holding Company Share Based Plans Total Member | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Independence Holding Company Share Based Plans Total Member | Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
American Independence Corp Share Based Plans Total Member
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	6,490,553
American Independence Corp Share Based Plans Total Member | Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	4 years
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number	166,616	222,285
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number	148,837
American Independence Corp Share Based Plans Total Member | Employee Stock Option | Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years

Note_12_Sharebased_Compensatio8

Note 12. Share-based Compensation (Details) (USD $)	1 Months Ended		12 Months Ended
In Thousands, except Share data, unless otherwise specified	31-May-14	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Independence Holding Company Share Based Plans Total Member
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			377,286
Independence Holding Company Share Based Plans Total Member | Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			0	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms	In May 2014, option agreements affecting 15 employees were modified to extend the expirations of their terms from 2015 to 2017 and as a result, the Company recorded incremental compensation costs of $405,000.	In March 2013, option agreements affecting 5 employees were modified to extend the expiration term 5 years. The incremental cost of the modified awards was $618,000, which is being recognized over the new 2-year vesting period starting from the date of the modification.
Employee Service Share-based Compensation, Cash Received from Exercise of Stock Options				$430
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value				243
Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options				85
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			5 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			3 years
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options			55
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Period For Recognition 1			2 months 16 days
Independence Holding Company Share Based Plans Total Member | Modified Stock Option Awards
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Number of Employees Affected	15	5
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost	405	618
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		5 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		2 years
Independence Holding Company Share Based Plans Total Member | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			3 years
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Period For Recognition 1			1 year 9 months 18 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			7,425	7,425	7,425
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			$13.27	$11.66	9.39
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value			103	69	40
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Share-based Awards Other than Options			131
Independence Holding Company Share Based Plans Total Member | Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			3 years
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number			136,850	251,800
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised			112,200	14,850	13,750
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid			529	74	33
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures			2,750	3,300	2,750
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted					56,000
Independence Holding Company Share Based Plans Total Member | Stock Appreciation Rights (SARs) | Accounts Payable and Accrued Liabilities
Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent			791	1,307
Independence Holding Company Share Based Plans Total Member | Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid				83	57
American Independence Corp Share Based Plans Total Member
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			6,490,553
American Independence Corp Share Based Plans Total Member | Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			13,334		0
Employee Service Share-based Compensation, Cash Received from Exercise of Stock Options			33
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value			38
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			4 years
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options			$83
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value			$5.70	$4.04
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			6,667	0	0

Note_12_Sharebased_Compensatio9

Note 12. Share-based Compensation: Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Independence Holding Company Share Based Plans Total Member
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	$306	$382	$319
Allocated Share-based Compensation Expense, Net of Tax	462	577	480
Independence Holding Company Share Based Plans Total Member | Selling, General and Administrative Expenses
Allocated Share-based Compensation Expense	768	959	799
Independence Holding Company Share Based Plans Total Member | Employee Stock Option | Selling, General and Administrative Expenses
Allocated Share-based Compensation Expense	669	210	237
Independence Holding Company Share Based Plans Total Member | Restricted Stock Units (RSUs) | Selling, General and Administrative Expenses
Allocated Share-based Compensation Expense	85	66	45
Independence Holding Company Share Based Plans Total Member | Stock Appreciation Rights (SARs) | Selling, General and Administrative Expenses
Allocated Share-based Compensation Expense	14	698	428
Independence Holding Company Share Based Plans Total Member | Performance Shares | Selling, General and Administrative Expenses
Allocated Share-based Compensation Expense		-15	89
American Independence Corp Share Based Plans Total Member
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	18	15	11
Allocated Share-based Compensation Expense, Net of Tax	34	27	22
American Independence Corp Share Based Plans Total Member | Selling, General and Administrative Expenses
Allocated Share-based Compensation Expense	52	42	33
American Independence Corp Share Based Plans Total Member | Employee Stock Option | Selling, General and Administrative Expenses
Allocated Share-based Compensation Expense	$52	$42	$33

Recovered_Sheet21

Note 12. Share-based Compensation: Schedule of Share-based Compensation, Stock Options, Activity (Details) (Employee Stock Option, USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Independence Holding Company Share Based Plans Total Member
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number	616,858
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$9.35
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period	2,178
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price	$14.75
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number	614,680	616,858
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$9.33	$9.35
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0	0	0
American Independence Corp Share Based Plans Total Member
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number	222,285
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$11.46
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period	62,336
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price	$14.58
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number	166,616	222,285
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$10.50	$11.46
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	13,334		0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$10.80
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	6,667	0	0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price	$4.87

Recovered_Sheet22

Note 12. Share-based Compensation: Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding (Details) (Employee Stock Option, USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014
Independence Holding Company Share Based Plans Total Member
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	614,680
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number	532,180
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	$9.33
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price	$9.23
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	$2,838
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value	2,512
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term	2 years 3 months 18 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term	2 years 2 months 12 days
American Independence Corp Share Based Plans Total Member
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	166,616
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number	148,837
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	$10.50
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price	$10.64
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	217
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value	$196
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term	3 years 2 months 5 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term	2 years 5 months 23 days

Recovered_Sheet23

Note 12. Share-based Compensation: Schedule of Share-based Compensation, Restricted Stock Units Award Activity (Details) (Independence Holding Company Share Based Plans Total Member, Restricted Stock Units (RSUs), USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Independence Holding Company Share Based Plans Total Member | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	14,850
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$10.60
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	7,425	7,425	7,425
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$13.27	$11.66	$9.39
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	7,425
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	$10.30
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	14,850	14,850
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$12.09	$10.60

Recovered_Sheet24

Note 12. Share-based Compensation: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) (American Independence Corp Share Based Plans Total Member, Employee Stock Option)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
American Independence Corp Share Based Plans Total Member | Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	2.72%	2.30%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate	38.27%	45.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	5 years	5 years

Note_13_Commitments_and_Contin2

Note 13. Commitments and Contingencies (Details) (USD $)	12 Months Ended			1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Apr. 30, 2014	Sep. 30, 2013
Operating Leases, Rent Expense, Net	$3,403,000	$3,470,000	$3,750,000
Threatened Litigation | Madison National Life and Former Policyholder
Loss Contingency, Settlement Agreement, Terms					On September 1, 2013, Madison National Life entered into an agreement with a former policyholder for a return of premium in connection with health insurance business written during 2007. The agreement was entered into in response to a potential lawsuit. In April 2014, the Company fulfilled its obligation under the terms of the agreement with a payment of $1,541,000 representing return of premium reserves (net of recoveries). The Company terminated the MGU that produced this business in 2008.
Loss Contingency, Period of Occurrence					during 2007
Loss Contingency Accrual, Payments				$1,541,000

Note_13_Commitments_and_Contin3

Note 13. Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Details) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Details
Operating Leases, Future Minimum Payments Due, Next Twelve Months	$3,291
Operating Leases, Future Minimum Payments, Due in Two Years	2,723
Operating Leases, Future Minimum Payments, Due in Three Years	1,206
Operating Leases, Future Minimum Payments, Due in Four Years	790
Operating Leases, Future Minimum Payments, Due in Five Years	118
Operating Leases, Future Minimum Payments, Due Thereafter	29
Operating Leases, Future Minimum Payments Due	$8,157

Note_14_Concentration_of_Credi1

Note 14. Concentration of Credit Risk (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013
Assets Held by Insurance Regulators	12,523		$12,637
Due from reinsurers	278,242		380,229
Stockholders' Equity, Total
Concentration Risk, Percentage	10.00%
Credit Concentration Risk
Fair Value, Concentration of Risk, Investments	0	[1]
Credit Concentration Risk | Guggenheim Life and Annuity Company Member
Due from reinsurers	115,188
Credit Concentration Risk | MarkelBermudaLtdMember
Due from reinsurers	40,581
Credit Concentration Risk | RgaReinsuranceCompanyMember
Due from reinsurers	42,534
[1]	Except for investments in obligations of the U.S. Government and its agencies and mortgage-backed securities issued by GSEs.

Note_15_Dividend_Payment_Restr2

Note 15. Dividend Payment Restrictions and Statutory Information (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval	$25,507
Common stock dividend	1,223	[1]	1,241	[1]	1,271	[1]
Statutory Accounting Practices, Risk Based Capital Requirements Compliance Assertion			At December 31, 2014 and 2013, the statutory capital of our insurance subsidiaries is significantly in excess of their regulatory RBC requirements
Madison National Life Subsidiaries Member
Payments of Dividends	4,000		3,950		3,450
Standard Security Life Subsidiaries Member
Payments of Dividends	6,000		8,000		7,980
IndependenceAmericanSubsidiariesMember
Payments of Dividends	$0		$0		$2,000
[1]	$0.07 per share

Note_15_Dividend_Payment_Restr3

Note 15. Dividend Payment Restrictions and Statutory Information: Statutory Accounting Practices Disclosure (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Madison National Life Subsidiaries Member
Statutory Accounting Practices, Statutory Net Income Amount	$9,876	$11,704	$11,903
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	81,534	77,969
Standard Security Life Subsidiaries Member
Statutory Accounting Practices, Statutory Net Income Amount	12,074	9,180	15,805
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	116,525	113,972
IndependenceAmericanSubsidiariesMember
Statutory Accounting Practices, Statutory Net Income Amount	3,127	3,176	3,271
Statutory Accounting Practices, Statutory Capital and Surplus, Balance	$60,168	$57,875

Note_16_Segment_Reporting_Sche1

Note 16. Segment Reporting: Schedule of Segment Reporting Information, by Segment (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
TOTAL REVENUES	$127,090	$129,752	$136,019	$141,072	$143,618	$141,644	$151,900	$137,882	$533,933	$575,044	$428,061
Income (loss) from continuing operations before income taxes									23,312	23,654	24,614
Amortization of Intangible Assets									2,632	3,220	2,840
TOTAL ASSETS	1,187,717				1,269,035				1,187,717	1,269,035
Goodwill	50,318				50,318				50,318	50,318
Operating Segments
TOTAL REVENUES									526,245	555,294	423,666
Income (loss) from continuing operations before income taxes									17,421	-5,819	22,310
Segment Reconciling Items | Net realized investment gains
TOTAL REVENUES									7,688	19,750	5,099
Income (loss) from continuing operations before income taxes									7,688	19,750	5,099
Segment Reconciling Items | Net Impairment Losses Recognized in Earnings
TOTAL REVENUES											-704
Income (loss) from continuing operations before income taxes											-704
Segment Reconciling Items | Interest Expense
Income (loss) from continuing operations before income taxes									-1,797	-1,915	-2,091
Medical Stop-Loss Segment Member
TOTAL REVENUES									184,775	171,963	146,378
Income (loss) from continuing operations before income taxes									21,933	12,677	15,818
TOTAL ASSETS	235,429				200,991				235,429	200,991
Goodwill	5,664				5,664				5,664	5,664
Fully Insured Segment Member
TOTAL REVENUES									239,101	278,105	171,492
Income (loss) from continuing operations before income taxes									-1,987	832	4,360
Amortization of Intangible Assets									1,948	2,393	2,453
TOTAL ASSETS	170,522				198,000				170,522	198,000
Goodwill	44,654				44,654				44,654	44,654
Group disability, life annuities and DBL Segment Member
TOTAL REVENUES									67,641	63,155	52,049
Income (loss) from continuing operations before income taxes									12,168	8,647	8,607
TOTAL ASSETS	231,109				213,952				231,109	213,952
Individual life annuities and other Segment Member
TOTAL REVENUES									34,551	41,966	53,207
Income (loss) from continuing operations before income taxes									-6,618	-10,396	905
TOTAL ASSETS	525,519				620,891				525,519	620,891
Corporate
TOTAL REVENUES									177	105	540
Income (loss) from continuing operations before income taxes									-8,075	-5,941	-7,380
TOTAL ASSETS	$25,138				$35,201				$25,138	$35,201

Note_17_Quarterly_Data_unaudit2

Note 17. Quarterly Data (unaudited): Schedule of Quarterly Financial Information (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Details
TOTAL REVENUES	$127,090	$129,752	$136,019	$141,072	$143,618	$141,644	$151,900	$137,882	$533,933	$575,044	$428,061
Net income (loss)	4,212	4,824	3,880	4,005	2,142	3,916	4,158	5,040	16,921	15,256	22,611
(Income) loss from noncontrolling interests in subsidiaries	-178	-114	-32	-304	-394	-277	-467	-339	-628	-1,477	-2,950
NET INCOME (LOSS) ATTRIBUTABLE TO IHC	$4,034	$4,710	$3,848	$3,701	$1,748	$3,639	$3,691	$4,701	$16,293	$13,779	$19,661
Basic income (loss) per common share	$0.23	$0.27	$0.22	$0.21	$0.10	$0.21	$0.21	$0.26	$0.93	$0.78	$1.09
Diluted income (loss) per common share	$0.23	$0.27	$0.22	$0.21	$0.10	$0.21	$0.21	$0.26	$0.92	$0.77	$1.09

Summary_of_Investments_Other_T2

Summary of Investments, Other Than Investments in Related Parties: Summary of Investments-Other Than Investments in Related Parties Table Text Block (Details) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Summary of Investments, Other than Investments in Related Parties, Cost	$651,047
Summary of Investments, Other than Investments in Related Parties, Fair Value	650,961
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	650,961
US Treasury and Government
Summary of Investments, Other than Investments in Related Parties, Cost	37,537
Summary of Investments, Other than Investments in Related Parties, Fair Value	37,617
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	37,617
US States and Political Subdivisions Debt Securities
Summary of Investments, Other than Investments in Related Parties, Cost	238,514
Summary of Investments, Other than Investments in Related Parties, Fair Value	239,381
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	239,381
Foreign Government Debt
Summary of Investments, Other than Investments in Related Parties, Cost	34,863
Summary of Investments, Other than Investments in Related Parties, Fair Value	34,700
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	34,700
Public Utility, Bonds
Summary of Investments, Other than Investments in Related Parties, Cost	42,977
Summary of Investments, Other than Investments in Related Parties, Fair Value	42,380
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	42,380
All Other Corporate Bonds
Summary of Investments, Other than Investments in Related Parties, Cost	227,233
Summary of Investments, Other than Investments in Related Parties, Fair Value	225,603
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	225,603
Mandatorily Redeemable Preferred Stock
Summary of Investments, Other than Investments in Related Parties, Cost	4,036
Summary of Investments, Other than Investments in Related Parties, Fair Value	4,199
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	4,199
Fixed Maturities
Summary of Investments, Other than Investments in Related Parties, Cost	585,160
Summary of Investments, Other than Investments in Related Parties, Fair Value	583,880
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	583,880
Public Utility, Equities
Summary of Investments, Other than Investments in Related Parties, Cost	868
Summary of Investments, Other than Investments in Related Parties, Fair Value	861
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	861
Banks, Trust and Insurance, Equities
Summary of Investments, Other than Investments in Related Parties, Cost	752
Summary of Investments, Other than Investments in Related Parties, Fair Value	764
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	764
Industrial, Miscellaneous, and All Others
Summary of Investments, Other than Investments in Related Parties, Cost	18,172
Summary of Investments, Other than Investments in Related Parties, Fair Value	19,227
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	19,227
Nonredeemable Preferred Stock
Summary of Investments, Other than Investments in Related Parties, Cost	4,004
Summary of Investments, Other than Investments in Related Parties, Fair Value	4,138
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	4,138
Equity Securities, Investment Summary
Summary of Investments, Other than Investments in Related Parties, Cost	23,796
Summary of Investments, Other than Investments in Related Parties, Fair Value	24,990
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	24,990
Policy Loans
Summary of Investments, Other than Investments in Related Parties, Cost	10,667
Summary of Investments, Other than Investments in Related Parties, Fair Value	10,667
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	10,667
Short-term Investments
Summary of Investments, Other than Investments in Related Parties, Cost	16,840
Summary of Investments, Other than Investments in Related Parties, Fair Value	16,840
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	16,840
Other Long-term Investments
Summary of Investments, Other than Investments in Related Parties, Cost	14,584
Summary of Investments, Other than Investments in Related Parties, Fair Value	14,584
Summary of Investments, Other than Investments in Related Parties, Carrying Amount	$14,584

Condensed_Financial_Informatio4

Condensed Financial Information of Parent Company Only Disclosure: Condensed Balance Sheet (Parent Company Only) (Details) (USD $)	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Cash and cash equivalents	$25,083		$24,229		$23,945	$18,227
Fixed maturities, available-for-sale	583,880		542,287
Trading securities	11,095		7,125
Other investments	25,251		25,123
Deferred Tax Assets, Net	5,467		15,906
Goodwill	50,318		50,318
Other assets	57,126		78,712
TOTAL ASSETS	1,187,717		1,269,035
Accounts payable, accruals and other liabilities	67,641		71,889
Junior subordinated debt securities	38,146		38,146
TOTAL LIABILITIES	886,615		990,729
Preferred stock		[1]		[1]
Common Stock	18,531	[2],[3]	18,524	[2],[4]
Paid-in capital	127,098		126,239
Accumulated other comprehensive income (loss)	22		-10,472		15,013	7,853
Treasury stock, at cost	-12,141	[5]	-8,169	[6]
Retained earnings	157,667		142,669
TOTAL IHC STOCKHOLDERS' EQUITY	291,177		268,791
NONCONTROLLING INTERESTS IN SUBSIDIARIES	9,925		9,515
TOTAL EQUITY	301,102		278,306		302,847	276,144
TOTAL LIABILITIES AND EQUITY	1,187,717		1,269,035
Parent Company
Cash and cash equivalents	389		61		589	3,098
Fixed maturities, available-for-sale	9,647		2,406
Trading securities	1,916		944
Other investments	1,146		1,146
Equity Method Investments	387,270		356,378
Deferred Tax Assets, Net	11,414		13,347
Goodwill	228		228
Other assets	97		69
TOTAL ASSETS	412,107		374,579
Accounts payable, accruals and other liabilities	7,140		6,403
Due to Affiliate	57,220		45,000
Accrued Income Taxes	7,871		6,096
Junior subordinated debt securities	38,146		38,146
Dividends Payable	628		628
TOTAL LIABILITIES	111,005		96,273
Common Stock	18,531		18,524
Paid-in capital	127,098		126,239
Accumulated other comprehensive income (loss)	22		-10,472
Treasury stock, at cost	-12,141		-8,169
Retained earnings	157,667		142,669
TOTAL IHC STOCKHOLDERS' EQUITY	291,177		268,791
NONCONTROLLING INTERESTS IN SUBSIDIARIES	9,925		9,515
TOTAL EQUITY	301,102		278,306
TOTAL LIABILITIES AND EQUITY	$412,107		$374,579
[1]	None issued.
[2]	$1.00 par value.
[3]	23,000,000 shares authorized, 18,531,158 shares issued and 17,371,040 shares outstanding.
[4]	23,000,000 shares authorized, 18,523,733 shares issued and 17,660,390 shares outstanding.
[5]	1,160,118 treasury shares
[6]	863,343 treasury shares

Condensed_Financial_Informatio5

Condensed Financial Information of Parent Company Only Disclosure (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Common Stock, par value	$1	$1
Common Stock, shares authorized	23,000,000	23,000,000	23,000,000	20,000,000
Common Stock, shares issued	18,531,158	18,523,733
Common Stock, shares outstanding	17,371,040	17,660,390
Treasury Stock, shares	1,160,118	863,343
Parent Company
Common Stock, par value	$1	$1
Common Stock, shares authorized	23,000,000	23,000,000
Common Stock, shares issued	18,531,158	18,523,733
Common Stock, shares outstanding	17,371,040	17,660,390
Treasury Stock, shares	1,160,118	863,343

Condensed_Financial_Informatio6

Condensed Financial Information of Parent Company Only Disclosure: Condensed Income Statement (Parent Company Only) (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Net investment income									$21,692	$27,471	$33,356
Net realized investment gains									7,688	19,750	5,099
Other income									4,859	4,878	4,953
TOTAL REVENUES	127,090	129,752	136,019	141,072	143,618	141,644	151,900	137,882	533,933	575,044	428,061
Interest expense on debt									1,797	1,915	2,091
TOTAL EXPENSES									510,621	551,390	403,447
Income taxes (benefits)									6,391	8,398	2,003
Equity income from equity method investments									1,106	2,506	1,435
Net income (loss)	4,212	4,824	3,880	4,005	2,142	3,916	4,158	5,040	16,921	15,256	22,611
(Income) loss from noncontrolling interests in subsidiaries	-178	-114	-32	-304	-394	-277	-467	-339	-628	-1,477	-2,950
Parent Company
Net investment income									112	61	491
Net realized investment gains									-78	349	2
Other income									2,129	2,327	2,251
TOTAL REVENUES									2,163	2,737	2,744
Interest expense on debt									1,546	1,563	1,638
General and Administrative Expense									5,606	4,301	5,125
TOTAL EXPENSES									7,152	5,864	6,763
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest									-4,989	-3,127	-4,019
Income taxes (benefits)									-2,389	-1,228	-1,528
Equity income from equity method investments									19,521	17,155	25,102
Net income (loss)									16,921	15,256	22,611
(Income) loss from noncontrolling interests in subsidiaries									-628	-1,477	-2,950
NET INCOME (LOSS) ATTRIBUTABLE TO IHC									$16,293	$13,779	$19,661

Condensed_Financial_Informatio7

Condensed Financial Information of Parent Company Only Disclosure: Condensed Cash Flow Statement (Parent Company Only) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Net income (loss)	$16,921	$15,256	$22,611
Equity income from equity method investments	-1,106	-2,506	-1,435
Other adjustments to reconcile net income	8,629	4,573	7,010
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	27,331	-162,316	-115,394
Purchases of fixed maturities	-421,285	-462,823	-412,753
Sales of fixed maturities	353,143	551,756	483,092
Net Cash Provided by (Used in) Investing Activities, Continuing Operations	-15,853	181,689	122,867
Payments for repurchases of common stock	-3,972	-3,636	-1,244
Cash paid in acquisitions of noncontrolling interests		-8,825	-58
Dividends paid	-1,233	-620	-1,681
Proceeds from exercise of stock options		430
Other financing activities	-431	-1,176	-92
Net Cash Provided by (Used in) Financing Activities, Continuing Operations	-10,624	-19,089	-1,755
Net change in cash and cash equivalents	854	284	5,718
Cash and cash equivalents, beginning of period	24,229	23,945	18,227
Cash and cash equivalents, end of period	25,083	24,229	23,945
Parent Company
Net income (loss)	16,921	15,256	22,611
Equity income from equity method investments	-19,521	-17,155	-25,102
Other adjustments to reconcile net income	3,748	4,398	604
Increase (Decrease) in Other Operating Assets and Liabilities, Net	440	-1,609	-439
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	1,588	890	-2,326
Change In Investments In and Advances To Subsidiaries	11,138	6,708	5,109
Purchases of fixed maturities	-9,953		-11,781
Sales of fixed maturities	2,751	3,260	6,109
Payments for (Proceeds from) Limited Partnership			3,152
Net Cash Provided by (Used in) Investing Activities, Continuing Operations	3,936	9,968	2,589
Payments for repurchases of common stock	-3,972	-3,636	-941
Cash paid in acquisitions of noncontrolling interests		-7,626	-58
Dividends paid	-1,233	-620	-1,681
Proceeds from exercise of stock options		430
Other financing activities	9	66	-92
Net Cash Provided by (Used in) Financing Activities, Continuing Operations	-5,196	-11,386	-2,772
Net change in cash and cash equivalents	328	-528	-2,509
Cash and cash equivalents, beginning of period	61	589	3,098
Cash and cash equivalents, end of period	$389	$61	$589

Supplementary_Insurance_Inform2

Supplementary Insurance Information, for Insurance Companies Disclosure: Supplementary Insurance Information for Insurance Companies Disclosure Table Text Block (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Supplementary Insurance Information, Deferred Policy Acquisition Costs	$30,806	$29,777	$33,401
Supplementary Insurance Information, Liability for Future Policy Benefits, Losses, Claims and Loss Expense Reserves	700,626	800,029	762,802
Supplementary Insurance Information, Unearned Premiums	9,455	12,423	8,453
Supplementary Insurance Information, Premium Revenue	479,048	495,991	356,067
Supplementary Insurance Information, Net Investment Income	21,692	27,471	33,356
Supplementary Insurance Information, Benefits, Claims, Losses and Settlement Expense	326,035	354,790	244,791
Supplementary Insurance Information, Amortization of Deferred Policy Acquisition Costs	4,941	15,132	6,566
Supplementary Insurance Information, Other Operating Expense	177,848	179,553	149,999
Supplementary Insurance Information, Premiums Written	476,311	500,908	359,617
Medical Stop-Loss Segment Member
Supplementary Insurance Information, Liability for Future Policy Benefits, Losses, Claims and Loss Expense Reserves	80,128	72,307	59,029
Supplementary Insurance Information, Premium Revenue	176,941	166,302	139,724
Supplementary Insurance Information, Net Investment Income	4,327	5,055	4,990
Supplementary Insurance Information, Benefits, Claims, Losses and Settlement Expense	122,469	115,599	90,406
Supplementary Insurance Information, Other Operating Expense	40,373	43,687	40,154
Supplementary Insurance Information, Premiums Written	176,941	166,302	139,724
Fully Insured Segment Member
Supplementary Insurance Information, Deferred Policy Acquisition Costs	624	361	48
Supplementary Insurance Information, Liability for Future Policy Benefits, Losses, Claims and Loss Expense Reserves	50,767	57,323	41,034
Supplementary Insurance Information, Unearned Premiums	6,568	9,828	6,897
Supplementary Insurance Information, Premium Revenue	218,949	248,870	141,546
Supplementary Insurance Information, Net Investment Income	2,202	2,711	1,733
Supplementary Insurance Information, Benefits, Claims, Losses and Settlement Expense	146,431	177,290	94,700
Supplementary Insurance Information, Amortization of Deferred Policy Acquisition Costs	482	22	17
Supplementary Insurance Information, Other Operating Expense	94,175	99,961	72,415
Supplementary Insurance Information, Premiums Written	215,844	253,569	145,202
Group disability, life annuities and DBL Segment Member
Supplementary Insurance Information, Liability for Future Policy Benefits, Losses, Claims and Loss Expense Reserves	147,823	147,426	126,840
Supplementary Insurance Information, Unearned Premiums	2,700	2,398	1,347
Supplementary Insurance Information, Premium Revenue	64,260	60,004	49,315
Supplementary Insurance Information, Net Investment Income	3,156	2,763	2,618
Supplementary Insurance Information, Benefits, Claims, Losses and Settlement Expense	37,537	37,463	27,663
Supplementary Insurance Information, Other Operating Expense	17,936	17,045	15,779
Supplementary Insurance Information, Premiums Written	64,632	60,227	49,212
Individual life annuities and other Segment Member
Supplementary Insurance Information, Deferred Policy Acquisition Costs	30,182	29,416	33,353
Supplementary Insurance Information, Liability for Future Policy Benefits, Losses, Claims and Loss Expense Reserves	421,908	522,973	535,899
Supplementary Insurance Information, Unearned Premiums	187	197	209
Supplementary Insurance Information, Premium Revenue	18,898	20,815	25,482
Supplementary Insurance Information, Net Investment Income	11,830	16,837	23,475
Supplementary Insurance Information, Benefits, Claims, Losses and Settlement Expense	19,598	24,438	32,022
Supplementary Insurance Information, Amortization of Deferred Policy Acquisition Costs	4,459	15,110	6,549
Supplementary Insurance Information, Other Operating Expense	17,112	12,814	13,731
Supplementary Insurance Information, Premiums Written	18,894	20,810	25,479
Corporate
Supplementary Insurance Information, Net Investment Income	177	105	540
Supplementary Insurance Information, Other Operating Expense	$8,252	$6,046	$7,920

Supplemental_Schedule_of_Reins2

Supplemental Schedule of Reinsurance Premiums for Insurance Companies: Supplemental Schedule of Reinsurance Premiums for Insurance Companies Disclosure Table Text Block (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Life Insurance in Force, Gross	$11,054,484	$11,415,328	$11,293,128
Life Insurance in Force, Assumed	418,775	333,200	213,041
Life Insurance in Force, Ceded	6,128,608	6,493,122	6,004,459
Life Insurance in Force, Net	5,344,651	5,255,406	5,501,710
Life Insurance in Force, Percentage Assumed to Net	7.80%	6.30%	3.90%
Direct Premiums Earned	557,395	526,597	447,866
Assumed Premiums Earned	58,191	92,281	67,770
Ceded Premiums Earned	136,538	122,887	159,569
Premiums earned	479,048	495,991	356,067
Premiums, Percentage Assumed to Net	12.10%	18.60%	19.00%
Accident and Health Insurance Product Line
Direct Premiums Earned	482,511	461,336	396,805
Assumed Premiums Earned	52,063	85,627	60,232
Ceded Premiums Earned	116,163	102,053	140,653
Premiums earned	418,411	444,910	316,384
Premiums, Percentage Assumed to Net	12.40%	19.20%	19.00%
Life and Annuity Insurance Product Line
Direct Premiums Earned	44,407	46,416	47,790
Assumed Premiums Earned	6,128	6,654	7,538
Ceded Premiums Earned	20,214	20,820	18,916
Premiums earned	30,321	32,250	36,412
Premiums, Percentage Assumed to Net	20.20%	20.60%	20.70%
Property, Liability and Casualty Insurance Product Line
Direct Premiums Earned	30,477	18,845	3,271
Ceded Premiums Earned	161	14
Premiums earned	$30,316	$18,831	$3,271
Premiums, Percentage Assumed to Net	0.00%	0.00%	0.00%